University of South Florida

Digital Commons @ University of South Florida
Graduate Theses and Dissertations

Graduate School

6-27-2012

The Role and Regulation of NsaRS: a Cell-Envelope Stress
Sensing Two-Component System in Staphylococcus aureus
Stacey Lynn Kolar
University of South Florida, skolar@mail.usf.edu

Follow this and additional works at: https://digitalcommons.usf.edu/etd
Part of the American Studies Commons, and the Microbiology Commons

Scholar Commons Citation
Kolar, Stacey Lynn, "The Role and Regulation of NsaRS: a Cell-Envelope Stress Sensing Two-Component
System in Staphylococcus aureus" (2012). Graduate Theses and Dissertations.
https://digitalcommons.usf.edu/etd/4104

This Dissertation is brought to you for free and open access by the Graduate School at Digital Commons @
University of South Florida. It has been accepted for inclusion in Graduate Theses and Dissertations by an
authorized administrator of Digital Commons @ University of South Florida. For more information, please contact
scholarcommons@usf.edu.

The Role and Regulation of NsaRS: a Cell-Envelope Stress Sensing TwoComponent System in Staphylococcus aureus

by

Stacey L. Kolar

A dissertation submitted in partial fulfillment
of the requirements for the degree of
Doctor of Philosophy
Department of Cell Biology, Microbiology & Molecular Biology
College of Arts and Sciences
University of South Florida

Major Professor: Lindsey Shaw, Ph.D
Stanley Stevens, Ph.D
James Riordan, Ph.D
My-Lien Dao, Ph.D

Date of Approval:
June 27, 2012

Keywords: ABC transporter, Antibiotic Resistance, Regulator, Protease, Pathogenesis
Copyright© 2012, Stacey L. Kolar

Acknowledgments
I would like to thank all members of the Shaw lab for their support and help with these
projects. I would especially like to thank Halie Miller and Frances Rivera for taking the
time outside of lab to help me through this process. Dr. Shaw was a integral part of the
completion of this dissertation and his guidance and advice is the main reason I am able
to graduate. I would also like to thank Dr. Stevens for all his hard work and assistance on
the protein and mass spectrometry projects. Finally, I would like to thank Dr. Riordan for
always being an uplifting and strong motivator.

Table of Contents
Table of Tables ................................................................................................................. iv
Table of Figures ...................................................................................................................v
Abstract

.................................................................................................................. viii

Chapter 1: Introduction ........................................................................................................1
The Staphylococci ....................................................................................................1
Staphylococcus aureus .............................................................................................2
The diseases of S. aureus .............................................................................3
Virulence factors of S. aureus ......................................................................5
The regulation of virulence factors in S. aureus ..........................................9
Antibiotic resistance of S. aureus ..............................................................14
Hosptial-acquired and community-acquired S. aureus ..............................16
Two-component systems .......................................................................................19
Structure and function of histidine protein kinases....................................23
Structure and function of response regulators ...........................................23
The occurrence of two-component systems in prokaryotes .......................26
Intramembrane-sensing histidine kinases ..................................................27
Subgroups of intramembrane-sensing histidine kinases ............................27
Two-component systems of S. aureus ...................................................................30
The SaeRS two-component system of S. aureus .......................................33
The VraRS system of S. aureus .................................................................33
The GraRS two-component system of S. aureus .......................................34
Project aim .............................................................................................................36
Chapter 2: The role and regulation of NsaRS: a cell-envelope stress-sensing twocomponent system of S. aureus .......................................................................38
Introduction ............................................................................................................38
Results ....................................................................................................................42
Chapter 3: The role and regulation of the ABC transporter, SACOL2525/2526 of
S. aureus...........................................................................................................43
Introduction ............................................................................................................43
Materials and methods ...........................................................................................46
Bacterial strains, plasmids and growth conditions .....................................46
Construction of the SACOL2525/2526 mutant strain ...............................46
Construction of the SACOL2525/2526 reporter fusion strain ...................48
Construction of SACOL2525/2526 complemented strain .........................48
i

Plate-based assay for determination of altered transcription from
external stress .............................................................................................49
Real-time PCR ...........................................................................................50
Microtitre MIC Assay for cell-wall targeting drugs ..................................50
Survival in the free unsaturated fatty acid, oleic acid ................................50
Survival in toluene .....................................................................................51
Negative staining electron microscopy ......................................................51
Hydrophobicity assay using hexadecane ...................................................51
Cytochrome C binding assay .....................................................................51
Peptidoglycan lysis kinetics assay .............................................................52
Survival in daptomycin ..............................................................................52
Lysostaphin treatment for removal of the cell envelope ............................52
Spontaneous mutation frequency ...............................................................52
Results ....................................................................................................................54
In silico analysis of SACOL2525/2526 .....................................................54
Transcriptional profiling of the SACOL2525/2526 ABC
transporter ..................................................................................................56
NsaRS, but not GraRS, regulates transcription of
SACOL2525/2526 in response to a variety of cell-envelopetargeting compounds ..................................................................................63
SACOL2525/2526 aids in resistance to daptomycin .................................65
SACOL2525/2526 aids in the ability of S. aureus to spontaneously
resist the action of a variety of cell-envelope targeting antibiotics ...........74
SACOL2525/2526 is part of the S. aureus resistance mechanism
against toxic non-antibiotic chemicals that target the cell
membrane ...................................................................................................76
SACOL2525/2526 mutants of S. aureus have altered cell envelope
architecture .................................................................................................80
SACOL2525/2526 contributes to protection against lysostaphin ..............87
Discussion ..............................................................................................................89
Chapter 4: The role of secreted proteases in Community Acquired-Methicillin
Resistant Staphylococcus aureus infections ..................................................103
Introduction ..........................................................................................................103
Manuscript introduction .......................................................................................109
Materials and methods .........................................................................................113
Ethics Statement.......................................................................................113
Bacterial strains, plasmids and growth conditions ...................................113
Real-time PCR .........................................................................................114
Whole human blood survival assay .........................................................114
Antimicrobial peptide sensitivity assay ...................................................114
Murine model of wound formation ..........................................................115
Murine model of sepsis and dissemination ..............................................116
Proteomic analysis of surface and secreted proteins................................116
Results ..................................................................................................................119
Verification of extracellular protease depletion in the LACii

protease null strain ...................................................................................119
The protease-null strain has fitness defects during growth in
peptide based media and pig serum .........................................................121
Secreted proteases play a role in resistance to antimicrobial
peptides ....................................................................................................124
Extracellular proteases are required for survival during interaction
with the innate immune system................................................................126
Secreted proteases contribute to CA-MRSA wound formation ...............126
Extracellular proteases play a key role during systemic CA-MRSA
infections ..................................................................................................128
Secreted proteases are primary effectors of virulence determinant
stability.....................................................................................................131
Discussion ............................................................................................................143
Acknowledgments................................................................................................150
Chapter 5: Final discussion ..............................................................................................151
Discussion ............................................................................................................151
References cited ...............................................................................................................169
Appendix 1

..................................................................................................................203

iii

Table of Tables
Table 1: S. aureus possesses 16 two-components systems ................................................31
Table 2: Strains, plasmids and primers used in this study .................................................47
Table 3: Stressor compounds used in the plate-based assay to determine the
inducibility of SACOL2525/2526 expression .....................................................60
Table 4: Cell-envelope-targeting antibiotics utilized to determine the transcription
of SACOL2525/2526 under cell-envelope stress ...............................................62
Table 5: Collective alterations in protein abundance for secreted proteins upon
deletion of extracellular proteases in S. aureus USA 300 ................................133
Table 6: Individual fraction analysis of alterations in protein stability
for secreted proteins upon deletion of extracellular proteases in S. aureus
USA 300.............................................................................................................135
Table 7: Collective alterations in protein abundance for surface proteins upon
deletion of extracellular proteases in S. aureus USA 300 .................................137
Table 8: Individual fraction analysis of alterations in protein stability for surface
proteins upon deletion of extracellular proteases in S. aureus USA 300...........138

iv

Table of Figures
Figure 1: The regulation of virulence factors in a growth phase dependent manner .........11
Figure 2: A functional Schematic of Two-Component Systems .......................................20
Figure 3: The phosphotransfer reactions of two-component systems ...............................22
Figure 4: The architectural features of histidine kinases ...................................................24
Figure 5: The architectural features of response regulators ...............................................25
Figure 6: Predicted topology plot of the IM-HK, SACOL2645 from S. aureus ...............28
Figure 7: The NsaRS/NsaAB locus from Staphylococcus aureus .....................................40
Figure 8: Amino acid sequence alignment of SACOL2525 ..............................................55
Figure 9: The SACOL2525/2526 operon ..........................................................................57
Figure 10: Transcription of SACOL2525/2526 during growth in standard
conditions .........................................................................................................58
Figure 11: Inducibility of SACOL2525/2526 by antibacterial agents ...............................64
Figure 12: The impact of GraRS and NsaRS on the transcription of
SACOL2525/2526 ...........................................................................................66
Figure 13: SACOL2525/2526 do not present enhanced sensitivity to a number of
cell-wall targeting chemicals ...........................................................................68
Figure 14: SACOL2525/2526 aids in the resistance of S. aureus to daptomycin .............69
Figure 15: Lysostaphin treatment does not lead to increase death in the
SACOL2525/2526 mutant ...............................................................................70
Figure 16: SACOL2525/2526 mutants have a weakened cell membrane .........................71
Figure 17: SACOL2525/2526 mutant protoplasts have elevated sensitivity to
daptomycin .......................................................................................................73
v

Figure 18: SACOL2525/2526 aids in the ability to spontaneously resist the action
of a variety of cell-envelope-targeting antibiotics ............................................75
Figure 19: SACOL2525/2526 mutation protects the cell in the presence of free
unsaturated fatty acids......................................................................................78
Figure 20: Transcription of SACOL2525/2526 in the presence of oleic acid ...................79
Figure 21: SACOL2525/2526 contributes to resistance against solvent stress .................81
Figure 22: SACOL2525/2526 mutants have increased capsule production ......................82
Figure 23: SACOL2525/2526 mutant cells have altered hydrophobicity .........................84
Figure 24: SACOL2525/2526 deletion does not effect cell surface charge ......................86
Figure 25: SACOL2525/2526 mutants have decreased sensitivity to the cell wall
targeting agent lysostaphin ..............................................................................88
Figure 26: Schematic representation of peptidoglycan synthesis of S. aureus ..................91
Figure 27: The extracellular proteases of S. aureus and their regulation ........................105
Figure 28: Activation cascade of S. aureus secreted proteases .......................................106
Figure 29: Gelatin zymography of the LAC wild-type and its protease-null mutant ......120
Figure 30: Exoprotease deletion does not lead to observable difference in agr or
hla transcript levels ........................................................................................122
Figure 31: Secreted proteases aid in survival during growth in peptide based
media and pig serum ......................................................................................123
Figure 32: Secreted proteases play a role in the resistance of S. aureus to
antimicrobial peptides ....................................................................................125
Figure 33: Secreted proteases are protective during interaction with the human
innate immune system....................................................................................127
Figure 34: Secreted proteases contribute to CA-MRSA abscess formation ....................129
Figure 35: Secreted proteases have contrasting roles in the morbidity and
mortality of systemic CA-MRSA infections..................................................130
Figure 36: Extracellular proteases modulate the stability of a wealth of known
secreted virulence factors ...............................................................................137
vi

Figure 37: Extracellular proteases modulate the stability of a number of surfaceassociated virulence factors ...........................................................................141
Figure 38: Transcription of nsaRS, nsaAB and SACOL2525/2526 in response to
cell-envelope-targeting drugs.........................................................................153
Figure 39: NsaRS regulates NsaAB and SACOL2525/2526 in response to
different cell envelope stress ...........................................................................156

vii

Abstract

S. aureus has 16 predicted two-component systems (TCS) that respond to a range of
environmental stimuli, and allow for adaptation to stresses. Of these 16, three have no
known function, and are not homologous to any other TCS found in closely related
organisms. NsaRS is one such element, and belongs to the intramembrane-sensing
histidine kinase (IM-HK) family, which is conserved within the Firmicutes. The
regulators are defined by a small sensing domain within their histidine kinase, suggesting
that they do not sense external signals, but stress in or at the membrane. Our
characterization of NsaRS in this work reveals that, as with other IM-HK TCS, it
responds to cell-envelope damaging antibiotics, including phosphomycin, ampicillin,
nisin, gramicidin, CCCP and penicillin G. Additionally; we reveal that NsaRS regulates a
downstream transporter, NsaAB, during nisin-induced stress. Phenotypically, nsaS
mutants display a 200-fold decreased ability to develop resistance to another cell-wall
targeting antibiotic, bacitracin. Microarray analysis reveals the transcription of 245 genes
is altered in a nsaS mutant, with the vast majority down-regulated. Included within this
list are genes involved in transport, drug-resistance, cell-envelope synthesis,
transcriptional regulation, amino acid metabolism and virulence. Using ICP-MS, a
decrease in intracellular divalent metal ions was observed in an nsaS mutant, when grown
under low abundance conditions. Characterization of cells using electron microscopy
reveals that nsaS mutants also have alterations in cell-envelope structure. Finally, a
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variety of virulence related phenotypes are impaired in nsaS mutants, including biofilm
formation, resistance to killing by human macrophages and survival in whole human
blood. Thus NsaRS is important in sensing cell wall damage in S. aureus, and functions
to reprogram gene expression to modify cell-envelope architecture, facilitating adaptation
and survival. Interestingly, in our microarray analysis, we observed a more than 30-fold
decrease in transcription of an ABC transporter, SACOL2525/2526, in the nsaS mutant.
This transporter bears strong homology to nsaAB, and is currently uncharacterized.
Exploration of the role of SACOL2525/2526 revealed that, along with NsaRS, it too
responds to cell-envelope damaging antibiotics. Specifically, its expression was induced
by phosphomycin, daptomycin, penicillin G, ampicillin, oxacillin, D-cycloserine and
CCCP. Mutation of this transporter results in increased sensitivity to the antibacterial
agent daptomycin, and decreased sensitivity to free fatty acids. These findings are
perhaps explained by altered membrane fluidity in the mutant strain, as the transporter
null-strain is more readily killed in the presence of organic solvents, such as toluene. In
addition, SACOL2525/2526 mutants have a decreased ability to form spontaneous
mutants in response to several other peptidoglycan synthesis targeting antibiotics,
suggesting a role for SACOL2525/2526 in antibiotic resistance. Inactivation of this
transporter alters the cell envelope, and produces similar effects to those observed with
the nsaS mutant, with increased capsule production, that may provide resistance to
lysostaphin. Interestingly, the nsaS microarray revealed that this TCS negatively
regulates only 34 genes, including 6 out of the 10 major secreted proteases. Despite a
number of reports in the literature describing these enzymes as virulence factors, the data
is often conflicting. Therefore, the contribution of proteases to CA-MRSA pathogenesis
ix

was investigated, by constructing a strain lacking all 10 extracellular protease genes.
Analysis of this strain using murine models of infection reveals secreted proteases
significantly impact virulence in both localized and systemic infections. Additionally,
inactivation of these enzymes strongly influences survival in whole human blood, and
increases sensitivity to antimicrobial peptides. Using a proteomics approach, we
demonstrate that the contribution of secreted proteases to pathogenicity is related to
differential processing of a large number of surface-associated virulence factors and
secreted toxins. Collectively these findings provide a unique insight into the role of
secreted proteases in CA-MRSA infections.

x

Chapter 1: Introduction

Introduction
The Staphylococci. Within the Firmicute phylum and the Staphylococcaceae family is
the genus Staphyloccoci. Staphylococci are spherical cells about 1 micrometer in
diameter and divide successively in more than one plane, as opposed to their closely
related relatives, the streptococci, which form chains. In Greek, staphyle means “bunch of
grapes”, corresponding to the clustered appearance of the bacteria when viewed under a
microscope. They are categorized as Gram-positive bacteria, and have a thick layer of
peptidoglycan surrounding a single lipid bilayer membrane (Kloos et al., 1991). The
staphylococcal cell wall is distinct due to its high glycine content, which makes them
susceptible to cell wall degradation by lysostaphin (Grundling & Schneewind, 2006).
This genus is comprised of non-spore forming, non-motile, facultative anaerobes that are
catalase-positive and oxidase-negative. They can generate energy through respiration or
fermentation (Woese, 1987). Thus far, there have been 36 species and 18 subspecies
identified within the Staphylococci genus (Cheung et al., 2006). The Staphylococci are
found everywhere in nature, including soil and water, and are able to remain on inanimate
objects for long periods of time. Commonly Staphylococci also inhabit the skin and
mucus membranes of mammals (Noble & Pitcher, 1978). The majority of this genus is
coagulase-negative, including S. epidermidis and S. hominis. However, one characteristic
1

that is used to distinguish S. aureus from other Staphylococci in the laboratory is that
they are coagulase-positive. In addition, most are staphylococci are non-pathogenic,
further distinguishing S. aureus from its relatives (Klevens et al., 2007).
Staphylococcus aureus. S. aureus isolates contain a circular chromosome composed of
approximately 2.8 million base pairs, although one or more plasmids may also be
included. The chromosome contains about 2700 coding sequences, as well as regulatory
RNAs. Many genes have assigned functions through homology with closely related
organisms, although only a small portion have been characterized. The genome consists
of coding sequences (CDs) involved in cell division and replication (0.5%), chaperones
(0.3%), adaptation and protection responses (1.7%), transport proteins (9.2%),
macromolecule degradation (1.5%), macromolecule biosynthesis (4.7%), cofactor and
carriers biosynthesis (0.6%), central and intermediary metabolism (2.2%), small
molecules degradation (3.2%), energy metabolism (1.4%), fatty acid synthesis (0.6%),
nucleotide biosynthesis (0.9%), cell envelope metabolism (20.3%), ribosome components
(2.4%), mobile genetic elements (7.2%), regulators (4.7%), toxins (0.8%) and
pseudogenes (2.6%). In addition, approximately 38% of the entire genome has no known
function, and a further 10% has only a tentative function (Suzuki et al., 2012).
The meaning of aureus is golden, which refers to the large colored colonies produced by
S. aureus on rich media; resulting from the carotenoid pigment staphyloxanthin (Marshall
& Wilmoth, 1981). S. aureus is found everywhere in nature, forms part of the normal
skin flora of warm blooded animals and resides in the anterior nares of one in three
people (Schechter-Perkins et al., 2011). S. aureus is able to survive on the skin or in the
2

nose asymptomatically, but can gain access to breaches in the skin that may lead to
disease (Foster, 2009). S. aureus is commonly transmitted through skin to skin contact
with a colonized or infected person. Places that are more crowded, such as military
camps, sports teams or dormitories increase the risk of dissemination (Ben-David et al.,
2008). This high human prevalence and ease of transmission largely accounts for why S.
aureus is the most common cause of infection within the Staphylococci (Lowy, 1998).
The diseases of S. aureus. S. aureus is the most common cause of infection by a single
agent in the United States (Kobayashi & DeLeo, 2009; Lowy, 1998). People with
diabetes, AIDS, indwelling intravenous catheters, intravenous drug users, surgical and
cancer patients have the highest risk of contracting S. aureus infections; however as an
opportunistic pathogen, all population groups are at risk (Frank, 1997, Zimakoff et al.,
1996). Disease normally starts as a localized infection via breaches of the skin, which can
result in abscesses or furuncles. These are commonly known as boils and are the most
common presentation of S. aureus skin infections (Ruhe et al., 2007; Frazee et al., 2005;
Miller et al., 2007). Such conditions can subsequently proceed to more serious and deepseated diseases of the hair follicles, known as carbuncles. In addition, S. aureus can also
cause cellulitis, hydradenitis, suppurtiva, impetigo, mastitis, pyodermas and pyomyositis
(Stack & Sanchez, 2007; Koning et al., 2003). Many of these infections appear red,
swollen and painful with liquid or pus exudates. Some may be resolved with antibiotic
therapy, but the majority are treated by surgical drainage. Ultimately, S. aureus is
believed to cause greater than 50% of all skin infections in the United States
(Abrahamian & Moran, 2007; Talan et al., 2011).
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From these localized sites of infection, S. aureus can then enter the bloodstream causing
bacteremia. Bacteremia is associated with high mortality and cost, which places a large
burden on healthcare systems (Shorr & Lodise, 2006; Steinberg et al., 1996). Percent
mortality from S. aureus bacteremia ranges from 15% to as high as 80% without
treatment (Mortara & Bayer, 1993; Selvey et al., 2000; Shorr,, 2006, Naber, 2009). Once
S. aureus gains access to the bloodstream it can then disseminate to other organs and
cause systemic infection. For example, S. aureus can cause osteomyelitis, which is an
infection of bone or bone marrow (Lew & Waldvogel, 2004). Acute osteomyelitis is
often seen in children, where it infects the long bones of the lower extremities
(Waldvogel & Vasey, 1980; Carek et al., 2001). In adults, osteomyelitis is more
commonly seen in vertebral bodies (Carek et al., 2001). S. aureus is also able to colonize
the lungs, causing pneumonia, which is mostly seen in patients that have recently had
surgery, have chronic lung disease, are older or are immunocompromised (Kollef et al.,
2005). In one study, the mortality rate of patients with pneumonia caused by S. aureus
was at least 31% (Jeffres et al., 2006). Antibiotic therapy is used to treat S. aureus
pneumonia, but must be aggressive, and may necessitate the use of harsh drugs, such as
vancomycin, for several weeks (Micek et al., 2004).
Surgical site infections are a major health concern since they are associated with high
morbidity and health care costs. S. aureus is the most common cause of surgical site
infections among patients in the ICU (Solomkin, 2001; Grimble et al., 2001). A major
reason for this is the presence of S. aureus on the skin and mucus membranes of patients
and operating room staff (Drinka et al., 2001).
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In addition to these infections, which are caused by live, viable S. aureus, toxinoses, such
as food poisoning, scalded skin syndrome and toxic shock syndrome are caused by toxins
that are secreted by this organism. Food poisoning results from ingesting one of several
staphylococcal enterotoxins (Holmberg & Blake, 1984), with symptoms usually
including nausea, vomiting, headache and diarrhea. The average time of symptom onset
after ingesting an enterotoxin is 4.4 hours (LeLoir et al., 2003), and the condition is
typically self limiting, and does not require antibiotics or hospitalization. Toxic shock
syndrome results from toxic shock syndrome toxin 1 (TSST-1), and can lead to
symptoms such as fever, hypotension, rash and hyperemia of the mucus membranes.
TSST-1 is a superantigen that elicits the production of multiple cytokines, resulting in a
rapid progression of infection that can cause life threatening complications. This
syndrome has been associated with high absorbent tampons (Fekety, 1964), and treatment
is usually the removal of any material connected to disease, alongside antibiotic therapy.
Virulence factors of S. aureus. S. aureus is a successful pathogen, causing a wide
variety of diseases, in part because of the plethora of virulence factors it produces.
Virulence factors are molecules expressed by the pathogen that allow it to survive within
the host, evade the immune system, invade and colonize, or obtain nutrients (Casadevall
& Pirofski,2009). The virulence process has multiple steps including: adhesion to the
surface of host components, escape from the host immune system, and dissemination and
tissue invasion (Ferry et al., 2005; Cheng et al., 2011). The ability of S. aureus to adhere
to extracellular matrix proteins is thought to be essential for colonization and the
establishment of infections (Patti et al., 1994; Pohlmann-Dietze et al., 2000). Microbial
surface components recognizing adhesive matrix molecules (MSCRAMMS) are anchored
5

to the peptidoglycan layer of cells, and protrude outwards. These are used to attach to
various host extracellular matrices including collagen, fibronectin and vitronectin (Foster
& Hook, 1998). Fibronectin binding proteins, FnbA and FnbB, are involved in cell
invasion by binding fibronectin, which facilitates uptake into the cell (Massey et al.,
2001; Jonsson et al., 1991). Clumping factor, ClfA and ClfB, bind fibrinogen which leads
to platelet aggregation (O’Brien et al., 2002). Clumping factor also protects the cell from
phagocytosis by macrophages (Palmqvist et al., 2004). Extracellular adhesion protein
(Eap) binds to several plasma proteins (fibrinogen, fibronectin, prothrobin and
vitronectin), epithelial cells and fibroblasts (Palma et al., 1999; Chavakis et al., 2002;
Hussain et al., 2002). Extracellular fibrinogen-binding protein (Efb) is secreted by S.
aureus and has been shown to prevent platelet aggregation, which is involved in wound
healing (Palma et al., 2001). Collectively, these virulence factors aid the cell in adhering
to host tissues, and facilitate the creation of infection foci.
Other virulence factors are associated with escape from the host immune system. For
example, protein A (Spa) is a cell-wall associated protein that binds to IgG. Normally
IgG associates with bacteria so that neutrophils can recognize the foreign entity and
facilitate phagocytosis, and destruction of the foreign organism. Protein A binding to IgG
attenuates the immune response by blocking the ability of IgG to stimulate neutrophils,
and ultimately inhibits phagocytosis. (Peterson et al., 1977). Protein A also binds IgM
associated with B cells, which induces apoptosis of these key host defense cells. S.
aureus also has another virulence factor that serves to bind immunoglobulins and host
proteins, Sbi. Sbi, is able to bind the complement protein C3 and blocks the activation of
the host complement pathway, allowing for S. aureus to evade the host immune system
6

(Haupt et al., 2008).The majority of S. aureus strains produce a capsule, with 11
serotypes thus far identified (Lee et al., 1994; Lin et al., 1994; Sau & Lee, 1996; Ouyang
and Lee, 1997); however, serotypes 5 and 8 account for 75-80% of all S. aureus strains
involved in human infections. Capsule allows S. aureus to evade the host immune
system by increasing resistance to phagocytosis and preventing it from being killed by
neutrophils and monocytes (Watts et al., 2005). Staphylokinase (Sak) is secreted by S.
aureus and functions to convert human plasminogen bound to the bacterial cells into
plasmin. This leads to plasmin activation, and cleavage of IgG and C3b, which
inactivates both and prevents phagocytosis (Rooijakkers et al., 2005). Chemotaxis
inhibitory protein (CHIPS) binds to human neutrophils and monocytes on the C5a
receptors, which represses their chemotaxis and antibacterial activity (Haas et al., 2005;
Wright et el., 2007). The staphylococcal complement inhibitor (SCIN) abrogates C3b
binding to the bacteria cell, and thus prohibits phagocytosis (Rooijakkers et al., 2005).
All of these virulence factors serve as a highly efficient defense to circumnavigate the
effects of the host immune system.
Virulence factors are also employed for dissemination and host tissue invasion and
include enterotoxins, toxic shock syndrome toxin-1 (TSST-1) and exfoliative toxins, are
all staphylococcal superantigens encoded on accessory mobile elements (Ferry et al.,
2005). Exfoliative toxin A and B (eta, etb) cause a unique array of damage, from
localized lesions to extensive exfoliation, and are the primary arbiters behind scaldedskin syndrome (Lee et al.,1987). S. aureus also produces extensive cytotoxins that are
involved in tissue invasion and the destruction of host cells, causing the lysis of
leukocytes, monocytes and/or erythrocytes. Specifically, α-hemolysin associates as a
7

hexamer to form pores in erythrocytes, resulting in lysis of the cell. Another mechanism
S. aureus utilizes for such processes are bi-component pore-forming leukotoxins
(Menestrina et al., 2003), such as: γ-hemolysin (HlgABC), LukSF-PVL, LukAB and
LukED (Alonzo et al., 2012). Further to this, γ-hemolysin has been shown to contribute
to S. aureus survival in blood and virulence in systemic murine models of infection by
targeting polymorphonuclear cells and monocytes (Malachowa et al., 2011). The PantonValentine leukocidin (PVL) was found to induce lysis of human polymorphonuclear
neutrophils, monocytes and macrophages and seems to contribute to the ability S. aureus
to cause pneumonia (Voyich et al., 2006; Labandeira-Rey et al., 2007; Diep et al., 2010;
Loffler et al., 2010). Recently the LukAB leukotoxins were identified and shown to
hinder killing by neutrophils (Dumont et al., 2011). The LukED proteins are the newest
identified leukotoxins and have been shown to target and kill murine phagocytes (Alonzo
et al., 2012).
In addition to bipartite toxins, another group of proteins, the phenol soluble modulins
(PSMs), have also been implicated in tissue invasion. PSMs share a common alpha
helical region that is thought to disrupt cell membranes and induce host cell lysis (Wang
et al., 2007). Several lipases are also produced by S. aureus: the geh gene encodes a
glycerolester hydrolase that cleaves long-chain and water-soluble triacylglycerols (Lee &
Iandolo, 1986; Arvidson, 2000), whilst an esterase, encoded by lip, cleaves short-chain
triacylglycerides. It has been suggested that lipases are chemotactic to granulocytes and
decrease phagocytic killing (Rollof et al., 1988), however the role of these esterases
remains unclear. In addition, two phospholipase C proteins have been identified,
sphingomyelinase or β-hemolysin, and phosphatidylinositol-specific phospholipase C.
8

Although these are known to contribute to virulence, their exact role and host target (s)
are unknown. Fatty acid modifying enzyme (FAME) catalyzes the esterfication of longchain free fatty acids to generate cholesterol, allowing enhanced invasiveness in
abscesses by diminishing the bactericidal effects of host lipids (Chamberlain and
Imanoel, 1996). Additionally, coagulase, a cell surface bound virulence factor, associates
with prothrombin and forms staphylothrombin, which converts fibrinogen to fibrin that
coagulates serum (Wegrynowicz et al., 1980). S. aureus also secretes ten major proteases
that aid in dissemination and tissue invasion by cleaving host proteins. Secreted proteases
have been shown to cleave the human protease inhibitor α1-proteinase inhibitor (Potempa
et al., 1986), the heavy chains of all human immunoglobulin classes (Prokesova et al.,
1992) and elastin (Potempa et al., 1988). Staphopain B was shown to cleave human
fibronectin, fibrinogen and kininogen (Coulter et al., 1998). These secreted proteases may
contribute to the switch from adhesive to invasive phenotypes, as they cleave S. aureus
surface, as well as other secreted virulence factors (McGavin et al., 1997; Karlsson et al.,
2001; McAleese et al., 2001; Lindsay & Foster, 1999). Although secreted proteases have
been suggested to be important virulence factors, the scope of proteins that they cleave is
currently unclear.
The regulation of virulence factors in S. aureus. The success of S. aureus in causing
disease is attributed not only to these virulence determinants, but in the rapid
environmental sensing and adaptation of their expression via precise genetic regulation.
The disease process begins with regulatory elements, which S. aureus has a multitude of,
including sigma factors, DNA binding proteins, regulatory RNAs and two-component
systems. Virulence factor production is tightly regulated, and correlates with classical
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growth phases experienced by bacteria (Figure 1). Shortly after entry into exponential
phase, adhesive surface proteins are expressed, including protein A, fibronectin binding
proteins A and B and clumping factors A and B. In addition, expression of the cytotoxin,
delta-hemolysin is also activated at this time, and remains expressed throughout postexponential and stationary growth (Schlievert et al., 2010). Other secreted virulence
factor expression correlates with bacterial population density, and is activated by a
quorum sensing system, agr (accessory gene regulator) later in growth. The agr system
of S. aureus is a global regulatory system that has been extensively studied and regulates
most staphylococcal virulence factors (Recsei et al., 1986). The agr operon contains four
genes, agrABCD that are transcribed from promoter 2 (P2, producing RNAII), alongside
promoter 3 (P3, producing RNAIII), which is divergent, and produces δ-hemolysin (hld)
(Novick et al., 1995).
AgrD is a 46 amino acid protein that is cleaved by two proteolytic digestions during the
exponential growth phase, before being secreted by AgrB. This results in a cyclic peptide
that is seven to nine amino acids in length, depending on the strain, and is referred to as
autoinducing peptide (AIP) (Ji et al., 1997). AgrC is a 46 kDa membrane protein that has
six transmembrane domains and is the histidine kinase of a two-component system
composed of AgrC and AgrA. AgrC contains a sensor domain which recognizes the
pheromone AIP, which, once a threshold concentration is reached, leads to AgrC
autophosphorylation at a conserved histidine residue in the cytoplasmic portion of this
protein. This phosphate is then passed to AgrA, which is a 28 kDa response regulator
that belongs to the AlgR/AgrA/LytR family of DNA binding proteins (Nikolskaya &
Galperin, 2002). AgrA subsequently binds to both agr promoters, although its affinity for
10

Figure 1. The regulation of virulence factors in a growth phase dependent manner.
Virulence factors are regulated in a growth phase dependent manner. During exponential
phase several surface-associated virulence factors, including, protein A, collagen-binding
protein, clumping factor, fibronectin-binding protein and coagulase are expressed. As
bacterial density increases, S. aureus switches from expressing adhesive surface proteins
to secreted proteins. During the post-exponential/stationary phases secreted virulence
factors are produced, including enterotoxins, secreted proteases, α-hemolysin, PVL and
lipases.
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P3 is considerably greater than for P2 (Koenig et al., 2004). RNAIII, produced from P3,
is a 0.5 kb transcript whose levels increase during growth, and is maximally observed
during post-exponential phase (Vandenesch et al., 1991). RNAIII ultimately serves as the
effector molecule of the agr system, seemingly by antisense mechanisms.
RNAIII was previously shown to regulate the α–toxin gene, hla, as transcript levels for
this hemolysin in a RNAIII mutant are one tenth of those in a wild-type strain, with
protein levels concomitantly reduced by 70-fold (Novick et al., 1993). The mRNA of hla
contains a long 5’ untranslated region of 330 nucleotides, which forms a hairpin that
contains and blocks the Shine-Dalgarno sequence (Novick et al., 1993). RNAIII binds to
this untranslated region, and the Shine-Dalgarno sequence is exposed by RNaseT1. This
binding stops the formation of a secondary structure, frees the ribosome binding site, and
allows for translation. The observation that both transcription and translation of hla were
impacted by RNAIII deletion suggests multiple methods of control are exerted by this
element. This was shown only recently, upon the determination that RNAIII interacts
with the mRNA for the DNA-binding protein Rot. The repressor of toxins (Rot) serves to
represses virulence determinant genes regulated by Agr (Said-Salim et al., 2003). To
relieve this repression, RNAIII binds to a complementary sequence on the rot mRNA,
inhibiting its translation (Geisinger et al., 2006; Boisset et al., 2007).
Although Agr contributes greatly to the regulation of virulence factors, it is not the only
regulator. The staphylococcal accessory regulatory locus (sar) was first identified by
screening transposon mutants for decreased exoproteins production (Cheung et al., 1992).
The sar locus consists of three transcripts that end at the same stem-loop sequence, but
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sarA is the only functional product produced (Bayer et al., 1996; Manna et al., 1998).
SarA can bind DNA as a dimer, however its target consensus sequence is currently
unknown. It has also been suggested that SarA is similar to Fis and IHF proteins of E.
coli, as SarA has similar characteristics as these proteins. These proteins regulate
transcription by mediating structural changes in DNA and supercoiling (Schumacher et
al., 2001). SarA has been shown to regulate many virulence factors, both positively and
negatively. In addition to binding DNA, SarA regulates mRNA stability, as transcripts for
several surface associated and secreted virulence factors have significantly shorter halflives upon sarA deletion (Roberts et al., 2006). In addition to SarA, several Sar
homologues have been identified as regulators of virulence factors. Specifically, SarR
represses SarA and hence genes regulated by SarA (Manna & Cheung, 2006), whilst SarS
is repressed by SarA and Agr (Tegmark et al., 2000; Cheung et al., 2001). SarT, another
homologue, has been suggested to repress RNAIII (Schmidt et al., 2001). In total, 12
different members of the SarA family of DNA binding proteins have thus far been
identified in the S. aureus genome (Schumacher et al., 2001 ; Liet al., 2003).
Agr and Sar-family proteins, although pleiotropic in action, are not the only virulence
factor regulators. Another global regulatory element is the Sae system, which influences
virulence factors independently of Agr and SarA (Giraudo et al., 1997). In addition to
proteins that bind promoters to exert their effects, sigma factors also play a role in
regulation. S. aureus also has an alternative sigma factor, σB, which regulates many
virulence factors during stress situations via both direct and indirect mechanisms
(Cheung et al., 1999; Nicholas et al., 1999). Collectively, the regulatory network of
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virulence factors is multifaceted and all contribute to the success of S. aureus as a
pathogen.
Antibiotic resistance of S. aureus. Genes encoding for antibiotic resistance typically
occur on mobile elements, such as genomic islands, transposons, plasmids and phages;
and are rapidly and easily transferred. Most antibiotic resistance mechanisms function by
either circumnavigating the effects of the drug (e.g. expelling it via efflux pumps) or by
modifying the drug directly. S. aureus is prolific at acquiring antibiotic resistance
cassettes, and thus is a major public health concern due to lack of available treatments.
The beta-lactam, penicillin, was the first antibiotic used to treat bacterial infections in
1942. Beta-lactams inhibit penicillin binding proteins (PBP) that perform the last
enzymatic reaction in cell wall synthesis (Goffin & Ghuysen, 1998). However, only a
year after its clinical introduction, penicillin resistance by S. aureus was reported
(Rammelkamp et al., 1943). Resistance was achieved by the acquisition of the blaZ gene,
which encodes a penicillinase that hydrolytically cleaves beta-lactam antibiotics
(Kernodle, 1989). Another antibiotic, methicillin, was introduced for clinical use in 1960.
Methicillin differs structurally from penicillin by sterically hindering the beta-lactam
cleavage site, and hence penicillinases are ineffective against it. A year after its
introduction, however, methicillin-resistant S. aureus (MRSA) was reported (Jevons
1963). Bacteria with methicillin resistance possess PBP2’ specified by the mecA gene;
which is commonly encoded on a mobile genetic element known as the staphylococcal
cassette chromosome (SCCmec) (Chamber 1997; Ito et al., 2001). Beta-lactams have low
affinity to PBP2’ and hence do not interfere with its essential function (Pinho et al.,
2001). Unlike resistance to penicillin, which is narrow in its activity spectrum, methicillin
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resistance is broad, and confers resistance to the entire class of beta-lactam antibiotics,
including penicillins, cephalosporins and carabapeneums (McCallum et al., 2009).
S. aureus has also recently gained resistance to glycopeptides antibiotics, such as
vancomycin. Vancomycin is considered a last resort antibiotic as it is often the only drug
still effective against many strains of S. aureus . Vancomycin binds to the D-ala-D-ala
residues of the lipid II molecule, which normally cross-links with other lipid II molecules
to form peptidoglycan in the cell wall. This binding event by vancomycin inhibits cross
linking and peptidoglycan biosynthesis, which results in weakened cell walls and
eventually cell death (Watanakunakorn, 1984). Two resistance mechanisms have arisen
in S. aureus towards glycopeptides. First, isolates with reduced susceptibility to
vancomycin were observed and are known as vancomycin intermediate resistant S.
aureus (VISA). These isolates have an elevated vancomycin minimum inhibitory
concentration of 8-16 μl/ml compared to 1-4 μl/ml, which is considered sensitive
(Hiramatsu, 2001). VISA isolates are associated with thickened and poorly linked
peptidoglycan, which results in an increased number of free D-ala-D-ala dipeptide targets
for the antibiotic to bind. Since these extra residues are free and not part of lipid II, this
binding event does not inhibit peptidoglycan synthesis (Cui et al., 2006). It has also been
proposed that this difference in cell architecture may reduce the diffusion rate of the
antibiotic into the cell (Pereira et al., 2007).
True vancomycin resistance was first reported in 1988 in Enterococcus isolates which
were found to resist vancomycin by utilizing the vanA cluster of genes (Leclercq et al.,
1988, Uttley et al., 1988). The first S. aureus isolate with vancomycin resistance was
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found in Japan in 1997 and mostly likely acquired the necessary genes from
Enterococcus (Hiramatsu et al., 1997). In 2002, vancomycin resistant S. aureus (VRSA)
was found in the United States, and contain the gene vanA (Clark et al., 2005, Weigel et
al., 2003). Since then, other VRSA strains have been isolated in the United States as well
as worldwide (Tiwari & Sen, 2006; Hiramatsu et al., 1997). vanA encodes for an enzyme
that changes the D-ala-D-ala residues in lipid II to D-ala-D-lac (Perichon & Courvalin,
2009). PBPs can still utilize these residues for peptidoglycan construction, but
vancomycin has a 1000-fold lower affinity in binding them (Bugg et at., 1991).
Hospital-acquired and community-acquired S. aureus. MSRA strains are widespread
in hospitals and intensive care units, and are one of the leading causes of bacterial
nosocomial infections worldwide (Diekema et al., 2001). In this setting these strains prey
upon the immunocompromised and elderly. Such strains are referred to as hospitalacquired MRSA (HA-MRSA), however, in the past decade MRSA strains have been
observed in the community infecting young and healthy individuals without any
connection to healthcare facilities, and are termed community-acquired MRSA (CAMRSA) (Johnson et al., 2007; Moran et al., 2005). These, CA-MRSA strains have
evolved independently in the community, and possess different combinations of virulence
factors and antibiotic resistance traits, which result in hypervirulent and more aggressive
isolates (Burlak et al., 2007; Chambers, 2005; Diep et al., 2006; Diep at al., 2008;
Kennedy et al., 2008; Vandenesch et al., 2003; Wang et al., 2007).
Multilocus sequence typing and pulsed-field gel electrophoresis (PFGE) has been used to
define S. aureus isolates according to CDC PFGE types USA100-USA1200 (Enright et
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al., 2002; Tenover et al., 2004). HA-MRSA infections, in the United States are
commonly caused by USA100, USA200, USA700 and USA800 types, with the former
being the most common (Tenover et al., 2004). In contrast, USA300 has become the
dominant CA-MRSA clone in the United States in the past 10 years (Moran et al.,
2006;Hulten et al., 2010; Talan et al., 2011), replacing USA400 in most regions (ComoSabetti et al., 2009; Simor et al., 2010).
Recent research has shown multiple differences between HA-MRSA and CA-MRSA.
First, the ability of CA-MRSA to invade healthy hosts is the result of a difference in the
expression profile of core-genomic elements, as well as newly acquired virulence factors.
CA-MRSA strains overproduce several core pathogenic determinants, including αhemolysin (Hla), delta-hemolysin, proteases and phenol soluble modulins (PSMs)
(Burlak et al., 2007; Chambers, 2005; Diep & Otto, 2008; Wang et al., 2007). A large
number of these factors are regulated by the two-component system Agr, and thus their
overproduction is due, at least in part, to a hyperactive Agr system. The Sae system also
positively regulates virulence factors and has been shown to have increased expression in
CA-MRSA strains (Giraudo et al., 1997, Goerke et al., 2005; Nygaard et al., 2010),..
Genome analysis of the CA-MRSA isolate MW2 revealed 19 unique virulence factors,
including several enterotoxins, leukocidins and surface-associated proteins that are not
found in other S. aureus genomes (Baba et al., 2002). Other CA-MRSA strains also carry
unique pathogenicity islands, such as SaPI5, which encodes two unusual enterotoxins, K
and Q (Diep et al., 2006) that are thought to contribute to virulence by stimulating Tcells. Also, the Panton-Valentine leukocidin (PVL) genes are found in 2% of clinical
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isolates, however all CA-MRSA strains that cause skin infections possess them
(Vandenesch et al., 2003). Of the virulence factor genes acquired by CA-MRSA strains,
only the arginine catabolic mobile element (ACME) is completely unique to USA300
(Diep et al., 2006). ACME encodes a complete arginine deaminase system that converts
D-arginine to L-ornithine for ATP and ammonia production. It has been proposed that
ACME contributes to colonization through ammonification of the acidic skin
environment (Diep et al., 2008; Joshi et al., 2011). In addition to toxin production,
antibiotic resistance genes also vary between these 2 lineages. Both HA-MRSA and CAMRSA strains carry SCCmec, with eight different types thus far identified. Types I-III
contains other drug resistance determinants, whereas types IV-VIII only carry resistance
to beta-lactam antibiotics (Carvalho et al., 2010). CA-MRSA typically carry SCCmecIV,
which means that CA-MRSA strains are commonly susceptible to antibiotics such as
clindomycin, macrolids, co-trimoxazole, tetracyclines and fluoroquinolones (Daum et al.,
2002). TypeIV SCCmec is also smaller in size, and seems to have less of a defect burden
on strains, comparead to types I, II and III, which are very large and result in decreased
growth rates of harboring isolates (Laurent et al., 2001; Ender et al., 2004; Diep et al.,
2008).
The type of infection caused by HA-MSA and CA-MRSA varies greatly. HA-MRSA
infections are often associated with invasive diseases such as surgical site infections and
bacteremia, which can result in dissemination to the lungs and cause pneumonia (Webb et
al., 2009; Selvey et al., 2000). CA-MRSA strains most frequently cause skin infections
(Cohen & Kurzrock, 2004), which are characterized by the development of necrotizing
lesions of the skin and soft tissues. These lesions can then progress into abscesses or
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cellulitis. CA-MRSA can also cause invasive infections, such as bacteremia, endocarditis
and necrotizing fasciitis, a condition rarely caused by S. aureus (Miller et al., 2005). CAMRSA is often associated with worse clinical outcomes and has increased sepsis and inhospital mortality rates (Kempker et al., 2010). On average, patients contracting CAMRSA are younger and otherwise healthier than those with HA-MRSA (Nair et al.,
2011). Recent reports reveal that the number of CA-MRSA infections is increasing in the
United States (Limbago et al., 2009; McDougal et al., 2003; Moran et al., 2005), and
these strains are being observed in the hospital setting, where they are displacing
traditional HA-MRSA isolates (D’Agata et al., 2009; Popovich et al., 2008; Webb et al.,
2009).
Two-component systems. The success of S. aureus as a pathogen is in part due to
precise regulation of genes needed to survive in different environments, including the
host. One class of elements used by S. aureus to sense the environment and adapt is twocomponent systems (TCS). The term “two-component” was first used to describe a class
of unique regulatory systems found in eubacteria (Hess et al., 1988). However, recently
two-component signal transduction systems have been found in Achaea, fungi, slime
molds and even plants (Hoch, 1995; Hwang et al., 2002;. As the name suggests, these
systems consist of two components, a membrane spanning histidine kinase (HK) and an
intracellular response regulator (RR). The histidine kinase acts as a sensor and the
response regulator, which is normally a DNA-binding protein, is responsible for changing
gene expression to aid in survival of the cell. The chemistry of most TCS consists of
three reactions, with two intermediates (Figure 2). The two partners of a TCS
communicate through three phospho-transfer reactions after the HK senses its specific
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Figure 2. A functional schematic of two-component systems. TCS are utilized by the
cell as a way to sense the external environment and alter expression profiles in order to
survive. The histidine kinase (HK) is a membrane bound protein that is able to sense
specific signals. When the HK senses its target at a threshold level, it autophosphorylates
at a conserved histidine residue. The phosphate group is then passed to the
cytoplasmically located response regulator (RR) at an aspartate residue. Once
phosphorylated, the RR can bind promoters of genes under its control and either increase
or decrease transcription in accordance with the stress being sensed.
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signal: (1) the histidine kinase (HK) autophosphorylates itself at a conserved histidine
residue; (2) the phosphate is transferred to the response regulator (RR) at a conserved
aspartate residue (Asp); (3) the RR changes gene expression profiles by binding to
promoters under its control (Figure 3). The phosphoryl group is then transferred to a
water molecule in a hydrolysis reaction, and is dephosphorylated to reset the system
(Parkinson, 1993).
TCS prototypically operate in this way; however some function differently and can
contain more than two components, yet still utilize the same sensing and phosphotransfer
system. The HK, CheA of E. coli can phosphorylate either of two RRs, CheY or CheB
(Stock et al., 1988). The sporulation TCS of B. subtilis is an example of a
multicomponent phosphorelay system. The HK is considered a hybrid HK due to its
multistep system and higher complexity. The RR Spo0F receives its phosphate from
either KinA or KinB. Then the phosphate is passed to another HK, Spo0B, and then
finally to RR Spo0A (Burbulys et al., 1991). Instead of the phosphate being passed to
different proteins, as in the sporulation system, it can also be passed to different domains
within a single HK. In the anoxic redox TCS from E. coli, the HK ArcB contains two
domains that autophosphorylate, before the RR, ArcA can be phosphorylated (Ishige et
al., 1994). In addition to these, not all kinases are membrane bound; some are actually
soluble cytoplasmic HKs. These HKs are regulated by stimuli within the cytoplasm, or
interact with the cytoplasmic domains of target proteins. The nitrogen sensing HK, NtrB,
is one such example of a soluble HK (MacFarlane & Merrick, 1985).
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Figure 3. The phosphotransfer reactions of two-component systems. The histidine
kinase (HK) and response regulator (RR) of a TCS communicate through three phosphotransfer reactions to ultimately alter gene expression. First, the HK autophosphorylates
itself at a conserved histidine residue; then the phosphate is transferred to the response
regulator (RR) at a conserved aspartate (Asp); which is followed by the RR changing
expression profiles by binding to promoters under its control. The final step consists of
the phosphoryl group being transferred to a water molecule in a hydrolysis reaction,
leading to dephosphorylation, which resets the system.
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Structure and function of histidine protein kinases. The main architectural feature of
all HKs is the kinase core, which is composed of a dimerization domain and an
ATP/ADP-binding phosphotransfer or catalytic domain (Figure 4) (Stock, 1999). It
contains the conserved amino acid motif, called the H box, which houses the histidine
residue where phosphorylation occurs (Stock et al., 1989). The ATP-binding pocket is
flexible, suggesting that it undergoes a conformational change when associated with ATP
(Ban et al., 1999). In addition to the kinase core, HKs contain a sensing domain located at
the N-terminus, which is used to sense specific environmental signals. This domain
shares little sequence similarity between HKs, supporting the idea that each protein is
designed to sense different, and very specific, stimuli. For many HKs the stimulus
remains unknown.
Structure and function of response regulators. The majority of RRs consist of two
domains: a conserved N-terminal regulatory domain, and a variable effector domain
located at the C-terminus (Figure 5). The RR is responsible for transfer of the phosphoryl
group from the His residue in the HK to a conserved Asp residue within its own
regulatory domain. In addition to the critical Asp residue, many RRs have acidic residue
adjacent to this (Stock et al., 1988). The carboxylate side chains of these acidic residues
are important in obtaining Mg2+, which is required for phosphoryl transfer (Needham et
al., 1993). Some RRs are able to obtain the phosphoryl group from small molecules such
as acetyl phosphate, carbamoyl phosphate, imidazole phosphate or phosphoramidate, in
addition to the cognate HK (Lukat et al., 1992). This suggests that some RRs can
phosphorylate independently of the HK, and that the concentration of these small
phosphor-donors can serve as a signal to change gene expression profiles.
23

Figure 4. The architectural features of histidine kinases. The histidine kinase is a
membrane spanning protein with a sensing domain in the extracellular environment and a
kinase core that is cytoplasmically located. The sensing domain of each HK is different
as each recognizes a unique signal. The kinase core is composed of an ATP/ADPbinding phosphotransfer domain and the H box. The ATP/ADP-binding phosphotransfer
domain uses the hydrolysis of ATP for energy, which creates a conformational change in
the protein. This leads to autophosphorylation at a conserved histidine residue in the H
box.
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Figure 5. The architectural features of response regulators. The response regulator
(RR) of a two-component system is a cytoplasmic located protein and is composed of an
effector domain and a regulatory domain. The effector domain contains a conserved
aspartate (Asp) residue where the phosphate group is received from the histidine kinase.
Once phosphorylated the RR can bind to genes under its control via its DNA-binding or
regulatory domain. This leads to either increased or decreased transcription of the target
gene(s).
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Phosphorylation ultimately promotes a conformational change in both the regulatory
domain, as well as the effector domain. The effector domain, the DNA sequences that it
binds to, the arrangement of the binding sites and the exact mechanism of transcriptional
regulation varies greatly amongst different RRs. It is thought that RRs exists in
equilibrium between the active and inactive state, with the phosphorylation event shifting
the equilibrium to the active state. In the active state the RR can promote dimerization
(McCleary, 1996), higher-order oligomerization (Webber et al., 1997), or interactions
with other proteins or DNA (Aiba et al., 1989). The majority of effector domains have
DNA-binding activity, which can either activate or repress genes under its control.
However, phosphorylation does not equate to activation, and for some RRs, activation is
the result of relieving inhibition. In this scenario, phosphorylation creates a
conformational change and modifies the binding of the RR to DNA. In certain situations
the unphosphorylated RR can bind DNA and inhibit transcription, under normal
conditions. Upon phosphorylation, the RR is no longer bound and thus repression is
relieved.
The occurrence of TCS in prokaryotes. With the availability of whole genome
sequencing, the frequency of TCSs among bacteria is readily determined. Homology
suggests that the total number of TCSs differs vastly between bacteria, and range from 0
in Mycoplasma genitalium to 80 in Synechocystis sp., which is a total of ~2.5% of its
entire genome (Mizuno et al., 1998). Analysis of other bacterial genomes reveals that
Bacillus subtilis possesses 70 TCSs; Haemophilus influenza, 9 ; Helicobacter pylori, 11;
(Mizuno et al., 1998) while E. coli has 30 HKs and 32 RRs (Mizuno, 1997). The exact
number of TCSs associated within a bacterium, however, changes as new ones are
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acquired. Indeed, many newly discovered TCSs are the result of horizontal gene transfer,
and are involved in sensing and responding to antibiotics, or affecting virulence
processes.
Intramembrane-sensing histidine kinases. Several different classes of TCS have been
identified in recent years, including the HWE (based on the H,W and E residues in the
kinase core domain), YwpD-like and PleD-like TCS (Karniol & Vierstra, 2004,
Wietzorrek & Bibb, 1997; Galperin, 2006) Recently, a class of histidine kinases was
identified and termed the intramembrane-sensing histidine kinases (IM-HKs) (Mascher,
2006). IM-HKs are small in size, are no more than 400 amino acids in length, and the Nterminus contains two transmembrane helices (TMH) with less than 25 amino acids
between them (Figure 6). This small linker region between TMHs is thought to be the
lone extracellular fragment, meaning that the majority of the kinase is cytoplasmic.
Therefore it is likely that these IM-HKs do not sense an external signal, but rather sense a
stimulus either inside or at the surface of the membrane (Mascher, 2006). From
approximately 350 sequenced genomes, 5000 HKs were identified. Of these 5000, 147
contain the architecture and characteristics of IM-HKs, with the majority of them
encoded by Gram-positive bacteria with low G+C content (Macher, 2006). Indeed, when
analyzing 79 different Gram-positive genomes, 110 proteins were identified as belonging
to the IM-HK family.
Subgroups of intramembrane-sensing histidine kinases. Two distinct subgroups of
IM-HKs have been characterized, and are almost exclusive to the Firmicutes. The major
characteristic of the first subgroup is that they belong to the HPK7 subclass, and the RR
27

Figure 6. Predicted topology plot of the IM-HK, SACOL2645 from S. aureus. IMHKs are characterized by having two transmembrane domains and an extracellular
sensing domain (circled) less than 25 amino acids, suggesting they sense changes at the
surface or in the membrane. S. aureus has 4 IM-HK’s, SACOL 2645, GraS, VraS, and
SaeS. This depicts the projected transmembrane domains and sensing domain of the
uncharacterized IM-HK, SACOL 2645. Produced using the SOSUI website.
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and HK proteins utilize an additional, conserved transmembrane protein to exert their
effects. Thus far 25 IM-HKs belonging to this group have been identified (Mascher,
2006). A well studied example is the LiaRS TCS from B. subtilis, which is encoded on
the liaIHGFSR operon. LiaRS senses and responds to lipid II-interacting antibiotics,
including bacitracin, vancomycin, ramoplanin and nisin. The LiaRS system is also
activated by cationic antimicrobial peptides, alkaline shock, organic solvents, detergents
and ethanol (Petersohn et al., 2001; Hyyrylainen et al., 2005; Pietiainen et al., 2005). In
the absence of these stimuli, LiaRS is inactive due to the membrane protein LiaF. In a
liaF deletion mutant, the LiaRS is constitutively activated, and additional stimuli are not
required. Therefore, LiaRS and LiaF form a three component system, and thus full
function relies on the presence and activity of all three elements, although the exact
functional mechanism of this three component system is unknown (Jordan et al., 2006).
The second group is the largest class, and is characterized by being genetically associated
with, and an adjacent ATP-binding cassette transporter (ABC transporter). ABC
transporters are transmembrane proteins that hydrolyze ATP for energy to translocate
various substrates across the membrane (Higgins, 2001). IM-HKs encompassing this
group belong to the HPK3i subfamily and regulate, and utilize, the adjacent ABC
transporter to pump various substrates across the membrane in response to the stimulus
sensed by the HK.(Mascher, 2006). The cognate TCS is often constitutively expressed,
and senses cell-wall-targeting compounds, or the damage they cause. Upon induction, the
RR is activated, and in turn induces transcription of the adjacent ABC transporter. A total
of 70 proteins belong to this subgroup, with 65 of them found in Gram-positive bacteria
with low a low G+C content (Mascher, 2006). Of note, almost all of these (53 of 55) are
29

very closely related from an evolution perspective, and gather tightly in a phylogenetic
tree.
Two-component systems of S. aureus. Through homology and domain comparisons, S.
aureus is thought to encode 16 TCSs within its relatively small genome. These TCSs
mediate the response to changing environments and facilitating survival in the presence
of a multitude of stresses (Table 1). In addition, these TCSs are a major contributor to the
success of this bacterium as an invasive and effective pathogen. The TCSs of S. aureus
sense a variety of signals covering a range of different processes. Only one TCS has been
shown to be essential for growth, and is involved in cell wall homeostasis. This TCS,
YycFG, has been shown to activate the expression of cell wall and fatty acid metabolism
genes, and has also been implicated in daptomycin resistance and vancomycin resistance
(Dubrac et al., 2007). Other TCSs are also involved in the cell wall stress response,
including GraRS and VraRS. GraS, VraS and a further unstudied protein that is the focus
of this work, SACOL2645, belong to the IM-HK class, which are known to sense damage
of the cell wall. Further to this, LytRS controls the rate of autolysis by regulating genes
involved in autolytic processing and cell wall metabolism by altering murein hydrolase
activity (Brunskill & Bayles, 1996). Similar to this, ArlRS regulates 114 genes, many of
which are also involved in autolysis, as well as cell division processes, growth and
pathogenesis. ArlRS also has been shown to regulate other TCS, including AgrAC,
LytRS and KdpDE (Liang et al., 2005).
TCS in S. aureus can also respond to elemental changes in the environment, including
potassium, iron, phosphate, oxygen and nitrogen. The activation of KdpDE is dependent
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Table 1. S. aureus possesses 16 two-components systems.
COL #

MW2 #

0019/20

Gene name

Function

yycFG/walkRS

Essential

0201/2

0199/8

Anaerobiosis (Preliminary investigations)

0246/5

0236/7

lytRS

Autolysis regulation

0716/7

0621/2

graRS

Cell-wall/vancomycin resistance

0766/5

0668/7

saeRS

Virulence determinant regulation

1355/4

1208/9

1451/0

1305/4

arlRS

Virulence determinant regulation and autolysis

1535/4

1446/5

srrRS

Oxygen sensing regulation

1740/39

1637/6

phoPR

Alkaline phosphatase regulation

1905/6

1790/1

yhcSR

Essential/cell wall/phosphomycin resistance

1942/3

1825/4

vraRS

Cell-wall synthesis

2026/5

1962/3

agrCA

Accessory gene regulation

2070/1

2002/3

kdpDE

Potassium transport regulation

2358/9

2282/3

hssRS

Iron transport and metabolism

2389/90

2313/4

nreBC

Nitrate reductase regulation

2646/5

2545/4

nsaRS

LuxR family
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on external levels of potassium, and inactivation of this system has been shown to
decrease the expression of several virulence factors. This suggests that S. aureus
determines its infectious state, in part, by sensing external potassium levels (Xue et al.,
2011). The HssRS TCS is essential for the adaptive response to iron-containing heme
within the host. HssRS responds to iron levels; in environments with low iron it
upregulates the heme regulated transporter efflux pump, HrtAB. Although iron is a
nutritional requirement for S. aureus, which it obtains in a host from heme, metabolizing
this molecule can lead to reactive oxygen species and membrane damage. HssRS
regulates HrtAB to alleviate hemin toxicity (Stauff et al., 2007). S. aureus uses the TCS
NreBC to senses nitrogen in the external environment. In the presence of low oxygen or
nitrogen, the RR of this system binds to genes that are involved in nitrate, nitrite
reduction and fermentative metabolism (Fedtke et al., 2002). This system is required for
the transport of nitrogen, as mutations in nreBC inhibits the use of nitrogen and force the
cell to use fermentative pathways (Schlag et al., 2008). Although the PhoPR TCS has not
been studied in S. aureus, its function can be inferred through comparison to a similar
system in B. subtilis, where it senses limiting phosphate levels, and regulates genes
accordingly (Martin et al., 1999). It is also implicated in cell wall homeostatsis, as
peptidoglycan synthesis is affected by low phosphate levels. SrrAB is involved in global
energy changes in response to oxygen availability. SrrAB directly regulates virulence
factors in response to this, and a mutation in srr results in decreased virulence (Yarwood
et al., 2001; Bae et al., 2004). Another TCS AirSR (formally known as YhcRS) is also
important in sensing low oxygen levels. This TCS uses a redox active Fe-S cluster within
the histidine kinase to sense oxidation signals and responds accordingly. This system has
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been shown to be important for resistance to H2O2, vancomycin, norfloxin and
ciprofloxacin (Sun et al., 2012).
Using comparative genomics, four of the sixteen TCSs of S. aureus appear to contain IMHKs. One of these is associates with a membrane protein (VraRS), two belong to the
subfamily associated with ABC transporters (GraRS and SACOL 2645/2646), and the
final one seems to be an outlier IM-HK that does not fall into this 2 sub-family structure
(SaeRS).
The SaeRS two-component system of S. aureus. The sae locus in S. aureus is
composed of four open reading frames: saeP, saeQ, saeR and saeS. The latter two genes
encode the HK (saeS) and the RR (saeR) of the two-component system. SaeS is 351
amino acids in length and has two transmembrane domains. The external or sensor
domain is nine amino acids long, suggesting that the SaeRS does not sense external
stimuli, as with other IM-HKs. A microarray analysis performed in the clinical isolate
MW2 showed that SaeRS regulates the expression of 212 genes, ranging in function from
energy and metabolism processes, ion transport, DNA repair and virulence (Voyich et al.,
2009). This TCS is required for the expression of several virulence factors including cell
wall-associated proteins, and secreted proteins (Giraudo et al., 1997, Giraudo et al., 1994,
Goerke et al., 2005). In addition, the sae locus is vital to the survival of S. aureus in
animal models (Voyich et al., 2009), although the exact conditions it responds to are
currently unknown.
The VraRS system of S. aureus. VraRS was first identified in a VISA isolate as being
upregulated in a strain with increased vancomycin resistance (McAleese et al., 2006). It
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was originally termed vancomycin resistance associated regulator and sensor (VraRS) as
a result of a microarray analysis of VSSA, VISA and VRSA strains which showed
upregulation of VraRS in VISA and VRSA. In addition to vancomycin, the presence of
cell wall-targeting antibiotics, including glycopeptides, beta-lactams, bacitracin, Dcycloserine, daptomycin and mersacidin also results in the upregulation of this TCS
(Gardete et al., 2006; Kuroda et al., 2003). While the exact signal for the activation of
VraRS is unknown, the fact that it is an IM-HK with a small sensing domain, and that it
responds to antimicrobial agents that target multiple steps in cell wall biosynthesis,
suggests that VraRS responds to general cell wall damage and not that caused by specific
antibiotics (McAlleese et al., 2006; Gardete et al., 2006). Functionally, VraRS controls
the expression of the cell wall stress stimulon, which includes many genes involved in
cell wall biosynthesis. This is suggested, at least in part, to be the reason for altered
resistance to cell-wall-targeting agents in vraRS mutants (Fan et al., 2007; McCallum et
al 2006). A microarray performed on S. aureus in the presence of vancomycin resulted in
139 genes with altered expression suggesting a requirement for these genes in
vancomycin resistance. However a vraRS mutant grown in the presence of vancomycin
had only 93 genes altered in expression, suggesting that 46 genes utilized by S. aureus to
combat vancomycin stress are dependent upon VraRS (Gardete, 2006).
The GraRS two-component system of S. aureus. The glycopeptides resistance
associated (Gra) TCS operon consists of three genes, GraXSR. graS encodes an IM-HK
that is 346 amino acids in length and has only four amino acids on the exterior of the
membrane. graR encodes the cognate response regulator, while graX specifies a protein
of unknown function that has been shown to be important for the function of this TCS
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(Falord et al., 2011). The GraSR TCS has been shown to be important in resistance to
vancomycin, a glycopeptide, which is where the name came from. In a microarray that
was performed on a VISA strain, GraSR was found to be upregulated (Cui et al., 2005).
GraSR has been shown to regulate approximately 248 genes, with 115 being upregulated
and 133 down regulated. A large portion of these genes are involved in cell wall
biosynthesis, however other regulators (Rot and MgrA) are contained in this regulon, thus
some of the 248 genes may be indirectly regulated by GraRS.
A mutation of graR was found to produce increased susceptibility to vancomycin (Meehl
et al., 2007). In correlation with these observances, overexpression of this TCS leads to
an increase in MIC for vancomycin. Directly downstream of graXSR is an ABC
transporter termed VraFG, which is regulated by this TCS, and also seems to play a role
in vancomycin resistance (Falord et al., 2011), however the exact mechanism by which
this is mediated is currently unknown. One of the proposed reasons for the change in
susceptibility to glycopeptides is the D-alanylation of teichoic acids which is controlled
by the dltABCD operon. Specifically, a mutation in this operon results in increased
vancomycin susceptibility (Peschel et al., 2000). This operon is regulated by GraRS, and
seemingly, GraXSR, VraFG, as well as other genes involved in cell wall biosynthesis
work together to maintain cell wall homeostasis when in the presence of cell-walltargeting compounds.
One of the main functions of GraSR is cationic antimicrobial peptide (CAMP)
resistance; and in fact this system has an alternate name, ApsRS (antimicrobial peptide
sensor) as a result of this. CAMPs are produced by all living organisms, and are a major
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component of the innate immune system. They are positively charged, and kill bacteria
by binding to their negatively charged cell wall, where they form pores, or enter the cell
and inhibit DNA, RNA or protein synthesis (Hale et al., 2007). The presence of CAMPs
induces GraSR, which changes gene expression to facilitate resistance by the Dalanylation of teichoic acids and lysylination of phosphatidylglycerol. D-alanylation of
teichoic acids increases the overall positive charge of the cell and decreases the affinity of
CAMP binding. D-alanylation of teichoic acids is performed by the DltABCD enzymes,
while MprF is responsible for the lysylination of phosphatidylglycerol. GraRS helps in
the infection process by limiting the activity of host CAMPs and has shown to be
important in several animal models of infection including drosophila, murine and
silkworm larvae (Kraus et al., 2008; Tabuchi et al., 2010; Kurokawa et al., 2007).
Project Aim: TCS have been shown to be important regulatory elements for
understanding both the virulence process as well as antibiotic resistance. S. aureus has
sixteen TCS sensing a variety of signals and covering a range of functions. Thirteen of
the sixteen TCS have definable roles, either through homology with closely related
organisms, or by their study in S. aureus. IM-HKs are a group of histidine kinases that
have been suggested to sense damage at the cell surface as they have small sensing
domains. GraRS and VraRS are highly important IM-HKs, involved in antibiotic
resistance and the evaluation of these systems is generating insight into resistance
mechanisms of S. aureus. One IM-HK, SACOL 2645/2646 has not been studied, and
does not have homology with any TCS in closely related organisms. This suggest that the
role of this TCS may be unique to S. aureus, and thus understanding its role may
elucidate important information regarding drug resistance mechanisms, as well as provide
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a better understanding of regulatory elements S. aureus utilizes during pathogenesis.
Accordingly, the aim of this project is to characterize SACOL 2645/2646 and determine,
as with other IM-HKs, if it is involved in cell wall homeostatsis. Further to this,
identifying genes under the control of SACOL 2645/2646 and determining their
contribution to the overall function of this TCS will provide exclusive unique insight into
the lifestyle of S. aureus.
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Chapter 2: The role and regulation of NsaRS: a cell-envelope stress-sensing twocomponent system of S. aureus

Introduction
Bacteria are exposed to a variety of environments in which they must adapt in order to
survive. As such, they have developed multiple mechanisms to adapt to, and survive
these stresses. While it may be considered that it is only the genes directly involved
with adaptation that are important, the regulators of these elements are a vital
component to survival and proliferation. Bacteria possess a variety of regulatory
elements, including sigma factors, DNA-binding proteins, regulatory RNAs and twocomponent systems. Understanding the function and control of these elements
commonly provides an important insight into the behavior of bacteria, and, in the case
of pathogens, may gives a greater understanding of virulence mechanisms.
Bacteria have specialized regulatory elements to detect when they are in a host, and
when virulence genes need to be expressed. One example from Group A Streptococcus
(GAS) is the TCS SilAB, which aids in the virulence process via a quorum sensing
mechanism, allowing GAS to sense the level of other GAS bacteria that are in the
immediate environment (Belotserkovsky et al., 2009). These systems have been shown
to be important in the virulence of GAS, as the allow for a delay in expression of
virulence factors until a large concentration of bacteria are present (Eran et al., 2007). S
.aureus also has a similar system, agr, which has been shown to be important to the
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virulence process. Agr is a quorum sensing TCS that regulates many virulence factors;
and mutants in this system are attenuated in murine models of infection (Mayville et al.,
1999; Schwan et al., 2003; Blevins et al., 2003).
While several TCS have been shown to be important in virulence, another aspect of the
infection process is treatment with antibiotics. TCS are also imperative in sensing either
the antibiotic itself, or the damage caused by these agents. In Enterococcus faecalis the
TCS, VanRS, is vital for resistance to glycopeptides, including vancomycin. In the
presence of glycopeptides this system is induced, leading to the upregulation of genes
including vanHAX, which alters the binding of glycopeptides to the cell wall, and
ultimately resulting in resistance (Bugg et al., 1991). S. aureus also has TCSs that
responds to glycopeptides, VraRS, and to a lesser extent GraRS (McAlleese et al., 2006;
Gardete et al., 2006; Meehl et al., 2007; Peschel et al., 2000).
S. aureus has 16 predicted TCS that respond to a range of environmental stimuli, and
allow for adaptation to various stresses. Of these 16, three have no known function,
including SACOL2645/2646, which is the focus of this work. Even using homology
analysis with closely related organisms, no function can be inferred for this TCS,
suggesting that it may be unique to the Staphylococci. SACOL2645/2646 was recently
termed nisin susceptibility associated response regulator and sensor (NsaRS) (Blake et
al., 2011), and thus this nomenclature will be used throughout. The nsaRS operon
consists of 3 genes that are expressed from one promoter (Figure 7). The first gene is
small, consisting of only 201 base pairs, and theoretically producing a protein of 67
amino acids. This is followed by the response regulator and then the histidine kinase.
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Figure 7. The NsaRS/NsaAB locus from Staphylococcus aureus. The two-component
system, NsaRS, is expressed from one promoter, and exists in an operon with another
small gene, SACOL 2647. NsaS is an IM-HK, belonging to the sub-family that uses an
adjacent ABC transport system to exert its affects. This is located 3’ of the regulatory
genes, and is termed NsaAB. nsaAB are putatively expressed from one promoter as
shown.
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Analysis of the histidine kinase revealed that NsaS is an IM-HK and has typical
characteristics of this family, bearing 2 transmembrane domains, and a sensing domain
of only 9 amino acids in length. This suggests that this TCS may sense damage at the
cell surface, rather than external signals. NsaS belongs to the group of IM-HKs that
regulate and utilize an adjacent ABC transporter to exert its affects. For NsaRS, this
transporter is NsaAB, which is located directly upstream of the TCS, and form an ABC
transport system of currently unknown function. It also remains unknown whether this
transporter is regulated by NsaRS. In addition, both GraRS and VraRS, two other IMHKs in S. aureus contribute to antibiotic resistance in some manner, and sense cell wall
disruption. Therefore, elucidating the role of NsaRS may better our understanding of the
mechanisms S. aureus uses to combat cell wall stress, and/or antibiotic resistance.
Therefore, the focus of this chapter is the characterization of NsaRS, which we
hypothesize is employed by S. aureus to combat cell-wall stress. As such the utilization
of NsaRS by S. aureus will be evaluated, and its response to antibiotics and cellenvelope-targeting agents determined. Since NsaRS is a regulator, identifying
components of its regulon will likely provide information leading to the discovery of its
function. The impact of NsaRS on the virulence of S. aureus will also be addressed, and
may generate insight into the mechanisms used by S. aureus during pathogenesis.
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Results
Note to Reader
These results have been previously published (Kolar et al., 2011) with permission of the
publisher and the published manuscript can be found in Appendix 1.
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Chapter 3: The role and regulation of the ABC transporter, SACOL2525/2526
of S. aureus

Introduction
NsaRS is involved in sensing cell-envelope stress, and exerts its effects by regulating
over 200 different genes. The majority of these are positively regulated, and cover a
range of functions, including cell wall biosynthesis genes (tagB, fmhA, and scdA),
osmoprotectants (opuCA and cudT), as well as other regulators (sarS and rex). The
ontology grouping that contains the most genes within the NsaRS regulon is
transporters, with 55 such genes being affected. One particular transporter,
SACOL2525/2526, not only had the largest decrease in expression of the transporters,
but in fact had the most alteration in transcription of all 245 genes. SACOL2525/2526
encodes an ABC-transporter, and homology analysis suggests that it is involved drug
resistance. Since the appearance and clinical use of penicillin in 1942, antibiotics have
been used to treat diseases caused by many bacterial pathogens, including S. aureus.
However, due to antibiotic resistance, some previous treatable infections are now major
public health threats. One mechanism bacteria utilize in antibiotic resistance is the
extrusion of the drug by either an efflux pump or carrier (Paulsen et al., 1996). Bacteria
typically have multiple drug resistance (MDR) transport proteins that they use to protect
against antimicrobial agents. MDR proteins have effectively been divided into two
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subgroups: the small multidrug resistance family (SMR) and the multidrug and toxic
compound extrusion (MATE) family.
The MATE family is the larger group of the two, and members expunge compounds by
using the proton motive force. The QacA protein of S. aureus is a classic example of a
MATE transporter, conferring resistance to more than 30 lipophilic antimicrobial
compounds (Tennent et al., 1989; Mitchell et al., 1998).

The SMR group also

contributes to antibiotic resistance, but does so by utilizing ABC transporters. ABC
transporters contain a membrane spanning protein that creates a translocation pathway
for specific substrates. In addition, 2 cytoplasmic adenosine triphosphate-binding
cassettes (ABCs) are associated with the membrane protein, and hydrolyze ATP to
generate energy for export. This action causes a conformational change that allows the
transporter to move substrates from one side of the membrane to the other (Higgins,
1992). ABC transporters are involved in moving a variety of molecules, nutrients, ions
and antimicrobial agents across the membrane. ABC transporters contribute to
antibiotic resistance by directly pumping out drugs, and this action by the transporter
can be specific for only one antibiotic, or be broad in spectrum, and transport several
different drugs.
In the context of this work, SACOL2526/2526 form an SMR ABC transporter.
SACOL2525 encodes the ATP-binding protein, while SACOL 2526 is the membranespanning protein. In the literature SACOL2525 is referred to as stpC and SACOL2526
smpC (Ross et al., 1996). This naming is due to homology with the stpA and smpA
genes from S. epidermidis. In S. epidermidis, StpA and SmpA interact with the protein
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MsrA, which has been found in coagulase negative staphylococci to confer macrolide
resistance (Schmitz et al., 2000). Although stpA and smpA have high similarity to stpC
and smpC, with 85% and 65% respectively, their functions appear to be divergent. S.
aureus does not have a chromosomally encoded msrA gene, and mutation of stpC and
smpC does not affect macrolide resistance (Ross et al., 1996). Although it has been
shown that SACOL2525/2526 does not have the same function as stpA and smpA, its
actual role is currently unknown.
In addition to our work with NsaRS, a microarray performed on a graRS mutant of S.
aureus also showed decreased expression of SACOL2525/2526 (Herbert et al., 2007).
This of significant interest as both NsaRS and GraRS are IM-HKs associated with an
ABC transporter, both regulate SACOL2525/2526, and both are involved in cell wall
homeostasis. While NsaRS regulates the downstream transporter, NsaAB, this effect is
only seen in the presence of nisin. Conversely, NsaRS regulates SACOL2525/2526
under standard conditions, during exponential growth. As such, understanding the
function of this transporter will provide better insight into mechanisms NsaRS utilizes
to respond to cell-envelope stress, and potentially drug resistance.
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Materials and Methods
Bacterial strains, plasmids and growth conditions. E. coli was grown in LuriaBertani (LB) medium at 37 C. S. aureus was grown in 100 ml Tryptic Soy Broth
(TSB) (1:2.5 flask/volume ratio) at 37 C with shaking at 250 rpm, unless otherwise
indicated. For all experiments one ml of relevant overnight S. aureus cultures were used
to inoculate fresh media, and allowed to grow for 3h. These cultures were sub-cultured
into new media at an OD600 of 0.05 and allowed to grow for as long as the experiment
needed. When necessary, antibiotics were added at the following concentrations:
ampicillin 100 mg/ml (E. coli), erythromycin 5 mg/ml (S. aureus), lincomycin 25
mg/ml (S. aureus), and chloramphenicol 5 mg/ml (S. aureus).
Construction of the SACOL2525/2526 mutant strain. Fragment A was amplified
using OL1299/OL1300 (Table 2), is ~ 1.5 kb upstream of SACOL 2525 and a Mlu1
restriction site was added. Fragment B was amplified using OL1301/OL1672, is ~ 1.5
kb downstream of SACOL 2526 with an added Mlu1 site to the beginning. These
fragments were ligated together cloned into the pJB38 plasmid creating pSLL2. This
plasmid was electroporated into the S. aureus strain RN4220 and clones were selected
for using TSA containing chloramphenicol (plasmid encoded). The resulting isolates
were confirmed by genomic extraction and PCR analysis. The plasmid was extracted
and

a

confirmed

isolate

electroporated

into

SH1000,

again

selecting

for

chloramphenicol. The resulting isolates were confirmed by genomic extraction and PCR
analysis. A confirmed isolate was streaked onto a TSA plate containing
chloramphenicol and incubated overnight at 43°C. Isolates were passaged for 5 days
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Table 2. Strains, plasmids and primers used in this study.
Strain, plasmid
or primer
Genotype or description
Reference or source
E. coli
DH5α
Φ80 Δ(lacZ)M15 Δ(argF-lac)U169 endA1 recA1
Lab Stocks
+
hsdR17 (rK mK ) deoR thi-1 supE44 gyrA96 relA1
S. aureus
RN4220
SH1000
2002
SLL1
SLL2
SLL3
SLL4
Plasmids
pAZ106
1991
pMK4
1984
pJB38
pSLL1
pSLL2
pSLL3

Primers
OL1299
OL1300
OL1301
OL1584
OL1672
OL1673
OL1703
OL1704

Restriction deficient transformation recipient
Wild-Type Laboratory Strain rsbU functional

Lab Stocks
Horsburgh et al.,

SH1000 SACOL 2525/2526-lacZ fusion
SH1000 SACOL 2525/2526 mutant
SH1000 SACOL 2525/2526 mutant complemented
with pSLL3
SH1000 graR mutant

This Study
This Study
This Study
This Study

Promoterless lacZ erm insertion vector.

Kemp

cm shuttle vector

et

al.,

Sullivan et al.,

pAZ106 containing a 1.5 kb SACOL2525/2526
promoter fragment
pJB38 containing an 1.5 kb SACOL2525/2526
AB fragment
pMK4 containing a 2.5kb SACOL2525/2526
complementation fragment

This study
This study
This study

ATG ATG GAA TTC GTC ACG AGA GGA ATA ATT CCG C
ATG ATG ACG CGT CAT TCG CTC CAA CGA GAC CAA C
ATG ATG ACG CGT CCC TTC ACC CAA ATA ATG GTG CG
ATG GGA TCC CCG CCA ACT GTC GCA TTT ATC C
ATG ATG GGT ACC TGA TCG ACG ACT AAG CGT TGT ACG G
ATG ATG GAA TTC TAC CTG CAC CAT TCG CTC C
AGG CAC ATT TGT TGG CGT
AGC AAT GGC TAC TCC CGT

47

onto TSA containing chloramphenicol and incubated at 43°C to ensure incorporation of
the plasmid into the chromosome. Isolates were confirmed by genomic extraction and
PCR analysis and an 80α phage lysate created for transduction into a clean SH1000 and
selected by chloramphenicol. A confirmed isolate was grown in TSB containing
chloramphenicol at 30°C overnight. The resulting culture was diluted 10,000 times and
100 μl plated on TSA containing 1μg/ml of anhydrous tetracycline and incubated at
30°C overnight. Resulting isolates were streaked onto TSA and TSA containing
chloramphenicol. Isolates that grew on TSA only were selected and confirmed by
Southern blotting creating strain SLL2.
Construction of the SACOL2525/2526 reporter fusion strain. The putative promoter
region of the SACOL 2525/2526 loci was amplified as ~1.5 kb PCR fragments using
primer pair OL1584/OL1673 . The PCR fragment was cloned into pAZ106 creating
plasmid pSLL1 (SACOL 2525/2526-lacZ). S. aureus RN4220 was transformed with the
resulting plasmid, with clones selected for using TSA containing erythromycin (plasmid
encoded). The resulting strains were confirmed by genomic DNA extraction and PCR
analysis. An 80α phage lysate was created and used for the transduction of S. aureus
SH1000, with clones again confirmed by PCR analysis. This created strain SLL1
(SACOL 2525/2526-lacZ).
Construction

of

SACOL2525/2526

complemented

strain.

The

entire

SACOL2525/2526 locus was PCR amplified as a 2.0 kb fragment using primer pair OL1584/OL-1926. This fragment was cloned into the shuttle vector pMK4, creating
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pSLL3. S. aureus RN4220 was transformed with this construct, with clones selected for
on TSA containing chloramphenicol (plasmid encoded). Isolates were confirmed by
genomic DNA extraction and PCR analysis. A representative clone was selected to
generate an 80α phage lysate, which was used to transduce the SH1000,
SACOL2525/2526 mutants of S. aureus. Clones were again confirmed by PCR analysis,
creating strain SLL3.
Plate-based assay for determination of altered transcription from external stress.
This assay was performed as described previously (Shaw et al., 2008). TSA plates were
overlayed with TSA top agar (0.7% w/v) containing X-GAL, and the lacZ reporterfusion strain. Sterile filter discs were placed onto these plates (3 per plate), before being
inoculated with 10 µl of the following stress inducing chemicals: 6M HCl, 85%
phosphoric acid, 100% TCA, 88% formic acid, 0.2M acetic acid, 6M sulphuric acid,
6M nitric acid, 6M sodium hydroxide, 2M NaCl, 1M glucose, 95% ethanol, 100%
methanol, 100% isopropanol, 10% SDS, 10% Triton X-100, 10%Tween-20, 1M Nlauroyl sarcosine, 30% hydrogen peroxide, 1M methyl viologen, 1% menadione, 2 mg
ml-1 pyrogallol, 1M sodium nitroprusside, 1M 4-MMS, 5 mg ml-1 penicillin G, 5 mg ml1

vancomycin, 2 mg ml-1 phosphomycin, 5 mg ml-1 spectinomycin, 100 mg ml-1

ampicillin, 5 mg ml-1 tetracycline, 50 mg ml-1 kanamycin, 50 mg ml-1 neomycin, 10 mg
ml-1 chloramphenicol, 20 mg ml-1 puromycin,

2 mg ml-1 bacitracin, 2 mg ml-1

mupirocin, 500 mM diamide, 12.8 mg ml-1 berberine chloride, 4.21M peracetic acid,
0.1M EDTA, 1M DTT. Plates were incubated for 24 h at 37OC and screened for a blue
halo around the perimeter of the filter discs indicating the induction of expression.
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Real-time PCR. One ml of an overnight culture was laced into fresh TSB and allowed
to grow for 3 hours at 37°C, shaking. Cultures were standardized to OD600 of 0.05 in
TSB or TSB with sub-inhibitory concentrations of various chemicals. After the
specified hour, 3 ml samples were collected, mixed with ethanol and acetone (50:50)
and placed at -80°C. Samples were centrifuged at 4150 rpm for 10 minutes and cells
lysed using bead beating. RNA was extracted using the Qiagen RNeasy kit. Resulting
RNA was used to make cDNA using the iSCRIPT from Bio-Rad. cDNA was measured
on a nanodrop and standardized for qRT-PCR. SYBR green from Takara was mixed
with cDNA and the appropriate primers and qRT-PCR was performed on an Eppendorf
Mastercycler.
Microtitre MIC assay for cell-wall targeting drugs. Cultures of SH1000 and
SACOL2525/2526 mutant were diluted 1:1000 in fresh TSB and 200 μl was applied to
the wells of a 96-well plate. Chemicals were added to the wells in decreasing
concentrations and mixed by pipetting. Plates were incubated at 37°C and the minimum
inhibitory concentration determined by visual examination for the well containing the
lowest concentration producing no growth.
Survival in the free unsaturated fatty acid, oleic acid. Bacterial overnight cultures
were sub-cultured in fresh TSB and allowed to grow for 3 hours. Cells were washed
three times with sodium phosphate buffer before being standardized to an OD600 reading
of 0.05 in 5 ml sodium phosphate buffer. Oleic acid was added to a final concentration
of 0.01% and 30 μl sample removed every 15 minutes, serial diluted and plated to
determine cfu/ml.
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Survival in toluene. Bacterial overnight cultures were sub-cultured in fresh TSB and
allowed to grow for 3 hours. Cells were standardized to an OD600 reading of 0.05 in 100
ml TSB. Toluene was added to a final concentration of 1.5% and 30 μl samples
removed every 15 minutes, serial diluted and plated to determine cfu/ml.
Negative staining electron microscopy. Aliquots of cells grown in TSB for 3h were
initially fixed in an equal volume of 2% osmium tetroxide in distilled water for 1h at
4˚C. Following fixation, cells were rinsed in distilled water and pelleted 3 times at 5000
RPM for 10 minutes. Dilutions were performed to obtain approximately 2000-3000
cells per drop, before one drop of each sample was applied to a carbon-formvar coated
copper grid. Grids were allowed to air dry and photographed by electron microscopy.
Hydrophobicity assay using hexadecane. The hexadecane assay was performed at
described by Greene et al., 1992. Synchronized bacterial cultures were standardized to
an OD540 of 0.5 in 1ml of PBS. To each 150 μl of hexadecane was added, mixed
thoroughly and left at room temperature for 20 minutes for phase separation. The
aqueous phase was removed and the OD540 collected. Percent adherence was calculated
using
% adherence = (initial OD540 – final OD540 / initial OD540) * 100
Cytochrome C binding assay. The cytochrome C binding assay was performed at
described by Peschel et al., 1999. Bacteria were grown for 3 hours and harvested by
centrifugation. Cells were washed three times in MOPS buffer (20mM, pH 7) and
resuspended to a final OD600 of 7. Cytochrome C was added (0.5 mg/ml) and incubated
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at room temperature for 10 minutes. Cells were pelleted by centrifugation and
supernatants analyzed at 530 nm.
Peptidoglycan lysis kinetics assay. The lysis kinetic assay was performed as described
by Shaw et al., 2005. Cells were harvested from exponential-phase cultures, washed
three times with sodium phosphate buffer before being resuspended to an OD600 of 1.0.
Excess lysostaphin (50μg/ml) was added and OD600 values were recorded every 5
minutes using a plate reader.
Survival in daptomycin. Overnight cultures were synchronized and then standardized
to an OD600 of 0.05 in 5 ml TSB. Daptomycin was added to a final concentration of 0.75
μg/ml and samples taken every hour, serially diluted and cfu/ml calculated.
Lysostaphin treatment for removal of the cell envelope. Overnight cultures were
subcultured into fresh TSB and allowed to grow for 3 hours. Cells were pelleted by
centrifugation, washed three times in TSM buffer (50 mM Tris-HCl, 0.5 M sucrose, 10
mM MgCl2) before being resuspended in TSM buffer to an OD600 of 0.05. Lysostaphin
was added at a concentration of 5 μg/ml and incubated at 37°C for 45 minutes. Aliquots
were taken and gram stained to ensure removal of the cell envelope but not cell lysis by
observing pink cocci under the microscope. The resulting protoplasts were washed three
times with sodium phosphate buffer and resuspended in either TSB or TSB with CaCl2,
daptomycin (0.4 μg/ml), kanamycin (1.0 μg/ml), or CCCP (0.005 μg/ml).
Spontaneous mutation frequency. Overnight cultures (100 μl) of SH1000 or the
SACOL2525/2526 mutant were plated on TSA plates containing 3X the MIC of
bacitracin, nisin, vancomycin, teicoplanin, daptomycin, CCCP, phosphomycin and
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penicillin G at incubated at 37°C overnight. The overnight culture was also serially
diluted and cfu/ml determined for mutation frequency calculation.
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Results
In silico analysis of SACOL2525/2526. Since the function of SACOL2525/2526 has
not yet been investigated, other than they do not fulfill the same role as StpA and
SmpA, an in silico analysis was performed to identify any conserved domains and
homology to other proteins. The family that SACOL2525 belongs to was determined by
analyzing amino acid sequences using the NCBI site. This revealed that SACOL2525 is
similar to other ATP-binding proteins that are part of the galliderm-class lantibiotic
ABC transporter family. This family of ABC transporters is known to transport
lantibiotics, including nisin (Tomii & Kanehisa, 1998). SACOL2525 is the ATPbinding protein that comprises part of the ABC transporter system and as such has the
attributes/domains of similar proteins, including an ATP-binding domain, an ABC
transporter signature motif, a Walker A/P loop and no transmembrane domains. Using
the ClustalW2 software, the amino acid sequence of SACOL2525, EpiF from
Staphylococcus epidermidis, MutL from Streptococcus mutans, and two other predicted
ATP-binding proteins that have similarity to members of the galliderm-class lantibiotic
ABC transporter family, from S. hominis and S. haemolyticus were compared (Figure
8). EpiF from S. epidermidis is part of an ABC transport system that mediates
protection from epidermin, by pumping it outside of the cell (Peschel & Gotz, 1996).
Interestingly, SACOL2525 was found to have 84% similarity to EpiF at the amino acid
level. Similarly, MutL from S. mutans is the ATP-binding protein of an ABC transport
system that confers resistance to mutacin (Chen et al., 1999). SACOL2525 only had
40% similarity with MutF at the amino acid level.
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Figure 8. Amino acid sequence alignment of SACOL2525. The amino acid sequence
of SACOL 2525; the lantibiotic transporter ATP-binding protein, EpiF, from
Staphylococcus epidermidis; the lantibiotic transporter ATP-binding protein MutL from
Streptococcus mutans; and two other predicted ATP-binding proteins (from S. hominis
and S. haemolyticus) that have similarity to the galliderm-class of lantibiotic ABC
transporters were compared using ClustalW2 software. The asterisks represent a
conserved residue in all sequences, whilst a colon indicates a strong similarity between
residues. A period signifies conservation between residues with similar biochemical
properties. Colors are designating according to the physicochemical properties of amino
acids: red (small and hydrophobic); blue (acidic); magenta (basic) and green (hydroxyl
+ sulfhydryl + amine).
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Analysis of the integral membrane protein, SACOL2526, shows that it does not have
domains specific for lantibiotic transport. SACOL2526 has six transmembrane domains,
which several other lantibiotic drug transporters have, including SpaG and NisG of B.
subtilis (Dawson & Locher, 2006; Kuipers et al., 1993). These proteins bind as dimers,
creating a 12 transmembrane channel for the passage of drugs. Collectively this data
suggests that SACOL2525/2526 may form the two components of an ABC transport
system that is specific to lantibiotics and/or other drugs. When one analyzes the coding
region for SACOL2525/2526 it is apparent that they are likely transcriptionally linked,
as only 15bp separates the 2 open reading frames. Upstream of SACOL2525 is a
putative consensus sequence for recognition by the housekeeping sigma factor, σA
(Figure 9). Specifically, we determined a -35 sequence of TTcACA, followed by a 17
bp spacer, and a -10 sequence of TATAAT. Since this predicted ABC transporter
contains the consensus sequence recognized by σA, this may suggest that
SACOL2525/2526 is utilized by the cell under standard conditions.
Transcriptional profiling of the SACOL2525/2526 ABC transporter. To analyze the
utilization of SACOL2525/2526 by S. aureus, its transcriptional profile was determined.
Using qRT-PCR, expression was observed during both the exponential and postexponential phases of growth (Figure 10). Primers specific for SACOL2525 or
SACOL2526 were utilized, however both produced similar results as they are predicted
to be transcribed under one promoter. As such, the data for primers specific to
SACOL2526 are presented herein, and throughout, even though SACOL 2525 primers
were also used, and corroborated findings in each case. We determined that expression
was highest at hour 3, which declined 2.4-fold by hour 5, and 3.2-fold by hour 15.
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Figure 9. The SACOL2525/2526 operon. The operon structure of SACOL2525/2526.
Shown are the consensus sequences for a lone predicted promoter found upstream of
SACOL2525 that appears to control both open reading frames. Also shown are relative
spacing between elements, and predicted ribosome binding-sites.
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Figure 10. Transcription of SACOL2525/2526 during growth in standard
conditions. qRT-PCR was performed on SACOL2525/2526 at hours 3 (exponential
phase), 5 (post-exponential phase) and 15 (stationary phase) in SH1000 grown under
standard conditions. The data presented are from three independent cultures and error
bars are shown +/- SEM.
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Given that SACOL2525/2526 has homology to other SMR multi-drug transporters, we
next set out to determine if any modulation in transcription of this transporter is seen in
the presence of stressor compounds. This was performed using a lacZ fusion in strain
SH1000, which was constructed by cloning the entire predicted promoter region
upstream of SACOL2525 upstream of the lacZ gene in the suicide vector pAZ106 (see
Methods). As such, each time SACOL2525/2526 is transcribed from its promoter, the
lacZ gene is also, which is then translated into β-galactosidase. When β-galactosidase
and X-Gal come into contact, the X-Gal is cleaved and a blue color is visualized. This
strain was then utilized in a plate based assay as described by ourselves and others (Cao
et al., 2002; Shaw et al., 2008), with a variety of antibacterial chemicals (Table 3). An
overlay containing the lacZ fusion strain, and the β-galactosidase substrate X-Gal at 40
μg/ml, which would not ordinarily result in blue coloration, was inoculated onto TSA
plates. A sterile filter disk was placed on the plates and 10 μl of each chemical was
added and allowed to dry. The plates were incubated overnight at 37°C and the
appearance of a blue ring around the zone on inhibition signified an increase in
transcription, as a result of X-Gal cleavage by β-galactosidase. We determined that
several cell-envelope-targeting agents, including penicillin G, phosphomycin,
bacitracin, chloropromazine, CCCP, oxacillin and ampicillin produced a blue ring in
this analysis, suggesting an increase in SACOL2525/2526 transcription (Table 4). In
addition, triclosan, which inhibits fatty acid synthesis by targeting FabI, also increased
transcription. Novobiocin, a drug that inhibits DNA replication by targeting the gyrase
enzymes produced the same effect. To quantitatively confirm these results, qRT-PCR
was conducted on the SH1000
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Table 3. Stressor compounds used in the plate-based assay to determine the
inducibility of SACOL2525/2526 expression.
Stress
Chemical
Concentration
Cell-envelopetargeting
Antibiotics

Daptomycin*
Gramicidin
CCCP*
Chloropromazine*
D-cycloserine
Penicillin G*
Oxacillin*
Cefotaxime
Phosphomycin*
Vancomycin
Ampicillin*
Bacitracin

10 µg
50 µg
1 µg
50 µg
50 µg
20 µg
50 µg
50 µg
20 µg
20 µg
1 mg
20 µg

Other Antibiotics

Nalidixic Acid
Ciprofloxacin
Novobiocin*
Triclosan*
Chloramphenicol
Phosphomycin
Spectinomycin
Tetracycline
Erythromycin
Lincomycin
Kanamycin
Neomycin
Puromycin
Mupirocin

50 µg
50 µg
50 µg
10 µg
50 µg
20 µg
50 µg
50 µg
50 µg
250 µg
500 µg
500 µg
250 µg
20 µg

Acid

Hydrochloric Acid
Phosphoric Acid
Formic Acid
Acetic Acid
Sulphuric Acid
Nitric Acid
Trichloroacetic Acid

6M
10 M
12 M
1M
12 M
6M
12 M

Alkali

Sodium Hydroxide

3M

Osmotic

Sodium Chloride
Glucose

1M
1M
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Table 3 continued
Alcohol

Ethanol
Methanol
Isopropanol

100%
100%
100%

Detergent

Sodium Dodecyl Sulfate
Triton X-100
Tween-20
N-lauroyl Sarcosine

10%
1%
1%
1%

Oxidative

Hydrogen Peroxide
Methyl Viologen
Menadione
Pyrogallol

30%
2M
1%
4 mg

Nitrosative

Sodium Nitroprusside

1M

DNA Damage

Methyl Methansulfonate
Ethyl Methanesulfonate

50 mM
50 mM

Miscellaneous

Berberine Chloride
Peracetic Acid

128 µg
4.2 M

*And in bold = chemicals that increased transcription of SACOL2525/2526
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Table 4. Cell-envelope-targeting antibiotics utilized to determine the transcription
of SACOL2525/2526 under cell-envelope stress
Drug

Target
intracellular peptidoglycan
subunit assembly
intracellular peptidoglycan
subunit assembly
transport and anchoring
via lipid II
transport and anchoring
via lipid II
extracellular cross-linking
of peptidoglycan subunits
extracellular cross-linking
of peptidoglycan subunits
extracellular cross-linking
of peptidoglycan subunits

Results in damage of
cell-wall biosynthesis
phosphomycin*
pathway
cell-wall biosynthesis
D-cycloserine*
pathway
cell-wall biosynthesis
nisin
pathway
cell-wall biosynthesis
teicoplanin
pathway
cell-wall biosynthesis
ampicillin*
pathway
cell-wall biosynthesis
penicillin G*
pathway
cell-wall biosynthesis
oxacillin*
pathway
cell-wall biosynthesis
bacitracin
re-entry of bactoprenol carrier
pathway
gramicidin
pore forming
cell-membrane
daptomycin*
pore forming
cell-membrane
CCCP *
loss of the proton motive force
cell-membrane
chloropromazine* ion flux across the cell membrane
cell-membrane
* denotes chemicals shown to increase transcription of SACOL2525/2526
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wild-type strain during a window of peak SACOL2525/2526 expression (3h), grown in
either TSB or TSB with sub-inhibitory concentrations of the compounds shown to
increase transcription. In addition, drugs that increase the transcription of nsaRS, but did
not produce an increase in SACOL2525/2526 on the plate based assay, including
daptomycin, D-cycloserine, nisin and gramicidin, were also included (Figure 11). The
largest effect was observed with CCCP, which produced a 10.2-fold increase in
transcription. Further to this, penicillin G produced a 7.8-fold increase, followed by
chloropromazine which showed a 6.3-fold elevation. Daptomycin and phosphomycin
produced a 3.9 and 2-fold increase respectively. The fatty acid targeting drug triclosan
produced a 2-fold increase, however the other, non cell-envelope-targeting drug,
novobiocin, did not alter expression. The remaining drugs, oxacillin, vancomycin,
bacitracin, nisin, novobiocim, ampicillin and D-cycloserine produced fold changes
below 2-fold, suggesting that they result in limited differences in SACOL2525/2526
transcription, at least using the concentrations and conditions tested herein.
NsaRS, but not GraRS, regulates transcription of SACOL2525/2526 in response to
a variety of cell-envelope-targeting compounds. NsaRS and GraRS have both been
shown to regulate SACOL2525/2526. As stated previously, SACOL2525/2526
transcription increases in the presence of a multitude of cell-envelope-targeting drugs
that affect various stages in the cell wall biosynthesis pathway. To determine if the
observed increase in transcription is influenced by either NsaRS or GraRS, qRT-PCR
was conducted for SACOL2525/2526 in either an nsaS or graR mutant. These strains
were grown in sub-inhibitory concentrations of the same drugs that increase
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Figure 11. Inducibility of SACOL2525/2526 by antibacterial agents. qRT-PCR was
performed on SACOL2525/2526 in SH1000 at hour 3 under standard conditions, or in
the presence of sub-inhibitory concentrations of the chemicals indicated. The data
presented are from three independent cultures and error bars are shown +/- SEM. A
Student’s T-Test was used with a 5% confidence level to determine statistical
significance, ** = p 0.01, *** = p< 0.001, **** = p 0.0001.
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SACOL2525/2526 transcription, and were compared to expression in the SH1000 wildtype (Figure 12). Interestingly, transcription of SACOL2525/2526 was not significantly
altered in a graR mutant in the presence of any drug tested. However, a decrease in
transcription was observed for several compounds in the nsaS mutant. Specifically,
mutation of nsaS caused a 2.7-fold reduction in expression in the presence of
daptomycin. In addition, a 5.2-fold reduction was observed for penicillin G. The largest
alteration was in the presence of the membrane targeting drug CCCP, with a 7.1-fold
decrease observed compared to the parental strain. All of the other drugs tested
generated a fold change less than 2, and thus NsaRS does not strongly influence the
increases

in

transcription

produced

by

ampicillin,

oxacillin,

D-cycloserine,

phosphomycin and chloropromazine. Collectively, this suggests that NsaRS regulates
SACOL 2525/2526 in response to a variety of cell-envelope- targeting antimicrobial
agents, although other factors also appear to be at work.
SACOL2525/2526 aids in resistance to daptomycin. Several cell-envelope-targeting
drugs increase the transcription of SACOL2525/2526, and hence a SACOL 2525/2526
mutant was constructed to determine the sensitivity of this strain to such agents. In
addition, the mutation was complemented by introducing SACOL2525/2526, along
with its native promoter, on the pMK4 shuttle vector into mutant strains (see methods).
The sensitivity of the mutant to a variety of chemicals was determined via MIC analysis
for phosphomycin, ampicillin, penicillin G, D-cycloserine, oxacillin, daptomycin,
chloropromazine, bacitracin, nisin, teicoplanin and gramicidin. No difference in
sensitivity was found between the two strains for any of these compounds. MIC assays
are performed overnight, and thus it is possible
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Figure 12. The impact of GraRS and NsaRS on the transcription of
SACOL2525/2526. qRT-PCR was performed on SACOL2525/2526 at hour 3 under
standard conditions, or in the presence of sub-inhibitory concentrations of the chemicals
listed. The strains used were the wild-type (blue), graR mutant (red) and nsaS mutant
(green). The data presented are from three independent cultures and error bars are
shown +/- SEM. A Student’s T-Test was used with a 5% confidence level to determine
statistical significance, ** = p 0.01, *** = p< 0.001, **** = p 0.0001.
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that the mutant might be more sensitive to a given compound initially, but it ultimately
does not impact final growth yields. To eliminate this possibility, death curves were
performed during 5 hours of incubation in the presence of lethal concentrations of
several of these compounds. No difference in the rate of death was observed with
penicillin G, bacitracin, gramicidin or CCCP (Figure 13). We did note, however, that in
the presence of daptomycin, the SACOL2525/2526 mutant had decreased survivability
compared to the wild-type and complemented strains (Figure 14). Daptomycin affects
the cell membrane, and must diffuse through any external barriers, including teichoic
acids, peptidoglycan and capsule, to impact its target. As S. aureus produces has many
such impediments when grown under standard conditions (O’Riordan & Lee, 2004), we
sought to determine if the decrease in survivability of the SACOL2525/2526 mutant in
the presence of daptomycin could be enhanced by the removal of these elements. As
such, strains were first treated with 5μg/ml of lysostaphin for 45 minutes to remove the
cell wall, along with all proteins and molecules external to the membrane. After
treatment, samples of the resulting protoplasts were Gram stained to ensure the removal
of peptidoglycan, and that cell lysis had not occurred. In addition, the cfu/ml of cells
before and after lysostaphin treatment was determined to ensure that treatment did not
affect one strain more than the other (Figure 15).

After treatment, the resulting

protoplasts were washed to remove the lysostaphin, before being subject to death curve
kill studies. First, control experiments were performed to determine if either TSB or
TSB with 1 mM CaCl2, had an effect on cell viability (Figure 16). For these analyses,
CaCl2 was used as a control because it is required for daptomycin to exert its activity
(Jung et al., 2004;
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Figure 13. SACOL2525/2526 do not present enhanced sensitivity to a number of
cell-wall targeting chemicals. Growth of the SH1000 wild-type (blue),
SACOL2525/2526 mutant (red) and complemented (green) strains was analyzed over 5
hours in the presence of lethal concentrations of: gramicidin (15 μg/ml), penicillin G
(0.5 μg/ml), CCCP (0.05 μg/ml) or bacitracin (25 μg/ml). The results presented are
representative of three independent cultures that show less than 10% viability.
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Figure 14. SACOL2525/2526 aids in the resistance of S. aureus to daptomycin.
Growth of the SH1000 wild-type (blue), SACOL2525/2526 mutant (red) and
complemented (green) strains was analyzed over 5 hours in the presence of a lethal
concentration of daptomycin (0.75 μg/ml + 1mM CaCl2). The results presented are
representative of three independent cultures that show less than 10% viability. A
Student’s T-Test was used with a 5% confidence level to determine statistical
significance, ** = p<0.01, **** = p 0.0001.
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Figure 15. Lysostaphin treatment does not lead to increase death in the
SACOL2525/2526 mutant. Lysostaphin was added to the wild-type (WT),
SACOL2525/2526 mutant (M) and its complemented strain (C)at 5 μg/ml for 45
minutes at 37°C. cfu/ml was calculated by serial dilution and plating before (black) and
after (grey) lysostaphin treatment. The error bars are shown as +/- SEM.
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Figure 16. SACOL2525/2526 mutants have a weakened cell membrane. The
SH1000 wild-type (blue), SACOL2525/2526 mutant (red) and complemented (green)
strains were treated with 5 μg/ml of lysostaphin and the resulting protoplasts were
incubated in either TSB, TSB with CaCl2 (1 mM) or TSB with NaCl (1 mM). Growth
was analyzed over the course of 5 hours; the results presented are representative of three
independent cultures that show less than 10% viability. A Student’s T-Test was used
with a 5% confidence level to determine statistical significance, *** = p< 0.001, **** =
p< 0.0001.
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Ho et al., 2008). In TSB alone, the SACOL2525/2526 mutant had decreased
survivability when compared to the wild-type and complemented strain. Specifically, a
31.3-fold decrease in the SACOL 2525/2526 mutant viability was observed at hour 2
that declined further at hour 3 (391-fold), and continued through hours 4 (343-fold) and
hour 5 (442-fold). Significantly, this phenotype was completely reversed upon the
addition of CaCl2, with all three strains surviving equally well upon its addition to TSB.
To determine if this effect was specific to CaCl2, survival in 1 mM NaCl was also
evaluated. Again, the decreased survival in TSB by the mutant strain was completely
reversed, as all three strains grew equally. Next, the survival of the three strains was
analyzed in TSB with 1 mM CaCl2 and 0.4 μg/ml of daptomycin (Figure 17). It should
be noted that this concentration is not normally lethal to cells, but is however, toxic to
protoplasts. Despite our findings when used by itself, the addition of CaCl2 in the
presence of daptomycin was unable to rescue viability of the SACOL 2525/2526 mutant
compared to the wild-type. Specifically, a significant difference was seen at hour 2,
which produced a 17.2-fold decrease in survival. This effect was further enhanced at
hours 3 (159-fold), hour 4 (209-fold) and hour 5 (264-fold). To determine if this effect
is specific to daptomycin, the same analysis was performed for CCCP (5.0 ng/ml),
gramicidin (10 μg/ml) and kanamycin (1.0 μg/ml). CCCP works by altering the proton
motive force of membranes, whilst gramicidin produces similar damaging effects to
daptomycin by inserting into the membrane. Kanamycin was used as a control as it does
not target the membrane or cell wall, but instead inhibits protein synthesis. Neither
CCCP, gramicidin or kanamycin produced the same effect as daptomycin when tested,
as all three strains had similarly declining viability upon
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Figure 17. SACOL2525/2526 mutant protoplasts have elevated sensitivity to
daptomycin. The SH1000 wild-type (blue), SACOL2525/2526 mutant (red) and
complemented (green) strains were treated with 5 μg/ml of lysostaphin. The resulting
protoplasts were incubated in either TSB with 1 mM CaCl2 and 0.4 μg/ml daptomycin,
5 ng/ml CCCP, 10 μg/ml gramicidin or 1.0 μg/ml kanamycin. Growth was analyzed
over the course of 5 hours and the results presented are representative of three
independent cultures that show less than 10% viability. A Student’s T-Test was used
with a 5% confidence level to determine statistical significance, ** = p<0.01, *** = p<
0.001.
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analysis. This suggests that SACOL2525/2526 aids S. aureus in resistance to
daptomycin specifically.
SACOL2525/2526 aids in the ability of S. aureus to spontaneously resist the action
of a variety of cell-envelope targeting antibiotics. Work by ourselves and others
reveals that NsaRS has a role in the resistance to nisin and bacitracin. NsaRS regulates
SACOL2525/2526, and their mutants share several phenotypic commonalities. In
addition, SACOL2525/2526 is predicted to be a multi-drug transporter based on
homology analyses, and disruption of this transporter leads to increased sensitivity
towards the cell-membrane-targeting antibiotic, daptomycin. Thus the ability of
SACOL2525/2526 to mediate resistance to cell-envelope-targeting drugs was
investigated. The spontaneous mutation frequency for bacitracin, nisin, vancomycin,
teicoplanin, daptomycin, CCCP, phosphomycin and penicillin G were analyzed using
10 different replicates from 3 independent cultures of either the wild-type or
SACOL2525/2526 mutant (Figure 18). Interestingly, no alteration in frequency was
observed for nisin, vancomycin, CCCP or phosphomycin. We did, however, observe
differences for the remaining 4 drugs, which all produced a significant difference in the
number of isolates that were able to spontaneously resist the action of these compounds.
The SH1000 wild-type produced a mutation frequency of 5.03 x 10-8 for teicoplanin,
while the SACOL2525/2526 mutant displayed a 3.1-fold decrease, with a frequency of
only 1.58 x 10-8. The spontaneous mutation frequency for daptomycin produced similar
results, with the wild-type generating a resistance frequency of 1.85 x 10-9, while the
SACOL2525/2526 mutant showed a 3.6-fold decrease of only 5.04 x 10-10. The
observed frequency for the mutant in response to penicillin G had a larger discrepancy,
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Figure 18. SACOL2525/2526 aids in the ability to spontaneously resist the action of
a variety of cell-envelope-targeting antibiotics. The SH1000 wild-type (WT) and
SACOL2525/2526 mutant (M) were grown on TSA containing 3X the MIC of the
antibiotics indicated. Plates were incubated overnight, and spontaneous mutants were
allowed to develop. Mutation frequencies were calculated with respect to the initial
inoculum. Data is presented from three independent cultures and at least 10 replicates.
Error bar are shown as +/- SEM. A Student’s T-Test was used with a 5% confidence
level to determine statistical significance, * = p<0.05, ** = p<0.01.
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with a 13.7-fold decrease in mutability. Specifically, we observed a frequency for the
wild-type of 1.31 x 10-9 towards penicillin G, and 9.52 x 10-11 for the mutant. The
largest difference was seen with bacitracin, with a 17.1 decrease in the mutant, with the
parent generating a 1.63 x 10-8 mutation frequency, and the SACOL 2525/2526 mutant
resulting in a frequency of 9.25 x 10-10.
SACOL2525/2526 is part of the S. aureus resistance mechanism against toxic nonantibiotic chemicals that target the cell membrane. In contrast to many of the other
agents analyzed above, triclosan increases transcription of SACOL2525/2526, but does
not target the bacterial cell envelope. Instead, triclosan impacts fatty acid synthesis via
inhibition of FabI (Slater-Radosti et al., 2001). To determine if the mutant was sensitive
to triclosan, the minimum-inhibitory concentration (MIC) determined for this strain
compared to the wild-type. Upon analysis it was found that both strains have an MIC
for this compound of 0.1μg/ml. Next, growth of the wild-type and mutant strain in the
presence of a sub-inhibitory concentration of this agent (0.05 μg/ml) was evaluated over
5 hours, with no difference again observed in either growth rates or yields. Fatty acids
are synthesized and inserted into the membrane to control fluidity, among other roles
(Zhange & Rock, 2008). Since the mutation of SACOL2525/2526 had no effect on
sensitivity to the inhibition of fatty acid synthesis, we examined the effect of free fatty
acids on the SACOL2525/2526 mutant. Oleic acid is an unsaturated free fatty acid that
inserts into the membrane of bacteria causing a variety of damage, including
interference with proteins needed for energy and metabolism, the inhibition of
biosynthetic pathways, peptidoglycan precipitation, altered membrane fluidity, cell
leakage and eventually lysis (Galbraith & Miller, 1973; Knapp & Melly., 1986; Speert
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et al., 1979; Chamberlain et al., 1991; Xiong & Kapral., 1992). As such, the wild-type,
mutant and complement strains were standardized to an OD600 of 1.0 in PBS containing
a lethal concentration of oleic acid (0.01%) and the cfu/ml was evaluated every 15
minutes for 90 minutes. What was found was that the viability of all strains vastly
decreased compared to the inoculum, however the SACOL2525/2526 mutant survived
considerably better than the other strains (Figure 19). Specifically, after 15 minutes
0.002% of the wild-type, 0.08% of the SACOL2525/2526 mutant, and 0.005% of the
complemented strain inoculums was recovered; resulting in a 30-fold increase in
survivability of the mutant. Additionally, no cells from the wild-type or complemented
strain could be recovered after 15 minutes, while viable SACOL2525/2526 mutant
cells were found up to 90 minutes post-inoculation. The increased survivability of the
SACOL2525/2526 mutant clearly shows that it is more resistant to unsaturated free
fatty acids than either the parental or complemented strains. Gram-positive bacteria
often resist the action of free fatty acids by decreasing the fluidity of their membrane
(Desbois & Smith, 2010). Therefore, we hypothesized that, in the presence of
unsaturated free fatty acids, S. aureus decreases fluidity of its membrane to cope with
this stress, and may do so by decreasing the expression of SACOL2525/2526. In order
to determine if this in fact the case, qRT-PCR for SACOL2525/2526 transcript levels in
the presence of oleic was performed. Upon analysis, we observed a 5-fold decrease in
expression of the transporter for SH1000 grown in 1.5% Oleic acid, compared to
unsupplemented TSB (Figure 20). Surprisingly when S. aureus is grown in rich media
(TSB) it is able
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Figure 19. SACOL2525/2526 mutation protects the cell in the presence of free
unsaturated fatty acids. A). The SH1000 wild-type (blue), SACOL2525/2526 mutant
(red), and SACOL2525/2526 complement (green) strains were standardized in PBS
containing 0.01% oleic acid. The survivability of strains was then evaluated over time
by serial diluting and plating. Error bars are shown as +/- SEM. B). Fold change in
viability of the mutant (M) and complemented (C) strains compared to the wild-type.
Data is presented from three independent cultures, with a student’s T-Test using a 5%
confidence level used to determine statistical significance, * = p<0.05. The error bars
are shown as +/- SEM.
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Figure 20. Transcription of SACOL2525/2526 in the presence of oleic acid. qRTPCR was performed on SACOL2525/2526 in SH1000 cells grown for 3h in TSB under
standard conditions, or in the presence of a sub-inhibitory concentration of oleic acid
(1.5%). The data presented are from three independent cultures, with error bars are
shown as +/- SEM. A Student’s T-Test was used with a 5% confidence level to
determine statistical significance, *** = p< 0.001.
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to withstand much higher concentrations of oleic acid than in PBS. As such, despite the
fact that 1.5% oleic acid is a very high concentration, it was not toxic and did not affect
growth of SH1000 in TSB. To further corroborate this finding, growth in toluene was
investigated as Gram-positive bacteria that have increased membrane fluidity also have
higher solvent tolerance (Nielsen et al., 2005). Death in 1.5 % toluene was evaluated
over a 120 minute time span for SH1000 and its SACOL2525/2526 mutant and
complemented strains (Figure 21). While all strains decreased over time, the
SACOL2525/2526 mutant declined far more rapidly than the parent. Specifically, after
30 minutes a 4.2-fold decrease was observed in mutant cell numbers, followed by a 5.8fold reduction after 60 minutes when compared to the wild-type. Collectively this data
suggest that SACOL2525/2526 contributes to the membrane composition by putatively
aiding in membrane fluidity.
SACOL2525/2526 mutants of S. aureus have altered cell envelope architecture. Our
data thus far suggests that SACOL2525/2526 mutants potentially have altered
membrane architecture. In addition, a microarray performed on S. aureus grown in the
presence of linoleic acid, another unsaturated free fatty acid, which disrupts the cell
wall in a manner akin to oleic acid, revealed decreased SACOL2525/2526 transcription,
and an increase in the expression of capsule genes (Kenny et al., 2009). This is
intriguing as nsaS mutants have both decreased SACOL2525/2526 transcription, and
increased capsule production. As such, negative staining TEM analysis was performed
on the SH1000 wild-type, SACOL2525/2526 mutant and the complemented strains
grown in TSB for 3 hours (Figure 22). Interestingly, the SACOL2525/2526 mutant
showed increased encapsulation when compared to the other strains. It has been
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Figure 21. SACOL2525/2526 contributes to resistance against solvent stress. The
SH1000 wild-type (blue), SACOL 2525/2526 mutant (red) and complemented (green)
strains were inoculated into TSB containing 1.5 % toluene. Their survivability was
evaluated by serial diluting, plating and calculation of the percent recovery compared to
the initial inoculum. The data presented are from three independent cultures. A
Student’s T-Test was used with a 5% confidence level to determine statistical
significance, *** = p< 0.001, **** = p 0.0001. Error bars are shown as +/- SEM.
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Figure 22. SACOL2525/2526 mutants have increased capsule production. SH1000,
along with the SACOL2525/2526 mutant and complemented strains were grown in TSB
(3 h), and prepared for negative staining analysis. Presented are TEM images that are
representative of more than 10 separate frames, from three independent cultures.
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previously been shown that along with decreasing membrane fluidity for resistance to
fatty acids, S. aureus also increases capsule production in an attempt to construct a
barrier to lessen the contact of free fatty acids with the membrane (Kenny et al., 2009).
When the cell changes the composition or abundance of fatty acids in the membrane,
either increasing or decreasing fluidity, the phosphatidylglycerol outer polar head
groups attached to the fatty acid, commonly stay the same, and only the fatty acid tails
are altered (Mishra et al., 2011). For example, by placing more saturated fatty acids in
the membrane, the cell can decrease fluidity because fatty acids do not contain any
double bonds, and therefore pack together tightly; however the polar head group
remains the same. Using this mechanism, the outer polar head groups of the membrane
lipids still come into contact with any environmental chemicals (free fatty acids) no
matter the composition. Therefore, increasing capsule production acts as a barrier to try
to limit the contact of the free fatty acids with the membrane (Kenny et al., 2009). As a
result, increased capsule production has been shown to increase the overall
hydrophilicity of the bacterial cell (Greene et al., 1992). This change in hydrophilicity is
a result of the proteins that are added to the cell envelope, including capsule proteins.
To determine if excess capsule seen with the TEM analysis alters the overall
hydrophilicity of the cell, a hexadecane assay was employed using the wild-type,
SACOL2525/2526 mutant and complemented strains (Figure 23).

Bacterial

suspensions were mixed with hexadecane and the two phases were allowed to separate
for 20 minutes. Hydrophilic encapsuled cells do not bind to hexadecane, and thus
remains in the aqueous layer upon exposure, which can be then be measure
photometrically. Upon analysis we observed that the SH1000 wild-type and
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Figure 23. SACOL2525/2526 mutant cells have altered hydrophobicity. A
hexadecane assay was performed on the SH1000 wild-type (WT), SACOL2525/2526
mutant (M) and complemented (C) strains. Bacterial suspensions were mixed with
hexadecane and the two phases were allowed to separate. The aqueous layer was
removed, the OD600 read and the percentage of cells in the aqueous layer, indicating
increased hydrophilicity, calculated. The data presented are from three independent
cultures and error bars are shown as +/- SEM. A student’s T-Test with a 5% confidence
level was used, * = p<0.05.
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SACOL2525/2526 complemented strains only retained 20% and 18% of the total
number of cells, respectively, in the aqueous layer. The SACOL2525/2526 mutant,
however, displayed a higher amount, with 31% of cells not binding to hexadecane, and
remaining in the aqueous layer. This suggests that the SACOL2525/2526 mutant cells
are more hydrophilic than the parent and complemented strains, which is perhaps
explained by its increased encapsulation. Another aspect of the cell envelope is surface
charge, which is controlled in S. aureus by a number of factors, including GraRS (Sass
& Bierbaum, 2009; Herbert et al., 2007). GraRS not only regulates SACOL2525/2526,
but also alters the expression of the dlt operon, which ultimately changes cell charge to
be more positive, in order to decrease the binding of harmful charged elements such as
antibiotics and antimicrobial peptides. Changing the overall surface charge differs from
altering cellular hydrophobicity. Hydrophobicity results from proteins and molecules
deposited on the outside of the cell membrane, whilst cell charge in S. aureus is altered
by introducing a positively charged lysyl group into the phosphatidylglycerol head
group of membrane lipids (Peschel et al. 2001). Since the SACOL2525/2526 mutant has
altered hydrophilicity, the cell surface charge was also evaluated. To determine if the
SACOL2525/2526 mutant has altered cell surface charge, a cytochrome C binding
assay was performed with the SH1000 wild-type, SACOL 2525/2526 mutant and the
graR mutant, which was included as a control (Figure 24). Cytochrome C is positively
charged and therefore binds to the negatively charge S. aureus cell. We determined that
SH1000 and its SACOL2525/2526 mutant bound very similar, low amounts of
cytochrome C (17% and 22%, respectively). In contrast, the graR mutant had a
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Figure 24. SACOL2525/2526 deletion does not effect cell surface charge. A
cytochrome C assay was performed on the SH1000 wild-type (WT), SACOL2525/2526
mutant (M) and graR mutant (G) strains. Cytochrome C was added to cells and allowed
to bind. The cells were pelleted and the OD540 of the supernatant was used to determine
the percentage of cytochrome C bound. The data presented are from three independent
cultures and error bars are shown as +/- SEM.
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2.7-fold increase, with 46% of the cytochrome C bound, suggesting that
SACOL2525/2526 mutants do not have altered surface charge and that the
phosphatidylglycerol head groups of the lipids are likely similar.
SACOL2525/2526 contributes to protection against lysostaphin. An altered cellenvelope has been reported to affect the interaction between antimicrobial compounds
and bacterial cells; and ultimately their activity and potency (Cui et al., 2006; Pillai et
al., 2007). Given that our data thus far shows that the SACOL2525/2526 mutant has
altered cell envelope architecture, particularly with regard to increased capsule
production, a lysostaphin kinetics assay was performed to determine if this alteration
affects resistance to lytic bacterial agents (Figure 25). The nsaS mutant was also
included in this analysis due to its increased capsule production. SH1000 wild-type, its
SACOL2525/2526 mutant and complemented strains, alongside and the nsaS mutant,
were standardized to an OD600 of 1.0 in PBS, before 50 μg/ml of lysostaphin was added.
OD600 readings were taken every 5 minutes, and the percent lysis, compared to the
initial inoculum, was determined. While the viability of all strains declined rapidly, the
SH1000 wild-type and complement strains lysed far faster than the SACOL2525/2526
or nsaS mutant strains. Specifically, after 15 minutes, 77% and 78% of the wild-type
and complement strains had lysed, yet only 53% and 48% of the SACOL2525/2526 and
nsaS mutants lysed, respectively. After 25 minutes of incubation, almost all of the wildtype and complement strains were lysed, whilst the 2 mutant strains, took an additional
10 minutes each to reach similar levels of lysis. This suggests that alterations in the cell
envelope of the SACOL2525/2526 and nsaS mutant strain perhaps decrease the
sensitivity to lysostaphin.
87

Figure 25. SACOL2525/2526 mutants have decreased sensitivity to the cell wall
targeting agent lysostaphin. Lysostaphin lysis reaction kinetics for the SH1000 wildtype (blue), SACOL2525/2526 mutant (red), complemented strain (green) and the nsaS
mutant (purple) were performed using excess lysostaphin (50 μg/ml). The OD600 for
each strain was recorded every 5 minutes, and the percentage of cell lysis was
calculated in relationship to cultures pre-exposure (T=0). The data presented are from
three independent cultures and error bars are shown as +/- SEM. A Student’s T-Test
was used with a 5% confidence level to determine statistical significance, *** = p<
0.001, **** = p 0.0001.
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Discussion
In silico analysis demonstrates that SACOL2525 is an ATP-binding protein that is
similar to members that transport galliderm-class lantibiotics. Only a few of these
proteins have been studied, but many have been found to aid in immunity of the cell to
lantibiotics by exporting these peptides (Peschel & Gotz, 1996; Chen et al., 1999).
Analysis of SACOL2526, located downstream of SACOL2525, revealed that it is an
integral membrane protein, although no major homology was observed with other
transporters in the database. Together these two proteins form an ABC-transport system
that may serve a role in the protection of S. aureus from lantibiotics and /or peptide
antibiotics. Lantibiotics are peptides that are ribosomally synthesized and have been
shown to contain unusual amino acids, such as lanthionine and dehydrated amino acids.
These agents of antimicrobial defense have largely been divided into 2 classes based on
their mode of action, with type A defined by inserting into the membrane and forming
pores, whilst type B inhibits peptidoglycan synthesis (Chatterjee et al., 2005; Sieber &
Marahiel, 2005). Interestingly, lantibiotics are not the only antibacterial agents to
contain unusual amino acids; for example daptomycin is a lipopeptide antibiotic that
contains the unusual amino acid L-kynurenine (Baltz et al., 2005; Wessels et al., 1996).
In our study, we found the SACOL2525/2526 mutant was not susceptible to nisin (type
A), the only lantibiotic tested. This effect implies that SACOL2525/2526 has no role in
type A lantibiotic detoxification, but may suggest that SACOL2525/2526 transports
lantibiotics belonging to different classes, or that perhaps it more generally transports
peptide antibiotics. It is also plausible that this transporter broadly translocates any
peptide-containing molecule, not just those considered antibiotics, across the
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membrane, such as perhaps lipid II. This observation is not entirely implausible as has
been shown that the membrane protein FtsW translocates Lipid II via flippase activity
in S. aureus (Weidenmaier & Peschel, 2008). In addition, the substrate for the
GatD/MurT ABC transporter from S. aureus, has recently been suggested to be lipid II
(Munchet al., 2012) Therefore, S. aureus may have multiple transport systems that can
shuttle lipid II transport across the membrane, which could include SACOL2525/2526.
This is made further possible by the observation that SACOL2525/2526 is transcribed
under standard conditions; however antibiotic transporters tend to be induced only
during specific stresses (Muthaiyan et al., 2008; Ouyang et al., 2010; Meehl et al.,
2007). Additionally, compounds that induce Lipid II stress do appear to upregulate
expression of SACOL2525/2526.
Both IM-HKs associated with ABC transporters in S. aureus (NsaRS and GraRS) have
been shown to regulate SACOL2525/2526 (Herbert et al., 2007; Kolar et al., 2011). The
expression of both graRS and nsaRS respond to a number of antimicrobial agents that
target the cell wall, or perhaps to the damage caused by these agents. NsaRS has a role
in sensing and adapting to changes caused by chemicals that affect every step in the cell
wall biosynthesis pathway. The transcription of SACOL2525/2526 in response to cellenvelope-targeting compounds revealed that several drugs, including phosphomycin,
daptomycin, chloropromazine, penicillin G, ampicillin, oxacillin, D-cycloserine and
CCCP caused an increase in transcription. The majority of these agents affect cell wall
biosynthesis, including the making of lipid II (phosphomycin, D-cycloserine) and
peptidoglycan synthesis (penicillin G, chloropromazine, ampicillin, oxacillin,) (Figure
26). The daptomycin mode of action is currently contentious, although it does appear to
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Figure 26. Schematic representation of peptidoglycan synthesis of S. aureus.
Antibiotics target specific steps in the peptidoglycan synthesis pathway are shown,
including: intracellular peptidoglycan subunit assembly (D-cycloserine and
phosphomycin), transport and anchoring of the Lipid II molecule (vancomcyin,
teicoplanin and nisin), cross-linking of peptidoglycan subunits (penicillin G, ampicillin,
chloropromazine and oxacillin) and finally re-entry of the bactoprenol carrier
(bacitracin). In addition, other drugs (Gramicidin and CCCP) target the membrane
instead of peptidoglycan synthesis. Drugs highlighted in green have been shown to
target both the membrane and the peptidoglycan biosynthesis pathway. *Indicates
compounds shown to increase transcription of SACOL2525/2526.
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target both the membrane and peptidoglycan synthesis (Canepari et al., 1990; Silverman
et al., 2003; Cotroneo et al., 2008). Of note, the only compound that increased
transcription of SACOL2525/2526, and that solely impacts membrane stability, is
CCCP. CCCP alters the proton motive force, which effects ATP levels and ultimately
impacts every process that utilizes ATP, which can also include peptidoglycan synthesis
(Dimroth & Cook, 2004). Therefore, the observed increase in expression of
SACOL2525/2526 in response to CCCP may be explained by the fact that the
peptidoglycan synthesis pathway is impacted, albeit as a downstream effect.
Collectively, this data suggests that SACOL2525/2526 overwhelmingly responds to cell
wall biosynthesis targeting compounds.
When comparing the transcription of SACOL2525/2526 to that of nsaRS, it is clear that
the expression profiles of these 2 elements is very similar. Seven of the ten drugs tested
(phosphomycin, ampicillin, penicillin G, D-cycloserine, CCCP, daptomycin and
oxacillin) resulting in increased expression of both loci, whilst only 3 drugs (nisin,
gramicidin and chloropromazine) show opposing effects. These 2 systems do not both
respond to every antimicrobial agent tested, suggesting some specificity, and the
likelihood of divergent regulation. Overall, this suggests that NsaRS relies heavily on
SACOL2525/2526 to exert its effects under standard conditions, as well as during cellenvelope stress. NsaRS has been shown to respond to several cell-envelope-targeting
drugs, but not to all of them. This is consistent with the literature on other IM-HKs, and
may be explained by the overlapping function of a number of other TCSs that respond
to cell wall stress, including VraRS, GraRS and WalKR (Li et al., 2007; Kraus et al.,
2008; Pietainen et al., 2009; Delaune et al., 2011). Also, SACOL2525/2526 only
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responds to certain cell-envelope-targeting drugs, which may be the result of differential
signaling through NsaRS, and GraRS, which has also been shown to regulate this
transporter (Herbert et al., 2007). The other two TCSs that respond to cell wall stress,
VraRS and WalKR, have not yet been shown to regulate SACOL2525/2526, however
the available transcriptomic data is currently limited, thus not discounting such a
possibility. Although NsaRS and GraRS both positively regulate SACOL2525/2526
under standard conditions, it is NsaRS, not GraRS, which mediates the increase in
transcription in response to cell-wall-targeting chemicals. Interestingly, while
expression of SACOL2525/2526 in a nsaS mutant in the presence of cell envelope
antibiotics decreased compared to the wild-type, these were not to the levels of
unstimulated cells. This suggests that, while NsaRS does positively regulate
SACOL2525/2526 in response to cell-envelope-targeting drugs, it is not the only
regulator. This is not surprising, as it has been demonstrated that resistance to
antibiotics is often modulated by a number of regulatory elements (Howden et al., 2010;
McAleese et al., 2006). For example, the WalKR TCS has been shown to contribute to
methicillin and glycopeptide resistance in a variety of S. aureus strains (Dubrac et al.,
2007; Martin et al., 2002). In addition, MgrA is a regulator of multidrug transporters,
and has also been shown to impact resistance to methicillin (Chen et al., 2006; TruongBolduc et al., 2005). As WalKR is essential in S. aureus, defining its regulon has proven
complex, however work by Luong et al. reveals that SACOL2525 is contained within
the MgrA regulon (Luong et al., 2006) Therefore, it is likely that NsaRS utilizes
SACOL2525/2526 under cell wall stress conditions; however other regulators,
responding to different types of damage may also employ SACOL2525/2526 for
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cellular detoxification. This is supported by microarray findings that demonstrate SarA,
Rot, ArlRS and the alternative sigma factor, σB, all influence SACOL2525 and/or
SACOL2526 expression (Bischoff et al., 2004; Cassat et al., 2006; Said-Salim et al.,
2003; Liang et al., 2005).
Transcription of the IM-HK GraRS TCS has also been shown to respond to cell-walltargeting agents, although again, to a select number, likely suggesting specificity (Cui et
al., 2005). Interestingly, GraRS and NsaRS produced opposing effects in response to the
cell-wall biosynthesis targeting compounds bacitracin, vancomycin, nisin and
phosphomycin (Meehl et al., 2007; Kolar et al., 2011). This may suggest that GraRS
may utilize SACOL2525/2526 either only under standard conditions, or in a manner
that is contrasting to NsaRS. Indeed, the response and resistance to antimicrobial agents
is commonly pleiotropic, with signaling occurring through multiple regulatory
pathways. For example, the GraRS TCS contributes to glycopeptide resistance by
regulating genes required to alter the cell surface charge in order to limit the binding of
glycopeptides to the cell (Meehl et al., 2007). In addition, the VraRS system regulates
genes involved in cell wall biosynthesis to repair the damage to the peptidoglycan layer
(Blake et al., 2009). Together, these 2 TCS systems regulate genes important in
different aspects of the vancomycin resistance mechanism. Therefore, NsaRS and
GraRS likely follow a similar model with regards to SACOL2525/2526, where NsaRS
regulates this transporter in response to cell-wall stress, while GraRS performs
alternative functions. Since GraRS is able to regulate SACOL2525/2526 under standard
conditions, it is possible that under cell-wall stress, a hierarchy exists between these 2
systems, where NsaRS has a higher capacity for SACOL2525/2526 regulation, and
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ultimately influences the expression of SACOL2525/2526 more so than GraRS. In
addition, the regulation of SACOL2525/2526 by GraRS may be indirect, and occur
through the action of the regulator MgrA. Indeed, GraRS has been shown to positively
regulate MgrA, which is a master regulator of multi-drug resistance efflux pumps
(Herbert et al., 2007; Luong et al., 2006).
Human sebum is the oil found on the skin, and contains free fatty acids to help limit
bacterial infections and carriage (Kligman, 2006). Free unsaturated fatty acids from
human sebum insert in bacterial membranes leading to cell death. Some proposed
models of how this occurs include peptidoglycan precipitation, peroxidative stress,
alterations of metabolism, inhibition of certain major biosynthesis pathways,
modulation of membrane permeability or alterations in membrane fluidity (Galbraith &
Miller, 1973; Knapp & Melly., 1986; Speert et al., 1979; Chamberlain et al., 1991;
Xiong & Kapral., 1992). Surprisingly, when the SACOL2525/2526 mutant was exposed
to oleic acid, a free fatty acid found in human sebum, it was better able to survive than
the wild-type. Of note, the nsaS mutant, which has a ~30-fold decrease in
SACOL2525/2526 transcription, also survives better than the wild-type during this type
of stress, although not to the levels of the transporter mutant (preliminary data).
Although the exact mechanism that mediates this is unclear, it has been shown that
Gram-positive bacteria resist free fatty acids by decreasing membrane fluidity (Desbois
& Smith, 2010). Specifically, it has been shown that enhanced production of the
carotenoid pigment staphyloxanthin is positively correlated with increased resistance to
fatty acids (Chamberlain et al., 1991). It has been suggested that the observed resistance
to fatty acids is not due to the pigment itself, but is the result of a decrease in membrane
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fluidity produced by its overproduction. (Xiong & Karpal.,1992). While enhanced
staphyloxanthin production decreases membrane fluidity, S. aureus can also change the
fluidity of its membrane in other ways, including altering the fatty acid composition of
membrane phospholipids (Mrozik et al., 2004). This may suggest that in the presence of
free fatty acids, S. aureus may decrease membrane fluidity for survival by limiting the
expression of SACOL2525/2526. To corroborate this, qRT-PCR was performed on cells
grown in the presence of oleic acid, revealing transcription of SACOL2525/2526 to be
decreased as expected. Following this, if an SACOL2525/2526 mutant does have
decreased membrane fluidity, then it should also have decreased survival in the
presence of stresses that S. aureus resists by increasing membrane fluidity. Certain
solvents, such as toluene, have been shown to force Gram-positive cocci to change their
membrane to become more fluid (Nielsen et al., 2005). Thus, survival in toluene was
evaluated, and, as hypothesized, the SACOL2525/2526 mutant showed a decrease in
survivability.

Collectively,

these

data

suggest

that

the

membrane

of

the

SACOL2525/2526 mutant does in fact have decreased fluidity. This is perhaps
explained by our finding that SACOL2525/2526 responds to chemicals that disrupt
peptidoglycan synthesis; perhaps suggesting that the substrate it transports is important
in this process. It has been shown that disruptions in the peptidoglycan layer cause a
weaken cell wall, and decreases in cellular integrity (Rohrer & Berger-Bachi, 2003).
Furthermore, alterations in the cell membrane, such as decreased carotenoid production,
have been shown to result in decreased membrane fluidity in an attempt to provide
increased cellular integrity (Mishra et al., 2011). Therefore, it seems likely that in the
SACOL2525/2526 mutant, peptidoglycan synthesis is impaired, leading to the potential
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for decreased cellular integrity. In response to this, the SACOL2525/2526 mutant
seemingly decreases membrane fluidity as a coping mechanism to these alterations, by
an as yet unknown mechanism.
Daptomycin was approved for skin and soft tissue infections caused by S. aureus and
other Gram-positive pathogens in 2003 (Arbeit et al., 2004). At this time one survey
showed that only 0.1% of S. aureus isolates were resistant to daptomycin, suggesting
that it was a promising antibiotic with high clinical relevance. Since then, reports of
daptomycin resistant S. aureus isolates have surfaced, and hence determining the
resistance mechanism has become a priority (Streit et al., 2004; Marty et al., 2006).
Daptomycin binds to the bacterial membrane in a calcium-dependent manner, and then
oligomerizes producing a pore, resulting in a flood of ions from inside the cell to the
extracellular environment, eventually leading to cell death (Steenbergen et al., 2005).
While the SACOL2525/2526 mutant did not show a difference in sensitivity to
daptomycin overnight, survivability in lethal concentrations of daptomycin was
decreased when compared to the wild-type. Interestingly, a study on daptomycin
resistant strains showed that the cells had altered cell surface charge as a result of
increased MprF expression, controlled by GraRS (Pillai et al., 2001;Mishra et al., 2009).
MprF

alters

surface

charge

by

changing

lysinylation

of

membrane

phosphotidylglycerol, which decreases binding of daptomycin to the cell membrane,
limiting its effects (Jones et al., 2008; Peschel et al., 2001; Weidenmaier et al., 2005).
The SACOL2525/2526 mutant did not have altered cell surface charge, as determined
by a cytochrome C assay, which suggests that the decrease in survivability is not the
result of altered binding capacity of daptomycin to the cell membrane. Daptomycin
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resistant strains have also been shown by others to have increased membrane fluidity
(Mishra et al., 2009). Interestingly, as suggested above, the SACOL2525/2526 mutant
may possess a membrane with decreased fluidity, which perhaps could explain the
decrease in survival. In addition, cationic antimicrobial peptides, which area chemically
similar to daptomycin, insert into the bacterial membrane forming pores; and resistance
to these agents is also influenced by increased membrane fluidity (Bayer et al., 2000;
Bayer et al., 2006).
Another explanation for these findings is that the cell envelope may limit the interaction
of daptomycin with the membrane of S. aureus cells. As such, the cell wall and capsule
was removed from wild-type and mutant strains using lysostaphin, to determine if the
observed decrease in survivability could be enhanced. As expected, the daptomycinmediated decrease in survival of the SACOL2525/2526 mutant was exacerbated upon
lysostaphin treatment. Of note, the SACOL2525/2526 mutant produced no difference in
survivability to other membrane targeting drugs, such as CCCP or gramicidin,
suggesting that this effect is specific to daptomycin. An explanation for this might be
that daptomycin is the only compound to form pores in the membrane, as CCCP effects
the proton potential and gramicidin binds to bacterial membranes before eventual
translocation into the cytoplasm (Hancock & Chapple, 1999; Silverman et al., 2003;
Cotroneo et al., 2008). Conversely, daptomycin can insert into the membrane, where it
forms pores that allow for the leakage of ions, leading to cell death. The
SACOL2525/2526 mutant has been suggested to have decreased membrane fluidity,
which may influence the stability of the formed pores, allowing for increased ion
leakage and more rapid death. A situation akin to this was observed in E. faecalis, as
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increased membrane fluidity decreased the stability of pores caused by the peptide
antibiotic, alamethicin (Cafiso, 1994).
Although daptomycin was the only chemical where the mutant had decreased
survivability, SACOL2525/2526 contributes to the ability of S. aureus to generate
spontaneous mutants in the presence of several cell-wall targeting agents, including
penicillin G, bacitracin, teicoplanin and daptomycin. These four drugs, having produced
lower mutation frequencies in the mutant compared to the wild-type, all inhibit cell wall
biosynthesis, although each at a different step of the pathway. It has been previously
shown that a nsaRS mutant is sensitive to bacitracin, and that the nsaS mutant produced
a decrease in mutation frequency compared to the wild-type in the presence of
bacitracin (Kolar et al., 2011; Matsuo et al., 2010). Because of the similarities between
NsaRS and SACOL2525/2526, this finding is therefore perhaps unsurprising. The
SACOL2525/2526 mutant produced a decrease in spontaneous mutation frequency
when exposed to daptomycin, which corroborates our data showing decreased survival
of the mutant in the presence of this agent. Teicoplanin and penicillin G both target
peptidoglycan cross-linking, and the decreased mutation frequencies observed for the
SACOL2525/2526 mutant may further suggest a role for this ABC transporter in the
response to peptidoglycan damage. As stated previously, SACOL2525/2526 does not
respond to every cell-wall-targeting agent.

The other drugs tested either did not

stimulate SACOL2525/2526 expression (nisin and vancomycin), or they did not impact
the cell wall biosynthesis pathway (CCCP). This may therefore explain the similar
mutation frequencies observed for these agents between the mutant and wild-type
strains. An explanation for these findings may again come from the putative
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involvement of this transporter in peptidoglycan biosynthesis. If SACOL2525/2526
transports a substrate important for this process, then its peptidoglycan layer is likely
weakened in some aspects in the mutant strain. Therefore, it is possible that such
alteration in peptidoglycan result in more rapid death in the mutant when exposed to
these compounds, presenting limited opportunity to spontaneously mutate before cell
death. The reason that we observed differences in mutation frequency but not sensitivity
to some of these agents may be due the high concentration of antibiotic used in this
experiment, which is 3 times the MIC. In other experiments using these compounds, the
SACOL2525/2526 mutant may not produce a difference in survival at lower
concentrations, due to its ability to compensate for the difference in peptidoglycan
and/or membrane composition, and thus the action of the compound.
S. aureus strengthens its peptidoglycan cell wall by cross-linking lipid II molecules via
a pentaglycine bridge (Schleifer & Kandler, 1972). Lysostaphin, a lytic agent produced
by the closely related species S. simulans, cleaves these pentaglycine bridges, leading to
lysis of the cell. (Grudling & Schneewind, 2006). Strains resistant to lysostaphin have
been shown to lower the glycine content by changing glycine to serine in the bridge,
and as such cleavage does not occur (Kumar, 2008). In addition, FmhB is responsible
for the attachment of the first glycine residue to the lysine of the lipid II molecule
(Rohrer et al., 1999), while the proteins FemAB aid in the successive addition of the
second through fifth glycine residues.

Accordingly, resistance to lysostpahin is

commonly mediated through mutation of FemA or FemB, resulting in a lone glycine
residue available for cross-linking; and such monoglycines cannot be cleaved by
lysostaphin (Ehlert et al., 1997; Stranden et al., 1997) Given the alterations in cell
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superstructure demonstrated for the SACOL2525/2526 mutant in this study, we
performed lysostaphin lysis kinetics to assess how these changes impacted cell lysis
rates. Unexpectedly, we found that the mutant strain was actually more resistant to the
action of this agent than the parental strain. Additionally, given the similarity of
phenotypes for the transport mutant and that of nsaS, we also performed these studies
with the TCS deficient strain, and revealed similar findings. Although both mutants
took longer to achieve complete, or near-complete, lysis, both did eventually reach the
same levels as that of the parent and complemented strains. These final lysis data may
suggest that the glycine content in the pentaglycine bridges are not changed in the
mutant strains. An alternative explanation might come from our analysis of the nsaS and
SACOL2525/2526 mutant using electron microscopy. Negative staining of the
SACOL2525/2526 mutant revealed an altered cell envelope, similar to that observed
with the nsaS mutant. The observed difference may be increased capsule production, as
the microarray for the nsaS mutant showed a decrease in expression of several cap
genes. Thus, increased capsule production may contribute to lysostaphin resistance by
limiting the contact of lysostaphin with peptidoglycan, and ultimately reducing the rate
of lysis.

Collectively, these data suggest that the SACOL2525/2526 mutant has

increased capsule production, and an altered cell envelope that allows for a decrease in
susceptibility to lysostaphin. The increased capsule produces a protective effect for
lysostaphin, as no difference in glycine content is suggested. It is also likely that the
increased production of capsule may limited the interaction of daptomycin with the
mutant membrane, perhaps explaining why we see no difference in MIC during
overnight growth. However we do show at very high concentrations, or in the absence
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of capsule and peptidoglycan that the transporter mutant is more susceptible to
daptomycin, which is likely explained, as suggested above, by the stabilization of pores
resulting from decreased membrane fluidity.
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Chapter 4: Extracellular Proteases are Key Mediators of S. aureus Virulence via the
Global Modulation of Virulence Determinant Stability

Introduction
Of the 245 genes modulated by NsaRS, only 34 are negatively regulated. These included
those involved in capsule production, such as capGOIHED; the virulence genes βhemolysin, hyaluronate lyase, fibronectin binding protein A; and six of the 10 major
secreted proteases. Proteases are enzymes that catalyze the cleavage of amide linkages in
proteins and peptides. Proteases can be divided into families based on the functional
group at their active site; with the major catalytic categories being serine, threonine,
aspartate, metallo and cysteine proteases. It has been shown that the secreted proteases of
S. aureus are inactive until they are secreted, and are processed outside of the cell, with
the exception of the Spl proteins (Rice et al., 2001 and Shaw et al., 2004; Reed et al,
2001). Upon activation, these enzymes modify proteins by breaking peptide bonds, which
can lead to activation or degradation. As this modification can only occur once the
proteases have been activated outside of the cell, it suggests that their targets must be: 1)
other secreted proteins, 2) cell surface associated proteins, or 3) host proteins. Included
within this list are self-derived virulence determinants secreted by S. aureus, which may
serve as targets of the proteases to help mediate their level in response to the
environment. Indeed, such a theory was proposed with regards to these enzymes more
than ten years ago (Lindsay & Foster, 1999). Since the presentation of this theory, only a
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few studies have actually been conducted investigating this phenomenon (Karlsson et al.,
2001; McAleese et al., 2001; McGavin et al., 1997; Zielinska et al., 2011).
The S. aureus genome encodes 129 putative proteases, with 10 being secreted enzymes.
These include a metalloprotease (aureolysin, aur), a V8 or SspA serine protease, two
cysteine proteases (staphopain A (ScpA) and staphopain B (SspB), and six serine-like
proteases that are SspA homologues (SplABCDEF) (Reed et al, 2001; Shaw et al., 2004).
These ten proteases are located in four different operons, all of which are polycistronic,
except aureolysin (Figure 27). It has been shown that these extracellular proteases are
activated by Agr, and strongly negatively affected by SarA, with the exception of the Spl
proteins (Gustafsson & Oscarsson, 2008; Horsburgh et al., 2002). In addition, the
proteases are also regulated by σB, SarR, SarZ, Rot and MgrA, although some of these
regulators most likely act through Agr or SarA (Karlsson & Arvidson, 2002; McNamara
et al., 2000; Tamber & Cheung, 2009). In addition to transcriptional regulation, the
proteases are regulated at the post-translational level, as each is secreted as a proenzyme,
with the exception of the Spl proteins. Each needs to be cleaved in order to gain
enzymatic activity in a cascade of activation that is thought to keep these proteases
inactive until secreted (Figure 28). First, aureolysin is able to activate V8 protease, which
then processes and activates staphopain B (Drapeau, 1978; Rice et al., 2001). The
activation of aureolysin and Staphopain A resides outside of this cascade, and occurs
through autocatalysis (Nickerson et al., 2007). In addition, both of the Staphopain
enzymes have specific, cytoplasmic inhibitory proteins (the staphostatins) encoded
downstream of the protease (Rzychon et al., 2003). The regulation of secreted proteases
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Figure 27. The extracellular proteases of S. aureus and their regulation. S. aureus
has 10 major secreted proteases: aureolysin or metalloprotease (Aur), a V8 or serineprotease (SspA), two cysteine proteases (ScpA and SspB) and 6 serine-protease like
enzymes (SplABCDEF). The two cysteine protease, ScpA and SspB are transcribed with
their specific inhibitor, staphostatin A (ScpB) and staphostatin B (SspC), respectively.
The secreted proteases are located on 4 different operons, which are positively regulated
(arrows) by RNAIII (Agr), and negatively regulated (lines) by SarA.
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Figure 28. Activation cascade of S. aureus secreted proteases. Secreted proteases are
regulated at the post-translational level, with each secreted as a proenzyme, apart from
the Spl proteins. Each needs to be cleaved in order to gain enzymatic activity in a cascade
of activation. First, aureolysin (Aur) activates the V8 protease (SspA), which then
processes and activates Staphopain B (SspB). The activation of aureolysin and
Staphopain A (ScpA) occur through autocatalysis.
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is complex and occurs at the transcriptional as well as at the post-translational level. This
intricate level of control suggests that secreted proteases are important elements of S.
aureus and understanding their role may give a unique insight into the pathogenesis of S.
aureus.
S. aureus is a dangerous pathogen causing infection in every part of the body. Recently,
MRSA strains have been found infecting the young and healthy, which appear to have
evolved independently within the community (Johnson et al., 2007; Moran et al., 2005).
Community-acquired Methicillin Resistant S. aureus CA-MRSA strains have increased
transmission and are hypervirulent, presenting a serious public health threat. The ability
of CA-MRSA to invade healthy hosts is the result of not only newly acquired virulence
factors, but alterations in the expression profile of key, core-genomic elements (Diep et
al., 2006; Diep et al., 2008; Kennedy et al., 2008; Vandenesch et al., 2003; Wang et al.,
2007). Included within this latter class is α-hemolysin (Hla), delta-hemolysin, phenol
soluble modulins (PSMs), and secreted proteases (Burlak et al., 2007; Chambers, 2005;
Diep & Otto, 2008; Wang et al., 2007). Most if not all of these factors are regulated by
the two-component system Agr, and thus their overproduction is due, at least in part, to a
hyperactive Agr locus (Li et al., 2009). While others have focused on identifying the role
of cytolytic toxins, such as Hla and Psms in CA-MRSA hypervirulence, the impact of
extracellular proteases has thus far been overlooked (Wang et al., 2007; Kobayashi &
DeLeo, 2009; Li et al., 2009; Montgomery et al., 2008; Burlak et al., 2007; Chambers,
2005; Diep & Otto, 2008). Whilst a number of studies on secreted proteases are contained
within the literature, their findings are contradictory. As such, the role of these enzymes
and their involvement in pathogenesis is currently unclear.
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Therefore, the focus of this chapter is to better understand the pathogenesis of CA-MRSA
infections and determine if secreted proteases are in fact key virulence factors.
Specifically, we will determine if secreted proteases are vital to the infection process
using both systemic and localized infection models. Additionally, we will explore the
theory that S. aureus secreted proteases modulate the stability of self-derived secreted
and surface-associated virulence factors.
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Manuscript Introduction
S. aureus is a highly successful and diverse pathogen causing an array of diseases. S.
aureus infections typically proceed from localized sites (e.g. wound), and can proliferate
via bacteremia to life-threatening systemic diseases, such as osteomyelitis, endocarditis
and septic arthritis. This diversity and pathogenic success can be attributed, largely, to its
vast array of temporally and environmentally regulated virulence factors (Lowy, 1998;
Novick, 2006). Formerly, S. aureus infections were confined to the healthcare setting,
afflicting the immunocompromised and elderly. Recently there has been a shift in S.
aureus epidemiology, with increased incidences of severe invasive disease in healthy
subjects lacking predisposing factors (Johnson et al., 2007; Moran et al., 2006). This
trendshift is the result of emerging, hypervirulent strains of methicillin-resistant S. aureus
(MRSA) that have evolved within the community (CA-MRSA). Of considerable concern,
these CA-MRSA strains appear to be moving into clinical settings and displacing existing
hospital-associated MRSA strains (D’Agata et al., 2009; Popovich et al., 2008; Webb et
al., 2009).
Several CA-MRSA lineages have appeared in the last decade (Diep & Otto, 2008;
Limbago et al., 2009; McDougal et al., 2009), with USA300 now representing the major
clone in the United States (Tenover et al., 2008). The reason for the surprising success of
this strain as the primary CA-MRSA, and perhaps MRSA, isolate in the USA is
somewhat unclear; however work by a number of groups suggests it may be attributable
to the differential expression of core genomic elements (Li et al., 2009), including the
PSMs, hemolysins, enterotoxins and extracellular proteases (Diep & Otto, 2008; Li et al.,
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2009; Adem et al., 2005; Kobayashi & Otto, 2009; Montgomery et al., 2008; Wang et al.,
2007). With regards to this latter class of enzymes, S. aureus possesses 10 major secreted
proteolytic enzymes. These include a metalloprotease (aureolysin, aur), a V8 or SspA
serine protease, two cysteine proteases (staphopain A (ScpA) and staphopain B (SspB)),
and six serine-like proteases that are SspA homologues (SplABCDEF) (Reed et al., 2001;
Shaw et al., 2004).
A number of studies have been conducted to determine the contribution of extracellular
proteases to the disease process; however many have been contradictory. In the RN6390
background, a SspA mutant displayed attenuated virulence in three different animal
models of infection (Coulter et al., 1998). Similarly, sspABC and sspBC mutations in the
8325-4 background also showed reduced virulence in a murine wound model (Shaw et
al., 2004). In addition to these findings, it has been shown that both S. aureus cysteine
proteases induce vascular leakage and shock in a guinea pig model of infection (Imamura
et al., 2005). Furthermore, it was shown that the ability of Newman to evade killing by
primary human macrophages is dependent on a functional aureolysin gene (Kubica et al.,
2008; Burlak et al., 2007). Finally, a number of studies have shown that Aur, SspA and
SspB are produced upon engulfment by human neutrophils, and that antibodies are
generated against these enzymes during infection (Burlak et al., 2007; Calander et al.,
2008; Holtfreter et al., 2009). In contrast, several other studies have produced opposing
results regarding the pathogenic role of extracellular proteases.

Specifically, single

mutations in aur and scpAB using strain 8325-4 had no effect on wound formation (Shaw
et al., 2004), whilst a non-polar sspA mutant in the RN6390 background displayed
enhanced virulence in a similar model (Rice et al., 2001). Additionally, mutants in
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sspABC, sspB, aur, and scpAB, in the SH1000 background produced no attenuation in
virulence in a murine septic arthritis model (Calander et al., 2004). It was also observed
that a splABCDEF deletion mutant showed no significant difference in virulence in a
murine peritonitis infection model (Reed et al., 2001).
In addition to these more general functions, S. aureus exoproteases have been shown to
cleave specific host proteins. Staphopain B can degrade human fibronectin, fibrinogen
and kininogen, and may contribute to the ability of S. aureus to disseminate (Imamura et
al., 2005; Massimi et al., 2002). Secreted proteases can also cleave human α1-proteinase
inhibitor (Potempa et al., 1986), the heavy chains of all human immunoglobulin classes
(Prokesova et al., 1992), and elastin (Potempa et al., 1988), which aids in tissue invasion.
Beyond their interaction with the host, it has been demonstrated that secreted proteases
modulate the stability of self-derived virulence determinants. Specifically, SspA was
shown to cleave surface proteins, including fibrinogen-binding protein (McGavin et al.,
1997) and surface protein A (Karlsson et al., 2001). In addition, Aur cleaves the surface
associated protein clumping factor B (McAleese et al., 2001). Cleavage of these proteins
by extracellular proteases is thought to affect the transition from an adhesive to invasive
phenotype. It has also been suggested that extracellular proteases can cleave secreted
toxins in order to regulate the abundance of virulence factors depending on the specific
niche encountered within the host (Lindsay & Foster, 1999). Indeed, our group has
recently shown that aureolysin modulates the stability of both α-toxin and phenol soluble
modulins in CA-MRSA strains (Gonzalez et al., 2012; Zielinska et al., 2011).
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Consequently, whilst there is a wealth of information on the role of secreted proteases in
S. aureus disease causation, the specific role of these enzymes as virulence factors
remains unclear. Therefore, in the present study, we sought to define the collective
impact of this class of enzymes on pathogenesis and virulence determinant stability. This
was achieved using the CA-MRSA strain USA300, which is known to hyperproduce
secreted proteases, and a strain genetically lacking all 10 of these enzymes.
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Materials and Methods
Ethics statement. This study was performed in strict accordance with the
recommendations in the Guide for the Care and Use of Laboratory Animals of the
National Institutes of Health. The protocol was approved by the Institutional Animal Care
and Use Committee of the University of South Florida (Permit Number: A-4100-01).
Bacterial strains, plasmids and growth conditions. The CA-MRSA USA300 LAC
isolate AH1263 served as the wild-type strain for analysis in this study. A derivative of
this has been generated and described previously (Wormann et al., 2011) that lacks all 10
major secreted proteases (strain AH1919). Strains were grown in TSB as documented
(Shaw et al., 2008), using the following protocol: 1 ml of overnight S. aureus cultures
were used to inoculate fresh medium and allowed to grow for 3 h. These exponentially
growing cultures were used to seed new medium at an OD600 of 0.05. These
exponentially growing test cultures were then allowed to grow for the necessary time
periods. Growth in milk broth was performed as previously described (Carroll et al.,
2012). Briefly, exponentially growing cultures of the LAC wild-type and protease null
strain were washed three times with PBS and resuspended in 100 ml 10% skimmed milk.
The initial inoculum of each strain was also determined at this time by serial dilution and
plating on TSA. Cultures were incubated at 37°C with shaking and the cfu/ml of each
strain determined at the times indicated, again by serial dilution and plating. All were
performed in triplicate, and significance in growth alterations was determined using a
Student T-Test with a 5% confidence limit. For growth in pig serum, exponentially
growing cultures of the LAC wild-type and protease null strain were washed three times
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with PBS and resuspended in 1 ml of pig serum (Sigma). Cultures were incubated at
37°C with shaking and the cfu/ml of each strain was determined by serial dilution and
plating, every hour for five hours. The initial inoculum of each strain was also determined
from the original culture in the same manner. Data are presented as percentage survival
of each strain compared with initial inocula. These experiments represent three
independent biological replicates. Statistical significance was evaluated using a Student
T-Test with a 5% confidence limit.
Real-time PCR. Quantitative real-time PCR analysis was conducted as described
previously (Livak & Schmittgen, 2001; Riordan et al., 2010) using primers specific for
RNAII

(F-

ATGCGCTGATGATATACCACG,

GTTGATAGACCTAAACCACGACC),

R-

RNAIII

(F-

ATTTGTTCACTGTGTCGATAATCC , R- GGAGTGATTTCAATGGCACAAG) and
hla

(F-

CGAAAGGTACCATTGCTGGTCAGT,

R

-

AAATGCTGAAGGCCAGGCTAAACC). The control primers were for the 16s rRNA
gene, as described elsewhere (Koprivnjak et al., 2006).
Whole human blood survival assay. Survival in whole human blood was performed as
previously described (Kolar et al., 2011). These experiments were performed with three
separate, de-identified blood samples (purchased from Bioreclamation) and represent
nine independent replicates. Data are presented as percentage survival of each strain
compared with initial inocula. Statistical significance was evaluated using a Student TTest with a 5% confidence limit.
Antimicrobial peptide sensitivity assay. Liquid cultures of LAC and its protease null
mutant were grown in Luria-Bertani (LB) media without NaCl. These were diluted
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1:1000 in fresh LB, again lacking NaCl, and 200 μl was applied to the wells of a 96-well
plate. The AMPs LL-37, Indolicidin or Histatin-5 were added to these wells in decreasing
concentrations and mixed by pipetting. Plates were incubated at 37°C overnight, followed
by the measurement of culture density by OD600 readings. LD50 values were determined
as the concentration required to generate a 50% reduction in OD600 compared to controls
wells, inoculated with S. aureus cells, but lacking AMPs.
Murine model of wound formation. These experiments were conducted as described
previously (Shaw et al., 2004; Bunce et al., 1992). Briefly, 6 week old, female SKH1-E
nude-mice were purchased from Charles River Laboratories, and housed at the vivarium
in the College of Medicine, University of South Florida. S. aureus strains LAC and LACprotease null were grown for 15h in TSB as described above. After this time, aliquots of
these bacterial suspensions were stored at -80°C, and their cfu/ml determined
retroactively by serial dilution and viable cell counts. For infection purposes cultures
were thawed, washed twice in PBS, and diluted in PBS containing 20 μg of sterile
Cytodex microcarrier beads to 5 x 108 cfu/ml. Ten mice per strain were inoculated
subcutaneously between the scapula with 200 μl bacterial suspension, giving a final
inocula of 1x108 cfu/ml. Mice were monitored for 6 days during the infectious process,
before being sacrificed, and any abscesses harvested and stored at -80°C. Each abscess
was subsequently homogenized in 3 ml sterile PBS, and the cfu/abscess determined via
serial dilution and viable count enumeration. The statistical significance of bacterial
recovery was evaluated using a Student T-Test with a 5% confidence limit.
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Murine model of sepsis and dissemination. These experiments were conducted as
described previously (Li et al., 2009; Voyich et al., 2006). Briefly, 6 week old, female
CD-1 Swiss mice were purchased from Charles River Laboratories, and housed at the
vivarium in the College of Medicine, University of South Florida. S. aureus strains LAC
and LAC-protease null were prepared as for the wound formation model. For infection
purposes, cultures were thawed, washed twice in PBS, and diluted in PBS to 1 x 109
cfu/ml. Thirty mice per strain were inoculated by tail vein injection with 100 μl bacterial
suspension, giving a final inocula of 1x108 cfu/ml. The infection was allowed to proceed
for 6 days, or until mice reached a pre-moribund state (used as a measure of mortality).
Mice were then euthanized and the brain, liver, kidneys, heart, lungs and spleens
collected and stored at -80°C. Any mouse sacrificed before day 6 was recorded for
mortality, but their organs were not analyzed for bacterial burden. Each organ was
subsequently homogenized in 3 ml sterile PBS, and the cfu/organ determined via serial
dilution and viable count enumeration. The statistical significance of bacterial recovery
was evaluated using a Mann-Whitney Test with a 5% confidence limit. Mortality was
measured using a Log Rank and Chi Squared Test with 1-degree of freedom.
Proteomic analysis of surface and secreted proteins. Stationary phase (15h) cultures of
wild-type and mutant strains were prepared in TSB, and their secretomes were harvested
and purified as described previously (Rivera et al., 2011). Surface proteins were extracted
by methods previously described (Gatlin et al., 2006). Briefly, wild-type and LACprotease null mutant cells were grown to stationary phase (15h) and sedimented via
centrifugation. Pellets were resuspended in TSM buffer (100mM Tris-HCl, 500 mM
sucrose, 10mM MgCl2) and incubated in the presence of 100 μg of lysostaphin for 60
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minutes at 37°C. Supernatants were collected and precipitated with 10% trichloroacetic
acid, followed by centrifugation to recover precipitates. These were then washed thrice
with 100% ice-cold ethanol, before being air dried. Triplicate samples of secreted and
surface proteins for each strain were resuspended in urea buffer, with 15 μg/ml loaded
and run on 12% SDS-PAGE gels. At least 2 lanes were left between each sample to
prevent loading contamination, with wild-type and mutant strains run on separate gels.
Following this, secreted protein gels were cut into 11 approximately equal fractions,
whilst surface proteins gels were separated into 10 approximately equal fractions. These
were then washed with ACN to remove SDS and bromophenol blue, before being dried
using a SpeedVac centrifuge. Gel pieces were rehydrated with 100μl of 45 mM DTT and
incubated at 55°C for 30 minutes. The supernatant was removed and replaced with 100
mM iodoacetamide and incubated in the dark at room temperature for 30 minutes.
Following this, the buffer was removed and washed thrice with 50% ACN/50 mM ABC
with agitation for 15 minutes. Gel pieces were dried again using a SpeedVac centrifuge.
Promega Trypsin (12.5 ng/μl) was dissolved in Promega trypsin buffer, and enough
trypsin solution was used to cover the gel pieces, before incubation at 37°C for 12-16h.
The supernatant was removed and retained, and the reaction stopped with 5% glacial
acetic acid. The gel pieces were covered with 100 μl of 50:50 ACN:water containing
0.1% formic acid and vortexed for 15 minutes. Supernatants were again removed and
added to the previously collected supernatants. Samples were dried using a SpeedVac
centrifuge, and resuspended in 1 ml of 0.1% formic acid in water. Samples were then
desalted and analyzed using a linear ion trap-LTQ instrument mass spectrometer (LTQ
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XL, Thermo) operated with Xcalibur (v2.0.7) data acquisition software, as described by
us previously (Rivera et al., 2011).
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Results
Verification of extracellular protease depletion in the LAC-protease null strain. An
extracellular protease-null strain of S. aureus has previously been generated and
described in USA300 LAC (Karlsson & Arvidson et al., 2002). As it forms the basis of
the work described herein, we first set out to confirm the lack of secreted proteases in this
strain using a targeted proteomics method. Targeted mass-spectrometry uses the inclusion
of mass to charge ratios in order to guide MS sequencing to a pre-determined subset of
peptides, and is more accurate than other methods that overlook certain proteins. The
Aur, SspA, SspB, ScpA and SplA (used as a representative for the spl operon) sequences
were analyzed using the Protein Prospector-MS digest program to determine the peptides
that would result after trypsin digest. A peptide that is unique to each protease was
chosen, and its mass to charge ratio included in a designed MS method. Overnight
secretome samples (15h) from the LAC wild-type and LAC-protease null mutant were
prepared and analyzed using an LTQ-MS. Spectral counts of proteins identified were
compared, with the LAC wild-type producing robust counts for SspA (48), ScpA (49),
SspB (50), Aur (47) and SplA (8). As expected, when the LAC-protease null mutant
secretome was probed, no extracellular proteases were detected. This finding was also
verified via gelatin zymogram, with the LAC wild-type producing several activity bands,
whilst the mutant displayed none (Figure 29). To ensure that no additional, unintended
mutations (specifically agr) had occurred in the LAC-protease null strain, we also
performed real-time PCR analysis with primers specific to RNAII, RNAIII and hla, with
the latter serving as a representative agr regulated virulence determinant. We found that,
at both 5h and 15h of growth, there was no observable different between the 2 strains in
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Figure 29. Gelatin zymography of the LAC wild-type and its protease-null mutant.
The secretomes of the LAC wild-type and protease-null mutant were collected (15 h) and
protease activity visualized on a zymogram gel containing gelatin.
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the levels of these transcripts (Figure 30). As such, these analyses verify that an
exoprotease-null strain of LAC was created, that seemingly bears no apparent additional
mutations that impact the synthesis of virulence determinants.
The protease-null strain has fitness defects during growth in peptide based media
and pig serum. We first sought to assess whether loss of extracellular proteases affected
viability of the USA300 LAC strain. As such, growth profiling was performed in
complex media (TSB) over a 96h period, with no difference observed compared to the
parental strain (Figure 31A). This is perhaps to be expected, as, for example, agr mutants
of S. aureus are aproteolytic, yet are undoubtedly viable. Following this, we next tested
the ability of the protease null strain to grow in peptide based media. This was performed
as many bacterial species possess a PrtP homolog, which is a surface exposed protease
that functions to generate oligopeptides from polypeptides for nutrition (Liu et al., 2010).
Such a protein is lacking in S. aureus (our unpublished data), and therefore we reasoned
that the extracellular proteases perhaps fulfill such a function for the generation of
oligopeptides in the absence of a PrtP protein in S. aureus. As such, we grew the LAC
parental strain and its protease null mutant in 10% milk broth (Figure 31B), which is
routinely used to evaluate peptide based nutrition (Borezee-Durant et al., 2009), as it
contains few free amino acids, and abundant peptides. During the first 24 hours of
profiling, no difference in viability for the LAC wild-type and its mutant strain was
observed. Interestingly, after this time, both strains began to lose viability, with the
protease null mutant proving significantly less able to resist starvation in peptide based
media compared to the parent. Specifically, by day 2, the protease mutant produced a 2.3
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Figure 30. Exoprotease deletion does not lead to observable difference in agr or hla
transcript levels. qRT-PCR was performed with primers specific to RNAII, RNAIII and
hla in the LAC wild-type (black) and protease-null (grey) strains. These analyses were
performed at (A) 5 hours and (B) 15 hours of growth. The data presented are from at least
three independent cultures; error bars are shown as +/- SEM.
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Figure 31. Secreted proteases aid in survival during growth in peptide based media
and pig serum. The average CFU/mL of the LAC wild-type (black) and LAC-protease
null mutant (grey) were compared over 4 days in: A) TSB and B) 10% milk broth. Data
represents three replicates showing less than 10% variability. A Student’s T-Test was
used with a 5% confidence level to determine statistical significance, * = p 0.05. C)
The average CFU/mL of the LAC wild-type (black) and LAC-ESPN mutant (grey) were
compared at the times indicated during growth in pig serum. Data is expressed as percent
recovery of the inoculum, and represents three independent experiments. A Student’s TTest was used with a 5% confidence level to determine statistical significance, ** = p
0.01, *** = p 0.001; error bars are shown as +/- SEM.
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fold decrease in average CFU/mL, which was exacerbated at day 3 with a 4-fold decrease
in survival. By day 4, a 3.1-fold decrease in mutant viability was determined.
We next set out to assess the fitness of the wild-type and protease mutant during growth
in a more pathogenically relevant medium, in this case pig serum. Accordingly,
exponentially growing cells of the parent and mutant were inoculated into pig serum, and
the survivability of triplicate cultures determined (Figure 31C). When growth was
analyzed during early time points, a large decrease in the viability of the protease null
strain was observed. Specifically, after 1h a 3.2-fold decrease in mutant cell viability was
observed (24.6% of the inoculum), compared to the parent strain (80.9% of the
inoculum). Viability stabilized after this time, yet still produced a consistent 2-fold
reduction in the mutant strain compared to the parent from hours 2-5. After 24h of
incubation, whilst both strains had robust growth (Wt = 480.8% recovery of inoculum,
protease-null strain = 355.6%), there was still a decrease in final loads of the mutant
strain. This suggests that secreted proteases may have a role in nutrition acquisition in S.
aureus, particularly during times of stress and starvation.
Secreted proteases play a role in resistance to antimicrobial peptides. Antimicrobial
peptides (AMPs) are small molecules that have a key role in the innate immune system,
displaying broad spectrum antibacterial activity. Previously it was shown that the S.
aureus secreted protease, aureolysin, is able to cleave the human cathelicidin, LL-37
(Sieprawska-Lupa et al., 2004). To determine if secreted proteases facilitate resistance to
only this AMP, or other such peptides, sensitivity profiling of the mutant was performed
(Figure 32). When LD50 values were compared for LL-37 we observed a 2.7-fold
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Figure 32. Secreted proteases play a role in the resistance of S. aureus to
antimicrobial peptides. The LAC wild-type (black) and protease null mutant (grey)
were cultured overnight with either LL-37, indolicidin or histatin-5. The LD50 for each
was determined by OD600 evaluation of cultures grown with AMPs compared to those
without. Data presented is from at least three independent replicates showing identical
values.
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increase in sensitivity for the protease null strain (35 μg/mL) when compared to the
parent (95 μg/mL). Similarly increased sensitivity was observed when testing was
performed with indolicidin, with the wild-type strain producing a LD50 of 10 μg/mL,
whilst the mutant was 3.33-fold lower at only 3 μg/mL. Finally, when histatin-5 was
used, the LAC wild-type LD50 was 10 μg/mL, yet the protease null strain displayed a 5fold increase in sensitivity, with an LD50 of 2 μg/mL. These findings suggest that secreted
proteases contribute to the ability of S. aureus to resist the toxic effects of AMPs.
Extracellular proteases are required for survival during interaction with the innate
immune system. The in vitro AMP sensitivity assays suggest that extracellular proteases
are important for survival during interaction with elements of the immune system.
Accordingly, we next profiled survivability of the mutant strain in the presence of the
innate immune system, including its cellular components. Accordingly, exponentially
growing LAC wild-type and protease null mutant cells were separately cultured in whole
human blood for 4 hours, and their viability determined (Figure 33). Analysis revealed
that the LAC wild-type had bacterial loads that decreased only marginally from the initial
inoculum (82.1% recovered). In contrast, the protease null mutant displayed significantly
impaired survival, returning only 12.6% of the inoculum. This results in a 6.5-fold
reduction in survivability of the mutant strain when compared to the parent. Ultimately
this data corroborates our serum and AMP findings, and suggests that secreted proteases
protect S. aureus during interaction with the host immune system.
Secreted proteases contribute to CA-MRSA wound formation. There are conflicting
results regarding the role of extracellular proteases in S. aureus virulence (Shaw et al.,
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Figure 33. Secreted proteases are protective during interaction with the human
innate immune system. The LAC wild-type and protease null strain were separately
cultured in whole human blood for 4 hours, before their viability was determined. Data is
expressed as percent recovery of the inoculum, and represents three separate blood
samples and nine individual replicates. Error bars are shown +/- SEM; statistical
significance was calculated using a Student’s t test with 5% confidence level, **** =
P 0.0005
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2004; Coulter et al., 1998; Kubica et al., 2008; Burlak et al., 2007; Rice et al., 2001;
Calander et al., 2004; Hossain et al., 2006; Diep et al., 2004). As such, we set out to
determine if the 10 major secreted proteases collectively contribute to localized infection
using a murine model of skin abscess. Accordingly, 10 mice were subcutaneously
inoculated with either the LAC wild-type or protease null mutant, and the infection was
allowed to proceed for 6 days. Following this time, all mice were euthanized, any
abscesses harvested, and the bacterial loads per abscess determined (Figure 34). We
observed that the protease null mutant had significantly reduced bacterial loads per
abscess when compared to the wild-type. Specifically, the average wild-type
CFU/abscess was 57.7% of the inoculum, whilst for the mutant it was 28.1%,
representing a 2.0-fold decrease in bacterial burden.
Extracellular proteases play a key role during systemic CA-MRSA infections. In
addition to presenting as skin and soft tissue infections, CA-MRSA is also a major cause
of bacteremia and systemic disease. As such, we next set out to determine if extracellular
protease deletion impacts systemic CA-MRSA infections. Accordingly, 30 mice each
were inoculated via tail vein injection with 1 X 108 cells of either the LAC wild-type or
protease null mutant. The infection was allowed to proceed for 6 days, or until mice
reached a pre-moribund state (used as a measure of mortality). Mice were then
euthanized and the brain, liver, kidneys, heart, lungs and spleens collected. Any mouse
sacrificed before day 6 was recorded for mortality, but their organs were not analyzed for
bacterial burden. Following recovery, each organ was homogenized, serial diluted and
plated to determine bacterial load (Figure 35). Of the 30 LAC wild-type animals, 2 died
prior to day 6, yielding a mortality rate of 3.3%. In contrast, 7 out of the 30 inoculated
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Figure 34. Secreted proteases contribute to CA-MRSA abscess formation. The LAC
wild-type and protease null mutant were used to subcutaneously inoculated the scapula of
10 SKH-1 mice each, at 1 x 108 cells. After 6 days abscesses were harvested and bacterial
loads determined via homogenization and serial dilution. The average cfu/abscess
returned is indicated by horizontal bars. Statistical significance was calculated using a
Student’s t test with a 5% confidence level (p < 0.05).
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Figure 35. Secreted proteases have contrasting roles in the morbidity and mortality
of systemic CA-MRSA infections. The LAC wild-type and mutant were inoculated via
tail vein injection into 30 mice each, at 1 x 108 cells. Mortality for the LAC wild-type
(black) and LAC-protease null mutant (grey) infected mice was measured over 6 days
(A), and analyzed using a Log Rank and Chi Squared Test with 1-degree of freedom (p =
0.079). After 6 days, all surviving mice were euthanized, and their organs harvested for
bacterial load determination (A-F). Average CFU/organ of the wild-type and mutant
strain were compared; error bars are shown as +/- SEM. A Mann-Whitney test was used
to determine statistical significance. *= p 0.05, ** = p 0.01, **** = p 0.0001.
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with the LAC-protease null mutant died, giving a 23.3% mortality rate. This represents a
7-fold increase in mortality for the protease null strain compared to the parental strain.
Conversely, when analyzing bacterial burden per organ between the two groups, we
observed significant decreases for the mutant strain in the liver, lungs, heart and spleen.
Specifically, the largest fold change, 98.7, was observed in the lungs, with the LAC wildtype returning an average CFU/lungs of 4.74 X 104 and the protease null mutant returning
4.80 X 102. Additionally, we observed a 7.4 fold decrease in bacterial load in the liver of
inoculated mice, with the wild-type producing an average CFU/liver of 4.32 X 105 and
the mutant 5.79 X 104. The heart produced a 5.7 fold decrease in mutant bacterial cells,
with LAC yielding 1.2 X 104 and the protease mutant yielding 2.1 X 103. With regards to
the spleen, we observed 2.01 X 103 CFU/spleen for the parental strain and 6.6 X 102 for
the mutant, which is a 3.0 fold decrease. Finally, in the brain we observed a 3.8 fold
decrease in the average CFU/brain for mutant infected mice, however this was found to
be outside the range of significance, although clearly trending towards it (p = 0.079).
Interestingly, there was no significant difference between the two strains in their ability to
infect the kidneys of inoculated mice. The LAC wild-type returned 5.57 X 107
CFU/organ whilst the protease null mutant returned 5.87 X 107. As such it appears that
secreted proteases play a major role in the survival of S. aureus during in vivo infection.
Secreted proteases are primary effectors of virulence determinant stability. It has
previously been proposed (McGavin et al., 1997; McAleese et al., 2007; Lindsay &
Foster 1999; Travis et al., 1995), and demonstrated by our group to a limited extent
(Gonzalez et al., 2012), that secreted proteases regulate the stability of self-derived
toxins. To determine if this is in fact the case, we assessed the impact of secreted
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proteases on virulence determinant stability using proteomic techniques. Accordingly,
stationary phase secretomes (15h) of the LAC wild-type and protease null mutant were
collected in triplicate and separated via SDS-PAGE. Each gel was then cut into 11
identical fractions to facilitate processing. The data from all 11 fractions was pooled, and
collectively analyzed for alterations in protein abundance using spectral counts (Table 5).
In total, 19 known secreted proteins had increased abundance upon deletion of
extracellular proteases. The highest fold change was seen for phenol soluble modulin
alpha 4, with a 4.2-fold increase in the mutant. Other well known virulence determinants
were also found to be more abundant in the protease-null strain, including 2 Lipases (Geh
= 3.8-fold, SAUSA300_2603 = 2.5-fold), components of the γ-hemolysin (HlgA = 2.4fold, HlgC = 2.1-fold), α-toxin (2.0-fold), leukotoxin LukE (2-fold) and enterotoxin Q
(1.5-fold). Our analysis also revealed increased abundance of certain proteins in the wildtype strain, including all 10 secreted proteases, as expected, along with catalase (9-fold),
the CamS pheromone (2-fold), and 2 putative lipoproteins (SAUSA300_2403 = 2-fold,
SAUSA300_0411 = 3-fold).
A consideration with this pooled analysis is that a protein may be processed by secreted
proteases into potentially inactive fragments, as a result of endoproteolysis. As the
protein is not completely degraded to free amino acids, each of these fragments will be
detected by MS-analysis; therefore one may not observe any fold-change in spectral
counts, yet cleavage has rendered the protein non-functional. As such, protein abundance
was next compared within individual fractions from the SDS-PAGE gels. Spectral counts
for a given protein were only analyzed for the single fraction that would contain its fulllength protein, based on predicted molecular weight. (Figure 36, Table 6). The 19
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Table 5. Collective alterations in protein abundance for secreted
proteins upon deletion of extracellular proteases in S. aureus USA 300.
Fold
Accession
a,c
b,c
M
Change
Protein
Gene Number
WT
Phenol-soluble modulin
alpha 4 peptide
4
17
4.25
psmα4
Triacylglycerol lipase
SAUSA300_0320
276 1062
3.84
geh
Autolysin
SAUSA300_1921
117 303
2.58
alt
Triacylglycerol lipase
SAUSA300_2603
168 425
2.52
lip
Gamma-hemolysin
component A
SAUSA300_2365
29
72
2.48
hlgA
Gamma-hemolysin
component C
SAUSA300_2366
17
37
2.17
hlgC
Alpha-hemolysin
SAUSA300_1058
226 462
2.04
hla
Staphylococcal
superantigen-like
protein 7
SAUSA300_0401
2
6
2
ssl7
Extracellular matrixbinding protein
SAUSA300_1327
2
4
2
ebh
Extracellular matrix
protein-binding protein emp
SAUSA300_0774
5
10
2
Leukocidin
SAUSA300_1975
88 176
2
lukA
Leukotoxin
SAUSA300_1769
8
16
2
lukE
Leukocidin
SAUSA300_1974
83 157
1.89
lukB
Putative staphylococcal
enterotoxin
SAUSA300_0370
7
13
1.85
Ear protein
SAUSA300_0815
8
14
1.75
ear
Phenol-soluble modulin
beta 1 peptide
5
8
1.6
psmβ1 SAUSA300_1067
Staphylococcal
enterotoxin Q
SAUSA300_0801
12
19
1.58
seq
Immunoglobulinbinding protein
SAUSA300_2364
17
26
1.52
sbi
Phenol-soluble modulin
alpha 3 peptide
2
3
1.5
psmα3
Putative lipoprotein
SAUSA300_2403
2
0
-2
Sex pheromone
2
0
-2
camS SAUSA300_1884
Uncharacterized
lipoprotein
SAUSA300_0411
3
1
-3
Catalase
SAUSA300_1232
9
0
-9
katA
Serine protease
SAUSA300_1758
14
0
-14
splA
Serine protease
SAUSA300_1755
15
0
-15
splD
Zinc metalloproteinase
aureolysin
SAUSA300_2572
15
0
-15
aur
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Table 5 continued
Serine protease
Serine protease
Serine protease
V8 protease
Serine protease
Cysteine protease
Staphopain A

splE
splC
splF
sspA
splB
sspB
scpA

SAUSA300_1754
SAUSA300_1756
SAUSA300_1753
SAUSA300_0951
SAUSA300_1757
SAUSA300_0950
SAUSA300_1890

a-LAC wild-type
b- LAC protease-null mutant
c- total spectral counts identified for each protein
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18
18
27
43
46
123
143

0
0
0
1
0
0
1

-18
-18
-27
-43
-46
-123
-143

Table 6. Individual fraction analysis of alterations in protein stability for
secreted proteins upon deletion of extracellular proteases in S. aureus USA 300.
Accession
Fold
Protein
Gene
Number
Size
Change
Immunoglobulin-binding
protein
SAUSA300_2364
50 kDa
9
sbi
Alpha-hemolysin
SAUSA300_1058
36 kDa
8.88
hla
Phenol-soluble modulin
alpha 4 peptide
2 kDa
5
psmα4
Leukocidin
SAUSA300_1974
39 kDa
4.66
lukB
Triacylglycerol lipase
SAUSA300_2603
77 kDa
4.6
lip
Gamma-hemolysin
component A
SAUSA300_2365
35 kDa
4
hlgA
Staphylococcal
complement inhibitor
SAUSA300_1919
13 kDa
3.66
scn
Leukotoxin
SAUSA300_1769
35 kDa
3.66
lukE
Gamma-hemolysin
component C
SAUSA300_2366
36 kDa
3.33
hlgC
Staphylococcal
superantigen-like protein
7
Extracellular matrix
protein-binding protein
Ear protein
Triacylglycerol lipase
precursor
Panton-Valentine
leukocidin
Autolysin
Secretory antigen
Extracellular matrixbinding protein
Staphylococcal
enterotoxin Q
Leukocidin
lukA
Staphylococcal
enterotoxin K
Phenol-soluble modulin
alpha 3 peptide
Phenol-soluble modulin
beta 1 peptide

ssl7

SAUSA300_0401

26 kDa

3

emp
ear

SAUSA300_0774
SAUSA300_0815

38 kDa
20 kDa

3
2.66

geh

SAUSA300_0320

76 kDa

2.55

lukS

SAUSA300_1382

2.45

alt
ssaA

SAUSA300_2249

ebh

SAUSA300_1327

35 kDa
137
kDa
29 kDa
1123
kDa

seq

SAUSA300_0801

28 kDa

2

SAUSA300_1975

40 kDa

2

SAUSA300_0800

28 kDa

2

3 kDa

2

4 kDa

1.75

sek
psmα3
psmβ1

SAUSA300_1067
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2.3
2
2

Table 6 continued
Putative staphylococcal
enterotoxin
Panton-Valentine
leukocidin,

lukF

SAUSA300_0370

23 kDa

1.66

SAUSA300_1381

37 kDa

1.5
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Figure 36. Extracellular proteases modulate the stability of a wealth of known
secreted virulence factors. The secretome of LAC and its protease-null strain were
collected and fractionated via SDS-PAGE. Known, full length secreted proteins were
analyzed and their spectral counts determined. Shown are the ratios of abundance for
each secreted protein in the wild-type (black) compared to the mutant (grey).
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proteins identified from the pooled sample all had decreased abundance in the wild-type
strain in their relative molecular weight fractions; in many cases to even greater degrees
than in our collective analysis. For example, we observed increased abundance for Sbi (9fold), alpha-toxin (8.8-fold), phenol soluble modulin alpha 4 (5-fold), γ-hemolysin (HlgA
= 4-fold) and LukE (3.6-fold) upon deletion of extracellular proteases using this method.
Furthermore, an additional 5 proteins that did not produce a significant fold change in the
pooled samples were identified as being altered in protein stability in the mutant strain.
These include the two components of the Panton-Valentine leukocidin (LukS = 2.4-fold,
LukF = 1.5-fold), the staphylococcal complement inhibitor (3.6-fold), enterotoxin K (2fold), and secretory antigen SsaA (2-fold).
Following this, we also performed a similar analysis for surface proteins between the two
strains. The rationale for this is that existing evidence in the literature suggests secreted
proteases can also target surface exposed proteins in S. aureus (Karlsson et al., 2001;
McAleese et al., 2001). As such, the cells used to generate secretomes were harvested,
and their surface protein fraction isolated, before being processed in an identical SDSPAGE based fashion. When performing a collective analysis of spectral counts for all
fractions, we observed 10 proteins with a 1.5-fold or greater increase in the protease null
mutant (Table 7). These include fibronectin-binding proteins A (4-fold) and B (3-fold), as
well as fibrinogen binding protein (2.3-fold), clumping factor A (1.7-fold) and IsdA (1.6fold). We also performed specific fraction analysis as detailed above to determine those
proteins with altered protein stability upon deletion of the extracellular proteases (Figure
37, Table 8). Specific analysis revealed that, in addition to the 10 surface proteins
identified from pooled studies, a further 7 had a fold change of 2 or higher in the protease
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Table 7. Collective alterations in protein abundance for surface proteins upon
deletion of extracellular proteases in S. aureus USA 300.
Fold
Accession
a,c
b,c
M
Change
Protein
Gene Number
WT
Fibronectin-binding
protein B
1
4
4
fnbB SAUSA300_1052
Fibronectin-binding
protein A
1
3
3
fnbA SAUSA300_2441
Enolase
SAUSA300_0760
45 129
2.86
eno
Staphylokinase
SAUSA300_1922
16
40
2.5
sak
Fibrinogen-binding protein efb
SAUSA300_1055
9
21
2.33
Cell wall surface anchor
family protein
33
74
2.24
sasG SAUSA300_2436
Transferrin receptor
SAUSA300_0721
1
2
2
tpn
Putative lipoprotein
SAUSA300_0372
24
44
1.83
Clumping factor A
SAUSA300_0772
11
19
1.72
clfA
Iron-regulated surface
determinant protein A
SAUSA300_1029
10
16
1.6
isdA
a-LAC wild-type
b- LAC protease-null mutant
c- total spectral counts identified for each protein
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Table 8. Individual fraction analysis of alterations in protein stability for surface
proteins upon deletion of extracellular proteases in S. aureus USA 300.
Accession
Fold
Protein
Gene Number
Size
Change
Clumping factor B
SAUSA300_2565 97kDa
8
clfB
Staphylokinase
SAUSA300_1922 18 kDa
4.8
sak
Fibrinogen-binding protein efb
SAUSA300_1055 19 kDa
4.25
Fibronectin-binding
protein B
4
fnbB SAUSA300_1052 13 kDa
Enolase
SAUSA300_0760 47 kDa
3.82
eno
Iron-regulated surface
determinant protein A
3.75
isdA SAUSA300_1029 39 kDa
Fibronectin-binding
112
protein A
3
fnbA SAUSA300_2441 kDa
Cell wall surface
anchor family protein
SAUSA300_2436 49 kDa
2.93
sasG
Putative lipoprotein
SAUSA300_0372 21 kDa
2.5
Putative surface protein
SAUSA300_0883 16 kDa
2.47
Probable transglycosylase
2.36
isaA SAUSA300_2436 24 kDa
Immunodominant
staphylococcal antigen B
2.2
isaB SAUSA300_2573 19 kDa
Clumping factor A
SAUSA300_0772 97 kDa
2.16
clfA
Immunoglobulin G binding
protein A
SAUSA300_0113 56 kDa
2.1
spa
Elastin-binding protein
2
ebpS SAUSA300_1370 53 kDa
Transferrin receptor
SAUSA300_0721
2
tpn
Staphylocoagulase
SAUSA300_0224 69 kDa
2
coa
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Figure 37. Extracellular proteases modulate the stability of a number of surfaceassociated virulence factors. The surfactome of LAC and its protease-null strain were
collected and fractionated via SDS-PAGE. Known, full length surface proteins were
analyzed and their spectral counts determined. Shown are the ratios of abundance for
each secreted protein in the wild-type (black) compared to the mutant (grey).
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mutant. These included immunodominant staphylococcal antigens A (2.3-fold) and B
(2.2-fold), staphylocoagulase (2-fold), immunoglobulin G binding protein A (Spa = 2.1fold), elastin-binding protein (2-fold) and a putative surface protein (SAUSA300_0883 =
2.4-fold). We again observed a general increase in protein abundance for the majority of
proteins identified by fraction analysis when compared to the pooled data. The most
striking of which was clumping factor B, which, upon fraction analysis, produced an 8fold increase in abundance in the mutant.
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Discussion
Recent reports suggest that MRSA is now the leading cause of infectious disease and
death by a single agent in the United States (Coulter et al., 1998). This pathogenic
success can largely be attributed to the meteoric increase in CA-MRSA infections in the
last decade (Burlak et al., 2007; Calander et al., 2008); Calander et al., 2004). Although
several CA-MRSA lineages exist, USA300 is now thought to account for more than 50%
of all MRSA infections in some regions (Johnson et al., 2007; Moran et al., 2006). The
reason for the surprising success of USA300 is somewhat unclear; however work by a
number of groups suggests it may be attributable to the differential expression of core
genomic elements (Li et al., 2009), including the PSMs, hemolysins, extracellular
proteases and enterotoxins (Diep et al., 2008; Li et al., 2009; Adem et al., 2005;
Kobayashi & DeLeo, 2009; Montgomery et al., 2008; Wang et al., 2007). A number of
studies performed by ourselves and others have focused on determining the contribution
of extracellular proteases to disease causation (Reed et al., 2001; Shaw et al., 2004;
Coulter et al., 1998; Rice et al., 2011; Calander et al., 2004; Karlsson & Arvidson, 2002;
Sifri et al., 2008; Prajsnar et al., 2008). Thus far these data have proved contradictory,
perhaps as a result of using strains that have varying proteolytic capabilities. Some
backgrounds used (e.g. RN6390) have limited clinical significance, whilst other studies
have focused only on individual protease mutations. This latter point is of particular
importance as it has been shown in other highly proteolytic bacteria that significant levels
of functional redundancy exist (Travis et al., 1995). For these reasons, and to explore the
role of this class of enzymes in CA-MRSA pathogenesis, we have focused in this study
on a total exoprotease null mutant of USA300 LAC.
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Interestingly, whilst we show that the mutant strain is viable in complex media, we did
observe a survival defect during extended culturing in peptide based media. Previous
reports have shown that S. aureus cells can only import octapeptides or smaller for
nutrition based purposes (Hiron et al., 2007). Therefore, it is possible that the
extracellular proteases of S. aureus cleave large oligopeptides into smaller fragments for
growth and nutrition. Interestingly, the defect was only apparent after 24h of growth.
Thus it is possible that at earlier time points, the major nutrient source is limited free
amino acids, and oligopeptides with less than 8 residues. Once these more readily usable
nutrients have been exhausted, the focus would then shift to breaking down oligopeptides
with greater than 9 residues. In this scenario, any strain lacking extracellular proteases
would be limited in their ability to generate smaller, importable peptides for nutrition,
explaining the growth defect observed. This contention is supported by the observation
that, unlike a variety of other organisms, S. aureus lacks a PrtP homolog, which serves to
breakdown large oligopeptides for import and nutrition (Siezen et al., 1999). We also
observed fitness defects in the protease null strain during growth in the more
pathogenically relevant pig serum. This is perhaps a result of an inability to degrade
proteins for nutritive purposes. Additionally, others have shown that nutrition defects
become emphasized during growth in serum (Hammer & Skaar, 2011). Alternatively,
given that serum contains complement, AMPs and other non-cellular components of the
immune system, it is possible the growth defects observed stem from a role for
extracellular proteases during interaction with innate immunity, as a decrease in survival
of the protease-null mutant is observed at early time points. This is support by the recent
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finding that aureolysin facilitates resistance of S. aureus to killing by complement as a
result of C3 cleavage (Laarman et al., 2011).
This contention is further corroborated by our observation that the protease mutant strain
is more sensitive to antimicrobial peptides (AMPs). It has previously been shown that
aureolysin cleaves the cathelicidin AMP, LL-37 (Sieprawska-Lupa et al., 2004). Herein
we show that cleavage of such agents by extracellular proteases is not confined to LL-37
alone, as we observed increased sensitivity to both indolicidin and histatin-5. During
infection, AMPs bind to bacterial cells through cationic interactions at the cell surface,
and exhibit antibacterial activity through several mechanisms (Nishi et al., 2004).
Therefore, in S. aureus, secreted proteases appear to aid in immune evasion by
preemptively degrading these agents of innate immunity. We further investigated this
assertion by evaluating survival in whole human blood. In addition to complement and
AMPs, whole human blood also contains cellular components of immunity. When such
profiling was performed we also saw major survival defects in the mutant strain. The
immune components of serum and blood are relatively similar, and thus the decreases in
survivability observed may result from a lack of AMPs and complement system
degradation in the mutant strain. However, in serum at 4h, the mutant produced a 2-fold
decrease, while in blood a 4.72-fold decrease was observed at the same time. This
suggests that secreted proteases are not only used for protection against the innate
immune system, but have a larger role in evasion of cell mediated immunity. This finding
is support by the previous work from our group, showing that a functional aureolysin is
required to survive phagocytosis by human macrophages (Kubica et al., 2008).
Additionally, others have shown that Staphopain B can cleave both CD11b and CD31,
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which block the phagocytosis of S. aureus by neutrophils and monocytes (Smagur et al.,
2009a; Smagur et al., 2009b). Further to this, a number of the secreted proteases have
been shown to cleave components of human blood, such as pro-thrombin and pro-uPA, in
order to facilitate survival and proliferation (Beaufort et al., 2008; Wegrzynowicz et al.,
1980). Collectively, findings from the literature, along with our data presented herein,
strongly argue that extracellular proteases play a protective and beneficial role during S.
aureus infection.
We also observed significant influence of the secreted proteases on in vivo pathogenesis.
This was first studied for localized infection, using a murine model of abscess formation.
Over the course of a 6 day period we observed an approximately 2-fold decrease in
virulence for the mutant strain. This decrease is perhaps not as large as would be
expected; previous work has shown that 8325-4 sspA and sspB mutants are more than 3fold impaired in virulence when using this same model (Shaw et al., 2004). The reason
why a complete protease null mutant would display less attenuation than single protease
mutants is likely explained by the proteomics works conducted in this study. We observe
that, upon deletion of the secreted proteases, the stability of a large number of key
virulence factors increases significantly. As such, a protease-null strain actually
accumulates more toxins, rather than less. This is particularly important in this model, as
key mediators of skin infections, such as α-toxin and the PSMs, are more abundant upon
protease inactivation. Therefore, the observed 2-fold reduction is actually quite
surprising, given the increased prevalence of wound enhancing toxins. As such, any
observed decrease at all upon protease deletion is a major finding, and suggests that the
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loss of these enzymes, despite being subverted by other wound-impacting toxins,
influences the ability of S. aureus to cause localized disease.
When using systemic infection models, we observed further, and profound alterations in
virulence that were far in excess of those seen for localized infections. Specifically, the
mutant displayed significantly decreased bacterial loads in the lungs (98.79-fold), liver
(7.45-fold), heart (5.72) and spleen (3.04-fold). The specific explanations for these
findings, are likely complex and multifactorial. However, it has previously been shown
that secreted proteases can cleave human α1-proteinase inhibitor (Potempa et al., 1986),
α1-antichymotrypsin, the heavy chains of all human immunoglobulin classes (Prokesova
et al., 1992), elastin (Potempa et al., 1988), fibrinogen, fibronectin, high molecular
weight kinininigen and plasminogen (Imamura et al., 2005; Massimi et al., 2002).
Cleavage of each of these host proteins aids in tissue invasion, and perhaps explain the
decrease in mutant cells in these organs. Further to this, we demonstrate in our
proteomics studies that protease null mutant cells have increased decoration of their cell
walls, as higher levels of surface proteins were observed upon deletion of proteolytic
enzymes. Indeed our preliminary studies have shown that the protease null-strain is
significantly more adhesive to surfaces coated with human proteins, including elastin (our
unpublished observations). This, coupled with our findings that the protease mutant strain
is less resistant to AMPs, and has decreased survival in both serum and whole-blood,
might begin to explain this phenotype. As such, one would hypothesize that, upon
inoculation into the blood, the protease null strain would immediately display decreased
fitness for survival, increased attachment, decreased dissemination and invasion, and an
inability to cleave key host proteins for survival, evasion and nutrition.
147

In stark contrast to this, we in fact observe increased virulence of the protease-null
mutant when using mortality as a measure of infection. This finding is of primary
importance, and speaks strongly to a major role for the secreted proteases in controlling,
and tightly regulating the infectious process. Herein we show major increases in
virulence determinant stability upon inactivation of extracellular proteases. Specifically
we show that α-toxin, γ-hemolysin, PSMs, LukE, LukAB, PVL and others are all more
abundant in protease-null strain. Importantly, each of these factors have been linked to
increased virulence and mortality during S. aureus infection (Wang et al., 2007; Prajsnar
et al., 2008; Bubeck Wardenberg & Schneewind, 2008; Bubeck Wardenberg &
Schneewind, 2007; Menestrina et al., 2003; Morinaga et al., 2003; Dumont et al., 2011;
Labandeira-Rey et al., 2007; Diep et al., 2007; Loffler et al., 2010 ; Tseng et al., 2009).
Thus, despite the loss of extracellular proteases and their affects on the host, other major
virulence factors are more prevalent and stable. We propose that, in the absence of
proteolytic activity, these other virulence factors exist unchecked, and therefore provide
the potential for the aggressive progression of infection observed. Indeed, the
overproduction of PVL has frequently been linked to the rapid and increased mortality
associated with necrotizing pneumonia (Garnier et al., 2006; Morgan, 2005). Indeed, such
a scenario is supported by reports on the role of the cysteine protease, SpeB, from Group
A Streptococci (GAS). When levels of this enzyme rise in GAS, the stability and
abundance of other virulence factors is reduced, leading to impairments in invasion and
virulence (Kansal et al., 2000; Kansal et al., 2003; Chatellier et al., 2000).
Therefore, this presents a scenario where, in addition to their own, independent virulence
affecting roles, the secreted proteases exist as key check point enzymes to control the
148

severity and intensity of infection via modulating the stability of other toxins and
virulence determinants. Indeed, one could suggest that the regulatory control of secreted
proteases by the agr system is no accident, but in fact evolutionary design. In such a
scenario, any enhancement of agr activity, such as that seen in CA-MRSA strains, would
lead to massive toxin production, and death of the host organism. As an opportunistic
pathogen, such rapid killing of the host by S. aureus is counterintuitive to survival.
Therefore, by tying the production of other toxins to extracellular protease expression and
activity, one is presented with an inbuilt mechanism to self regulate the overtly harmful,
and often lethal effects of secreted toxins on the host, thus tempering and controlling the
pathogenic process.
In summary, we demonstrate that the extracellular proteases of S. aureus play a variety of
key roles in the virulence process. Specifically, they aid in protection against the innate
immune system, at both cell-dependent and independent levels. They also strongly
impact the progression of both localized and systemic CA-MRSA infections. Finally, and
perhaps most importantly, they are key mediators of secreted and cell wall associated
virulence determinant stability. Collectively our findings provide a unique insight into the
progression of CA-MRSA infections, and the role of secreted proteolytic enzymes.
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Chapter 5: Final Discussion

Final Discussion
NsaRS is a two-component system which we show herein responds to several cellenvelope-targeting drugs. This is not surprising as it is an intramembrane-sensing
histidine kinase (IM-HK), which as a family have very small external sensing domain,
and most likely do not sense environmental signals, but damage to the cell superstructure
(Mascher et al., 2006). NsaRS belongs to the group of IM-HKs that exert their effects by
utilizing an adjacent transporter; NsaRS is located upstream of an ABC transporter,
NsaAB, which we show in this work to be controlled by this TCS. A microarray on the
nsaS mutant determined that NsaRS regulates 245 genes under standard conditions. The
gene with the largest alteration of expression in the nsaS mutant was another ABC
transporter, SACOL2525/2526, which homology analysis suggests may transport
peptides or lantibiotics.
Our analysis shows that NsaRS and SACOL2525/2526 are expressed during the
exponential phase of growth, which declines into stationary phase (Kolar et al., 2011;
Chapter 3 of this dissertation). The expression of SACOL2525/2526 seems to be strongly
regulated by NsaRS, which is in contrast to NsaAB, which is not temporally regulated,
and is seemingly not expressed under standard conditions. Therefore, it is likely that
NsaRS utilizes SACOL2525/2526 under standard conditions to exert its effects; with the
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expression and role of NsaAB being limited during these times of stasis. In this scenario,
NsaAB is only deployed by the cell, in an NsaRS dependent manner, to circumvent
damage by cell-wall antibiotics, and as such is only expressed during antibiotic exposure,
as is situation for other antibiotic transporters (Muthaiyan et al., 2008; Ouyang et al.,
2010; Meehl et al., 2007). This makes SACOL2525/2526 most unusual for a putative
drug transporter, in that it appears to have a role within the cell during standard growth
conditions, without the input of stress signals.
Each of these 3 elements have been shown to respond to certain cell-envelope antibiotics,
with some overlap in the compounds noted (Kolar et al., 2011; Hiron et al., 2011) when
one compares the transcription of SACOL2525/2526, nsaRS and nsaAB in response to
cell-envelope-targeting compounds (Figure 38). The expression profiles of nsaRS and
SACOL2525/2526 are very similar, with 7 of the 10 drugs tested (phosphomycin,
ampicillin, penicillin G, D-cycloserine, CCCP, daptomycin and oxacillin) producing an
increase in expression for both elements; whilst only 3 drugs (nisin, gramicidin and
chloropromazine) show opposing effects. In contrast, nsaAB shares only 4 drugs in
common with NsaRS: CCCP, daptomycin and nisin produce an increase in transcription,
and chloropromazine decreasing expression of both systems. Six drugs (phosphomycin,
ampicillin, penicillin G, D-cycloserine, oxacillin and gramicidin) produce contrasting
effects between NsaRS and NsaAB. None of the 3 systems respond to every drug tested,
suggesting some specificity exists, however the overall expression pattern of NsaRS is
more similar to SACOL2525/2526 than NsaAB. This further suggests that NsaRS relies
more heavily on SACOL2525/2526 to exert its effects than it does NsaAB, at least in the
conditions tested herein. Interestingly, NsaAB does not respond to any of the drugs tested
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Figure 38. Transcription of nsaRS, nsaAB and SACOL2525/2526 in response to cellenvelope-targeting drugs. qRT-PCR was performed on either nsaRS, nsaAB or
SACOL2525/2526 in the presence of sub-inhibitory concentrations of cell-wall-targeting
(blue) or cell-membrane-targeting (yellow) drugs, along with those that target both
(purple). Green boxes signifies an increase in transcription and grey boxes show no
change in expression to the corresponding antibiotic.
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that target the peptidoglycan synthesis pathway, as only drugs that target the cell
membrane increased transcription of this element. In contrast, SACOL2525/2526
responded to all peptidoglycan synthesis targeting agents tested, with the exception of
bacitracin, which none of the 3 systems appear to respond to. It has been shown by others
that NsaRS and NsaAB are important in bacitracin resistance (Hiron., et al 2011). The
inconsistency between this observation and our work may be the result of the
concentration used, as these systems seemingly respond to only low levels of bacitracin,
whilst in our study, the highest concentration of antibiotic that did not impair growth was
utilized. Therefore, SACOL2525/2526 may respond to antibiotics that target
peptidoglycan synthesis at high and possibly low concentrations, whereas NsaAB may
only respond to cell membrane targeting agents, and low concentrations of certain cellwall targeting drugs. This may suggest a broader spectrum of response by
SACOL2525/2526 than NsaAB. The drugs that produced an opposing effect for
SACOL2525/2526 and NsaRS target the membrane, although there are exceptions, as
CCCP and daptomycin impact the membrane but also increased the expression of both
systems. This is perhaps explained by the fact that daptomycin has also been shown to
affect cell-wall biosynthesis pathway, in addition to the membrane (Canepari et al., 1990;
Silverman et al., 2003; Cotroneo et al., 2008). When compared to other drugs that
dissipate the proton potential, daptomycin takes 10 times longer to exert the same
effects, however death still occurs, suggesting that an alteration in the proton potential
through targeting of the membrane may not be the leading mode of action (Muthaiyan et
al., 2007). Also, CCCP affects ATP levels within the cell, and a downstream affect of this
is likely felt on the peptidoglycan synthesis pathway (Dimroth & Cook, 2004). Therefore,
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NsaRS may deploy NsaAB in specific situations, such as in response to cell-membranetargeting drugs (Figure 39). In contrast, NsaRS likely utilizes SACOL2525/2526 in
response to drugs that target the peptidoglycan synthesis pathway.
NsaRS has been shown to be important in both bacitracin and nisin resistance by utilizing
either SACOL2525/2526 or NsaAB (Kolar et al., 2011; Blake et al., 2011; Hiron et al.,
2011). Both NsaRS and SACOL2525/2526 contribute to bacitracin resistance, as nsaS
and SACOL2525/2526 mutants produced lower spontaneous mutation frequencies in the
presence of this compound. Furthermore, Hiron et al. showed that NsaRS, NsaAB, and a
second transporter VraDE work in concert to aid S. aureus in bacitracin resistance.
Specifically, NsaRS utilizes NsaAB for sensing and signaling of bacitracin stress, with
VraDE serving as the detoxification module that causes export of intracellular bacitracin.
Since SACOL2525/2526 does not appear to be a detoxification module as it is expressed
under standard conditions, it may provide a similar role to NsaAB in sensing and
signaling. While it is currently unknown how NsaAB aids in sensing cell-wall stress,
SACOL2525/2526 may do this by changing the fluidity of the membrane. If
SACOL2525/2526 alters the cell-envelope, or specifically the fluidity of the membrane,
other IM-HKs may be able to sense this as they respond to alterations at, or in, the
membrane, and not an external signal. In addition, each histidine kinase contains a
membrane spanning domain, and alterations in the fluidity of the membrane may change
the conformational shape of the kinase, resulting in phosphorylation or dephosphorylation. Therefore, SACOL2525/2526 may respond to cell-wall stress, and as a
result, increases the fluidity of the membrane, which may in turn stimulate GraRS,
NsaRS or VraRS. We show that SACOL2525/2526 contributes to the resistance against a
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Figure 39. NsaRS regulates NsaAB and SACOL2525/2526 in response to different
cell envelope stress. A). NsaAB is not expressed under standard conditions but has been
shown to have increased expression in the presence of certain cell-membrane-targeting
drugs, as a result of NsaRS action. In this model, NsaRS only use NsaAB in response to
certain cell-membrane-targeting drugs. B). SACOL2525/2526 has increased expression
in the presence of drugs that targets peptidoglycan synthesis that is at least partly
dependent on NsaRS action. NsaRS may utilize SACOL2525/2526 in response to drugs
that target the peptidoglycan synthesis pathway.
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number of drugs, and may respond to cell wall stress and signal to NsaRS, either by
direct interaction; or by altering NsaRS activity by changing membrane fluidity, which
would then regulate an exporter for removal of the antibiotic. One might speculate that
the efflux pump utilized in the presence of bacitracin may be VraDE, with other
transporters involved in this system yet to be identified. Since NsaAB only responds to a
few cell-envelope targeting drugs, SACOL2525/2526 may respond to a broader spectrum
of peptidoglycan stress, contributing to resistance against many antibiotics. It could also
be possible that SACOL2525/2526 senses alterations in the peptidoglycan layer that are
not associated with damage from an antibiotic, but instead are centered around cell
division. Additionally, NsaRS was identified by Blake et al. as being important in nisin
resistance; herein we show that NsaRS upregulates nsaAB in the presence of this
compound. Therefore, a situation akin to the 6 component resistance mechanism for
bacitracin may also occur is response to nisin, where NsaRS uses NsaAB in signaling
nisin stress, and regulates an unknown transporter for the detoxification of nisin. Since
NsaAB is not expressed under standard conditions it may not contribute to the regular
functions of the cell, as SACOL2525/2526 does with membrane fluidity; NsaAB may
therefore directly interact with NsaRS to aid in signaling. Some IM-HKs are associated
with a membrane protein, which affects the phosphorylation cascade (Jordan et al., 2006).
However, it has not been investigated whether the IM-HKs associated with an adjacent
transporter may function in a similar fashion; instead of the transporter pumping a
substrate in or out, it may have dual roles and also function as a sensor. This direct
interaction may alter the phosphorylation state of the histidine kinase and ultimately the
response regulator. This further suggests that NsaRS is important in specific antibiotic
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resistance, and may utilize either SACOL2525/2526 or NsaAB for sensing and adaption
to various compounds.
Although both NsaRS and GraRS positively regulate SACOL2525/2526 under standard
conditions, only NsaRS contributes to the increase in transcription in response to cellwall-targeting chemicals. In a nsaS mutant, in the presence of drugs shown to increase
transcription, expression of SACOL2525/2526 decreased. Expression levels do not,
however, return to those observed in unstimulated cells, suggesting that while NsaRS
does positively regulate SACOL2525/2526 in response to cell-envelope-targeting drugs,
it is not the only regulator. NsaRS is also responsible, at least in part, for the increased
transcription of NsaAB in response to nisin. Again, the transcription of NsaAB decreased
in the nsaS mutant when exposed to nisin, but did not to levels observed in unstimulated
cells. Therefore, NsaRS does regulate NsaAB in response to nisin, but again, other
factors are clearly at work. This is consistent with the literature, as S. aureus possesses
multiple regulators that respond to the same stress. For example, glycopeptide resistance
has been shown to be influenced by several regulators, including VraRS, GraRS, WalKR,
the carbon catabolite control protein (CcpA), regulators of multidrug transporters
(MgrA), the staphylococcal accessory regulator A (SarA), and the alternative sigma
factor (σB) (Kuroda et al., 2007; Seidl et al., 2006; Meehl et al., 2007; Chen et al., 2006;
Truong-Bolduc et al., 2005; Ballal & Manna, 2009; Piriz-Duran et al., 1996; Meier et al.,
2007; Bischoff et al., 2004). Several other regulators have been identified for
SACOL2525/2526 by the utilization of microarrays, including MgrA, SarA, Rot, ArlRS
and σB (Bischoff et al., 2004; Cassat et al., 2006; Said-Salim et al., 2003; Liang et al.,
2005). MgrA is a DNA-binding protein that has been shown to contribute to antibiotic
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resistance by regulating several efflux pumps, including NorB and Tet38, along with an
additional 50 genes implicated in transport (Truong-Bolduc et al., 2005). MgrA aids in
antibiotic resistance by regulating efflux pumps that extrude drugs out of the cell, and
transporters that import nutrients, which may give the cell energy to combat the
encountered stress (Loung et al., 2006). Therefore, it is not surprising that MgrA has been
shown to regulate SACOL2525/2526, and further suggests that this transporter may be
important in antibiotic resistance. SACOL2525/2526 may also contribute to resistance by
altering membrane fluidity, which has been shown to change the activity of transporters
present in the membrane by increasing or decreasing their efficiency (Gustot et al., 2010).
In this situation, the cell would not need to alter the transcription of each transporter, but
instead change the expression of SACOL2525/2526 to produce similar effects, leading to
a more rapid modification in activity of other transporters. In addition, an increase in
membrane fluidity may stimulate other regulators, including the IM-HKs GraRS and
NsaRS, which each regulate around 50 transporters independently (Kolar et al., 2011;
Herbert et al., 2007). Thus far, only NsaRS has been demonstrated to regulate NsaAB,
with other regulators yet to be identified (Hiron et al., 2011; Kolar et al., 2011). One
could speculate that since GraRS has been shown to regulate genes important in nisin
resistance, it may also regulate NsaAB (Meehl et al., 2007; Li et al., 2007). Therefore, in
response to certain cell-envelope-targeting drugs, NsaRS, along with other factors,
manipulate the transcription of these 2 ABC transporters independently, and utilizes them
to exert effects in coping with stress.
Of the 245 genes modulated by NsaRS, only 34 are negatively regulated, and include
those involved in capsule production (capGOIHED); the virulence genes β-hemolysin,
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hyaluronate lyase, fibronectin binding protein A; and 6 of the 10 major secreted
proteases. Secreted proteases have been shown to be inactive until they are secreted, and
are processed outside of the cell, with the exception of the Spl proteins (Rice et al., 2001
and Shaw et al., 2004; Reed et al, 2001). Since extracellular proteases are only active
outside the cell, it has been suggested that their targets include: 1) other secreted proteins,
including virulence factors; 2) cell surface associated proteins; or 3) host proteins. These
former 2 facts would allow for the regulation of externalized S. aureus proteins, and may
suggest a post-translational modification mechanism utilized by S. aureus to respond and
adapt to a changing environment. Indeed, such a theory was proposed more than ten years
ago (Lindsay & Foster, 1999), however only a few studies have investigated this
phenomenon (Karlsson et al., 2001;McAleese et al., 2001; McGavin et al., 1997;
Zielinska et al., 2011). Whilst a number of reports on secreted proteases are contained
within the literature, their findings are contradictory, and the role of these enzymes in
protein modification and pathogenesis is currently unclear. In order to determine if the
proposed protein modification/regulation theory has validity, a strain was constructed
lacking all 10 major secreted proteases to study this phenomenon.
Using proteomics, we show that the secreted proteases do indeed play a major role in the
modification of S. aureus surface-associated and secreted proteins, as suggested by
Lindsay & Foster (Lindsay & Foster, 1999). Analysis of the wild-type strain revealed a
decrease in abundance of 24 known proteins in the absence of secreted proteases,
including 2 lipases, components of the γ-hemolysin, α-toxin, leukotoxin (LukE),
enterotoxin Q, Panton-Valentine leukocidin, the staphylococcal complement inhibitor,
enterotoxin K, and secretory antigen SsaA. A similar analysis was also performed for
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surface proteins revealing 17 proteins that are cleaved by secreted proteases. These
include fibronectin-binding proteins A and B, fibrinogen binding protein, clumping factor
A, IsdA, immunodominant staphylococcal antigens A and B, staphylocoagulase,
immunoglobulin G binding protein A, elastin-binding protein and a putative surface
protein (SAUSA300_0883). This data suggests that secreted proteases act as posttranslational regulators of several important secreted and surface-associated proteins.
To determine the effect of this accumulation, or lack of degradation, the mutant and
parental strain were evaluated in both localized and systemic models of infection. The
protease null mutant produced a decrease in bacterial loads recovered from murine
abscesses, suggesting a decrease in virulence of the protease null mutant strain compared
to the wild-type. When using systemic infection models, we observed further alterations
in virulence of the protease-null strain. Specifically, the mutant displayed significantly
decreased bacterial loads in the lung, liver, heart and spleen, again suggesting attenuation
of virulence for the mutant. Although there were lower bacterial loads, we did observe an
increase in virulence for the protease-null mutant when using mortality as a measure of
infection. Collectively, extracellular proteases contribute significantly to in vivo
pathogenesis, which is an important finding in itself. Although these results seem
contradictory, the observed results may be explained by the proteins secreted proteases
cleave. The reasoning behind the observed increase in mortality is likely the result of
increased stability for a large number of key virulence factors upon protease deletion.
Specifically we show that α-toxin, γ-hemolysin, PSMs, LukE, LukAB, PVL and others
are all more abundant in the protease-null strain. Importantly, each of these factors have
been linked to increased virulence and mortality during S. aureus infection (Wang et a.,
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2007; Prajnar et al., 2008; Bubeck Wardenburg & Schneewind, 2008; Bubeck
Wardenburg et al., 2007; Menestrina et al., 2003; Morinaga et al., 2003; Dumont et al.,
2011; Loffler et al., 2011; Tseng et al., 2009). We therefore that, in the absence of
proteolytic activity, certain virulence factors remain unregulated at the post-translational
level, and may lead to the aggressive progression of infection observed. The decrease in
bacterial loads recovered from abscesses and organs may be explained by our proteomics
studies, which show that protease null mutant cells have increased decoration of their cell
walls, with higher levels of surface proteins observed. It has been shown that S. aureus
sheds surface-associated proteins for increased dissemination via the action of these
proteases. Therefore the protease null mutant likely has a dissemination defect, and
cannot reach organs as efficiently as the wild-type. In addition, it has previously been
shown that secreted proteases can cleave human α1-proteinase inhibitor (Potempa et al.,
1986), α1-antichymotrypsin, the heavy chains of all human immunoglobulin classes
(Prokesova et al., 1992), elastin (Potempa et al., 1988), fibrinogen, fibronectin, high
molecular weight kinininigen and plasminogen (Massimi et al., 2002; Imamura et al
2005); each of which contribute to invasion and pathogenesis. It has previously been
shown that aureolysin cleaves the human cathelicidin AMP, LL-37, and we demonstrate
here that the cleavage of AMPs is not specific to LL-37, but also includes indolicidin and
histatin-5 (Sieprawska-Lupa et al., 2004). AMPs function as part of the host innate
immune system, and this suggests that proteases aid S. aureus in immune evasion by
degrading these elements. To further investigate the effects proteases on components of
host immunity, survival in whole human blood and serum was evaluated for the proteasenull strain. In both situations, the protease-null strain displayed decreased survivability
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when compared to the wild-type. Serum contains complement and AMPs, while whole
human blood also contains cellular components of immunity. The observed decreases in
survivability may result from a lack of AMP and complement system degradation by the
proteases. However, this also suggests that secreted proteases are not only used for
protection against the innate immune system, but also impacts evasion of cell mediated
immunity. This finding is support by previous work from a number of groups that show
secreted proteases play a protective role during S. aureus infection, vis the cleavage of
host factors (Smagur et al., 2009a; Smagur et al., 2009b; Wegrzynowicz et al., 1980).
Therefore, the lack of proteolysis in the mutant strain of host factors including
complement, AMPs and components of innate immune system may explain the observed
decrease in bacterial loads found in the organs and abscesses. Our study suggests that
extracellular proteases are not only virulence factors themselves, but also contribute to
pathogenesis by cleavage of S. aureus surface-associated and secreted proteins.
Collectively this provides insight into the role of secreted proteases on the virulence
process by regulating the stability of S. aureus virulence factors and cleavage of host
immune elements.
Future Directions
While some progress in understanding the role of NsaRS has been made, elucidating its
mechanism of action within the cell-envelope stress response will lead to a clearer
understanding of its function within the cell. We show that NsaRS regulates
SACOL2525/2526 and NsaAB in response to certain cell-envelope targeting drugs,
however it is not the only regulator, as transcription of these elements in the nsaS mutant
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does not completely revert to wild-type levels. Therefore it is possible that NsaR may be
able to utilize other phospho-donors in the absence of NsaS, which may account for the
transcription of SACOL2525/2526 and NsaAB in the absence of NsaS. To determine if
this is the case, NsaR could be purified, incubated with acetyl [P32] phosphate, and if
phosphorylation occurs in the presence of this phospho-donor, it could be visualized by
SDS-PAGE and Western blotting. In addition, the response regulator could be isolated
from wild-type or nsaS mutant cells via an incorporated affinity tag after exposure to
various growth conditions. The phosphorylation state could then be identified using
mass-spectrometry to determine if the response regulator is phosphorylated by its cognate
histidine kinase, or another phospho-donor under specific conditions. We have suggested
that the alteration in membrane fluidity caused by SACOL2525/2526 may impact the
phosphorylation status of IM-HKs, including NsaRS. To determine if this is the case, the
phosphorylation state of NsaRS or GraRS could be determined in the SACOL2525/2526
mutant using a similar mass-spectrometry protocol. In addition, a nsaAB mutant could be
constructed and the impact of this possible signal transporter on NsaRS and GraRS may
be evaluated using the same method. We show that in the presence of nisin, NsaRS
regulates NsaAB, yet the role of NsaAB in resistance to nisin and other antibiotics
remains unknown. Therefore, characterization of a nsaAB mutant may reveal its
contribution to membrane-targeting antibiotic resistance, as well as the function of
NsaRS. The sensitivity of a NsaAB mutant to cell membrane damaging agents may
reveal whether it acts as a specific signaling sensor to just bacitracin and nisin, or if its
function is more broad in spectrum, and aids NsaRS in resistance to various antibiotics.
Such sensitivity could be evaluated utilizing MIC assays, death curves, growth curves
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and spontaneous mutation frequency assays. In addition, the mutant was shown to have
increased capsule production and a more diffuse cell wall, which may impact the ability
to disseminate in a host. By conducting systemic models of infection, the contribution of
NsaRS in dissemination and tissue invasion may be elucidated, and provide new insights
into S. aureus pathogenicity. In addition, analyzing nsaS mutant cell wall may provide a
better understanding of the function of NsaRS and the genes it regulates. This can be
accomplished by muropeptide analysis using liquid chromatography and mass
spectrometry, and will not only determine any differences in muropeptide composition,
but also O-acetylation of the peptidoglycan layer.
The membrane of the SACOL2525/2526 mutant seems to have decreased fluidity based
on our findings herein. To determine the contribution of SACOL2525/2526 to membrane
fluidity, the composition of SACOL2525/2526 mutant membrane should be compared to
that of the wild-type. This could be determined by lipidomics, where lipids are extracted
from the membranes of each strain, and, using mass spectrometery, the composition of
fatty acids determined. One may expect the mutant membrane to contain more saturated
fatty acids, as these do not contain double bonds and decrease membrane fluidity. This
alteration in membrane fluidity may impact the proton potential of the cell, and hence
may change the activity of transporters. An alteration of the proton potential may be the
reason why a difference in survivability of mutant protoplasts in TSB was observed,
which was reversed upon the addition of ions. To determine if this is an alteration in
proton potential, the dye carbocyanine could be incubated with the wild-type or
SACOL2525/2526 mutant cells, and allowed to cross the membrane, which is dependent
on proton potential. This dye can then be measured using fluorescence, and will
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determine if the proton potential is altered. In addition, if metabolomics was performed
on the SACOL2525/2526 mutant and the metabolite profile compared to the wild-type,
this may lead to the identification of the pathways that are being altered in the mutant
strain. It is possible that genes in fatty acid synthesis, peptidoglycan synthesis and
capsule production would displayed a change in expression, and this may give insight
into the function of SACOL2525/2526; and also the substrate transported by this system.
Since this substrate remains unknown, and SACOL2525/2526 is similar to other
lantibiotic transporters, sensitivity of the mutant should be tested in the presence of other
lantibiotics, including mersacidin and cinnamycin. Each of these should be evaluated as
they belong to the type B class of lantibiotics, and in this study only nisin, which is a type
A lantibiotic, was utilized. The SACOL2525/2526 mutant also possesses increased
capsule production and may have decreased membrane fluidity, which may be important
in the virulence process. Therefore, evaluation of survival and dissemination of the wildtype and SACOL2525/2526 mutant strains in a systemic model of infection may give
insight into whether these attributes contribute to the success of S. aureus as a pathogen.
We have shown that secreted proteases are key virulence factors, and contribute to the
pathogenicity of S. aureus in multiple ways. One significant aspect of our study was the
identification of S. aureus surface-associated and secreted proteins that are modulated by
cleavage via secreted proteases. These studies were performed by growing the cells in
TSB, and it may be possible that when S. aureus is in a host, different secreted and
surface-associated proteins are expressed. Therefore, by growing the cells in human
blood or serum, followed by the same proteomics approached already performed herein,
other protein targets of these enzymes may be identified. While this demonstrates two
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types of proteins cleaved by proteases, surface-associated and secreted, another important
factor to pathogenicity is the interaction of S. aureus with its host. If a complete list of
host proteins cleaved by secreted proteases were produced, a better understanding of the
S. aureus-host interaction would result, and possibly give insight into future therapeutics.
Components of the host immune system that are cleaved by S. aureus secreted proteases
may be identified by growing the wild-type and protease-null mutant cells in whole
human blood, removing cellular components, and performing proteomics on the host
proteins in a similar fashion detailed in this work. It would be important to identify not
only substrates of the secreted proteases, but also the site of cleavage, as this may reveal
the molecular mechanism of specificity and signaling. The cleavage sites of the secreted
proteases may be identified using N-terminomics. This procedure tags the N-terminus of
proteins, separates the peptides containing the tag, which can then be identified using
mass spectrometry. While we demonstrate that a strain inactive in all 10 major secreted
proteases displays an abundance of virulence factors from the lack of proteolytic activity,
the contribution of individual proteases still remains unclear. As such, proteomics should
be performed on single mutations to determine if each secreted protease has specificity
for certain proteins. Finally, secreted proteases have been shown to be expressed at
different levels between the USA lineage strains, and their contribution may vary
depending on the isolate. Therefore, mutants lacking all 10 major secreted proteases
could be constructed in different backgrounds to determine if they are utilized in the
infection process globally, by performing systemic models of infections. However, each
strain has a preference for the infection site, and therefore these newly constructed
strains, along with the LAC protease null mutant, should be tested in a variety of
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systemic infection models, including

endocarditis model and osteomyelitis models.

Further to this, the cytolytic effect of mutant strains on neutrophils from humans, mice,
rabbits and monkeys should be evaluated to determine the effect of secreted proteases on
host specificity and virulence between the lineages.
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